10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

FORM 10-Q

☒  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

or

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the transition period from _________ to ________

Commission File Number:  001-36615

GWG HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware	26-2222607
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

220 South Sixth Street, Suite 1200

Minneapolis, MN  55402

(Address of principal executive offices, including zip code)

(612) 746-1944

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☒ Yes   ☐  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  ☐ Yes    ☐  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes    ☒ No

As of November 12, 2015, GWG Holdings, Inc. had 5,941,790 shares of common stock outstanding.

GWG HOLDINGS, INC.

Index to Form 10-Q

for the Quarter Ended September 30, 2015

		Page No.
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets as of September 30, 2015, and December 31, 2014	3
	Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2015 and 2014	4
	Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2015 and 2014	5
	Condensed Consolidated Statement of Stockholders’ Equity	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
Item 4.	Controls and Procedures	56
PART II.	OTHER INFORMATION
Item 6.	Exhibits	58
SIGNATURES		59

2

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2015			December 31, 2014
	(unaudited)
A S S E T S
Cash and cash equivalents	$	28,452,673		$	30,662,704
Restricted cash		7,271,560			4,296,053
Policy benefits receivable		357,014			1,750,000
Investment in life settlements, at fair value		329,562,250			282,883,010
Other assets		5,882,723			3,478,762
TOTAL ASSETS	$	371,526,220		$	323,070,529
L I A B I L I T I E S  &  S T O C K H O L D E R S’  E Q U I T Y
LIABILITIES
Revolving credit facility	$	65,011,048		$	72,161,048
Series I Secured Notes		23,566,913			27,616,578
L Bonds		243,126,585			182,782,884
Interest payable		11,377,385			11,128,519
Accounts payable and accrued expenses		3,063,995			1,718,009
Deferred taxes, net		4,608,650			5,273,555
TOTAL LIABILITIES		350,754,576			300,680,593
STOCKHOLDERS’ EQUITY
CONVERTIBLE PREFERRED STOCK
(par value $0.001; shares authorized 40,000,000; shares outstanding 2,756,549 and 2,738,966; liquidation preference of $20,674,000 and $20,542,000, respectively)		20,623,541			20,527,866
COMMON STOCK
Common stock (par value $0.001: shares authorized 210,000,000; shares issued and outstanding is 5,941,790 and 5,870,193 on September 30, 2015 and December 31, 2014, respectively)		5,942			5,870
Additional paid-in capital		17,163,249			16,257,686
Accumulated deficit		(17,021,088	)		(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		20,771,644			22,389,936
TOTAL LIABILITIES & EQUITY	$	371,526,220		$	323,070,529

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

3

 GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	Three Months Ended						Nine Months Ended
	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
REVENUE
Gain on life settlements, net	$	8,189,261		$	5,118,423		$	33,446,556		$	16,119,517
Interest and other income		93,841			10,229			233,516			23,975
TOTAL REVENUE		8,283,102			5,128,652			33,680,072			16,143,492
EXPENSES
Employee compensation and benefits		2,308,246			1,376,710			6,180,886			3,524,274
Legal and professional fees		822,077			760,130			1,988,261			1,627,769
Interest expense		8,650,149			6,796,736			23,149,030			19,731,327
Other expenses		2,231,341			1,453,367			5,646,402			3,277,850
TOTAL EXPENSES		14,011,813			10,386,943			36,964,579			28,161,220
LOSS BEFORE INCOME TAXES		(5,728,711	)		(5,258,291	)		(3,284,507	)		(12,017,728	)
INCOME TAX BENEFIT		(2,097,633	)		(1,858,100	)		(664,905	)		(4,129,670	)
NET LOSS	$	(3,631,078	)	$	(3,400,191	)	$	(2,619,602	)	$	(7,888,058	)
(Income) loss attributable to preferred shareholders		343,644			(117,674	)		1,041,648			(344,658	)
LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$	(3,287,434	)	$	(3,517,865	)	$	(1,577,954	)	$	(8,232,716	)
NET LOSS PER SHARE
Basic	$	(0.55	)	$	(0.76	)	$	(0.27	)	$	(1.80	)
Diluted	$	(0.55	)	$	(0.76	)	$	(0.27	)	$	(1.80	)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic		5,937,320			4,633,097			5,894,956			4,579,920
Diluted		5,937,320			4,633,097			5,894,956			4,579,920

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

4

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited)

	Three Months Ended						Nine Months Ended
	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(3,631,078	)	$	(3,400,191	)	$	(2,619,602	)	$	(7,888,058	)
Adjustments to reconcile net loss to net cash flows from operating activities:
Gain on life settlements		(14,516,881	)		(8,761,912	)		(26,651,363	)		(30,973,250	)
Amortization of deferred financing and issuance costs		1,933,776			863,217			1,891,772			2,570,881
Deferred income taxes		(1,916,686	)		(1,858,100	)		(664,905	)		(4,129,670	)
Convertible, redeemable preferred stock dividends payable		173,993			186,182			509,225			575,513
(Increase) decrease in operating assets:
Policy benefits receivable		2,142,986			300,000			1,392,986			-
Other assets		(417,990	)		(1,147,221	)		(774,539	)		(2,096,140	)
Increase in operating liabilities:
Accounts payable and accrued expenses		2,534,269			490,496			3,836,715			3,658,659
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(13,697,611	)		(13,327,529	)		(23,079,711	)		(38,282,065	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		(13,626,842	)		(680,000	)		(23,850,860	)		(11,559,435	)
Proceeds from settlement of life settlements		80,000			930,625			3,822,983			999,125
NET CASH FLOWS USED IN INVESTING ACTIVITIES		(13,546,842	)		250,625			(20,027,877	)		(10,560,310	)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility		-			-			(7,150,000	)		-
Payments for redemption of Series I Secured Notes		(890,586	)		(509,004	)		(4,508,130	)		(2,047,928	)
Proceeds from issuance of L Bonds		37,122,127			15,281,809			87,620,483			48,516,296
Payments for redemption and issuance of L Bonds		(19,363,047	)		(4,494,383	)		(32,376,104	)		(13,816,794	)
Proceeds (payments) from restricted cash		651,630			665,699			(2,975,507	)		3,688,236
Issuance of common stock		-			9,030,000			582,000			9,030,000
Payments for redemption of preferred stock		(21,187	)		(445,183	)		(295,185	)		(465,239	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		17,498,937			19,528,938			40,897,557			44,904,571
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(9,745,516	)		6,452,034			(2,210,031	)		(3,937,804	)
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD		38,198,189			23,059,955			30,662,704			33,449,793
END OF PERIOD	$	28,452,673		$	29,511,989		$	28,452,673		$	29,511,989

 The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

5

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS – CONTINUED

(unaudited)

	Three Months Ended				Nine Months Ended
	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	5,385,000	$	5,095,000	$	18,529,000	$	12,877,000
Premiums paid	$	6,603,000	$	5,692,000	$	19,069,000	$	17,059,000
Stock-based compensation	$	176,000	$	44,000	$	208,000	$	116,000
NON-CASH INVESTING AND FINANCING ACTIVITIES
Series I Secured Notes:
Conversion of accrued interest and commissions payable to principal	$	61,000	$	47,000	$	188,000	$	152,000
L Bonds:
Conversion of accrued interest and commission payable to principal	$	491,000	$	133,000	$	929,000	$	415,000
Convertible, redeemable preferred stock
Conversion to common stock	$	87,000	$	4,957,000	$	116,000	$	4,957,000
Conversion of dividends payable	$	172,000	$	192,000	$	507,000	$	573,000
Accretion of convertible, redeemable preferred stock to redemption value	$	-	$	118,000	$	-	$	345,000
Investment in life settlements included in accounts payable	$	559,000	$	-	$	559,000	$	-

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

6

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

	Preferred Stock			Preferred			Common		Common Stock		Additional Paid-in			Accumulated			Total
	Shares			Stock			Shares		(par)		Capital			Deficit			Equity
Balance, December 31, 2013		-		$	-			4,562,000	$	4,562	$	2,942,000		$	(8,438,577	)	$	(5,492,015	)
Net loss		-			-			-		-		-			(5,962,909	)		(5,962,909	)
Issuance of common stock		-			-			800,000		800		8,642,990			-			8,643,790
Series A Preferred Stock conversion		-			-			508,193		508		4,956,591			-			4,957,099
Reclassification of preferred stock from temporary equity to permanent equity due to initial public offering (*)		2,710,214			20,326,605			-		-		-			-			20,326,605
Issuance of preferred stock		28,752			201,261			-		-		-			-			201,261
Issuance of stock options		-			-			-		-		122,412			-			122,412
Extension of warrants		-			-			-		-		47,120			-			47,120
Accretion of preferred stock to liquidation value		-			-			-		-		(453,427	)		-			(453,427	)
Balance, December 31, 2014		2,738,966		$	20,527,866			5,870,193	$	5,870	$	16,257,686		$	(14,401,486	)	$	22,389,936
Net income															(2,619,602	)		(2,619,602	)
Issuance of common stock		-			-			60,000		60		581,940			-			582,000
Series A Preferred Stock conversion to common stock		(15,463	)		(115,973	)		11,597		12		115,961			-			-
Issuance of preferred stock		33,046			211,648			-		-		-			-			211,648
Issuance of stock options		-			-			-		-		207,662			-			207,662
Balance, September 30, 2015		2,756,549		$	20,623,541			5,941,790	$	5,942	$	17,163,249		$	(17,021,088	)	$	20,771,644

* Subject to the terms of the Certificate of Designation for Series A Convertible Preferred Stock, the listing of our common stock on The Nasdaq Capital Market on September 25, 2014 resulted in the termination of a redemption right in favor of the holders of such preferred stock. Preferred stock that is not redeemable by a stockholder is treated as stockholders’ equity as shown in the table above.

 The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

7

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(1) Nature of business and summary of significant accounting policies

Nature of business - GWG Holdings, Inc. (GWG Holdings) and subsidiaries, located in Minneapolis, Minnesota, purchases life insurance policies for its own investment portfolio through its wholly owned subsidiaries, GWG Life, LLC (GWG Life) and GWG Life USA, LLC (GWG Life USA), and GWG Life’s own subsidiaries, GWG Trust (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II), and GWG DLP Funding III, LLC (DLP III). All of these entities are legally organized in Delaware. Unless the context otherwise requires or we specifically so indicate, all references in this report to "we", "us", "our", "our Company", "GWG", or the "Company" refer to these entities collectively. References to particular entities, such as “GWG Holdings” or “GWG Life”, are meant to refer only to the particular entity referenced.

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1) the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Cash and cash equivalents - The Company considers cash in demand deposit accounts and temporary investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains its cash and cash equivalents with highly rated financial institutions. From time to time, the Company’s balances in its bank accounts exceed Federal Deposit Insurance Corporation limits. The Company periodically evaluates the risk of exceeding insured levels and may transfer funds as it deems appropriate. The Company has not experienced any losses with regards to balances in excess of insured limits or as a result of other concentrations of credit risk.

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1)	Receipt of death notice or verified obituary of insured
2)	Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. In an event of a sale of a policy, the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company. Such deposits and direct cost advances were $31,000 and $27,000 at September 30, 2015 and December 31, 2014, respectively.

Deferred financing and issuance costs – Costs incurred to obtain financing under the revolving credit facility, as described in note 5, have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. Amortization of deferred financing costs was $457,000 and $89,000 for the three-month periods ended September 30, 2015 and 2014, and $757,000 and $268,000 for the nine-month periods ended September 30, 2015 and 2014, respectively. Future amortization is expected to be $1,096,000 for the next seven months ending April 30, 2016.  The Series I Secured Notes, as described in note 6, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock, as described in note 8, was also reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which were amortized into additional paid-in-capital over the three-year redemption period. As of December 31, 2014, all of these costs had been fully amortized.

8

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Earnings (loss) per share - Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period. Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock, and outstanding warrants, and stock options.

Subsequent events - Subsequent events are events or transactions that occur after the balance sheet date but before consolidated financial statements are issued. The Company recognizes in the consolidated financial statements the effects of all subsequent events that provide additional evidence about conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing the consolidated financial statements. The Company’s consolidated financial statements do not recognize subsequent events that provide evidence about conditions that did not exist at the date of the balance sheet but arose after the balance sheet date and before the consolidated financial statements are available to be issued. The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are filed for potential recognition or disclosure.

Recently adopted pronouncements - On April 7, 2015 the FASB issued Accounting Standards Update (ASU) No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs,” as part of its simplification initiative. The ASU changes the presentation of debt issuance costs in financial statements. Under the ASU, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. For public business entities, the guidance in the ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. For entities other than public business entities, the guidance is effective for fiscal years beginning after December 15, 2015, and interim periods beginning after December 15, 2016. Early adoption is allowed for all entities for financial statements that have not been previously issued. Entities would apply the new guidance retrospectively to all prior periods (i.e., the balance sheet for each period is adjusted). The impact of the new ASU on the Company’s balance sheet would be a reduction of approximately $3,195,000 to assets and a corresponding reduction to liabilities. There would be no impact on the Company’s statements of operations.

(2) Restrictions on cash

The Company is required by its lenders to maintain collection and escrow accounts. These accounts are used to fund the acquisition, pay annual premiums of insurance policies, pay interest and other charges under the revolving credit facility, and collect policy benefits. DZ Bank AG, as agent for Autobahn Funding Company, LLC, the lender for the revolving credit facility as described in note 5, authorizes the disbursements from these accounts. At September 30, 2015 and December 31, 2014, there was a balance of $7,272,000, and $4,296,000, respectively, maintained in these restricted cash accounts.

(3) Investment in life insurance policies

The life insurance policies (Level 3 fair value measurements) are valued based on unobservable inputs that are significant to the overall fair value measurement. Changes in the fair value of these instruments are recorded in gain or loss on life insurance policies in the consolidated statements of operations (net of the cash premiums paid on the policies). The fair value is determined on a discounted cash flow basis that incorporates life expectancy assumptions.  Life expectancy reports have been obtained from widely accepted life expectancy providers. The discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed in the secondary market, market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies. As a result of management’s analysis, discount rates of 11.07% and 11.43% were applied to the portfolio as of September 30, 2015 and December 31, 2014, respectively.

9

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

A summary of the Company’s life insurance policies accounted for under the fair value method and their estimated maturity dates, based on remaining life expectancy is as follows:

	As of September 30, 2015						As of December 31, 2014
Years Ending December 31,	Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2015		-	$	-	$	-		3	$	5,063,000	$	6,000,000
2016		5		7,399,000		8,500,000		7		8,144,000		11,550,000
2017		14		14,484,000		19,557,000		17		21,916,000		35,542,000
2018		26		39,188,000		63,114,000		30		41,994,000		76,206,000
2019		50		55,126,000		109,625,000		45		47,303,000		106,973,000
2020		47		52,173,000		111,187,000		41		43,429,000		102,614,000
2021		51		47,957,000		129,006,000		36		29,789,000		90,921,000
Thereafter		150		113,235,000		437,893,000		112		85,245,000		349,293,000
Totals		343		329,562,000		878,882,000		291	$	282,883,000	$	779,099,000

The Company realized policy benefits of $357,000 and $3,000,000 during the three-month periods ended September 30, 2015 and 2014, respectively, related to policies with a carrying value of $80,000 and $931,000, respectively. The Company recorded realized gains of $277,000 and $2,069,000 on such policies. The Company recognized policy benefits of $29,732,000 and $3,300,000 during the nine-month periods ended September 30, 2015 and 2014, respectively, related to policies with a carrying value of $3,823,000 and $999,000, respectively.  The Company recorded realized gains of $25,909,000 and $2,301,000, respectively on such policies. Subsequent to September 30, 2015, one policy with insurance benefits of $1,500,000 has matured.

Reconciliation of gain on life settlements:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Change in fair value	$	14,517,000		$	8,762,000		$	26,651,000		$	30,973,000
Premiums and other annual fees		(6,605,000	)		(5,713,000	)		(19,114,000	)		(17,155,000	)
Policy maturities		277,000			2,069,000			25,909,000			2,301,000
Gain on life settlements, net	$	8,189,000		$	5,118,000		$	33,446,000		$	16,119,000

The estimated expected premium payments to maintain the above life insurance policies in force through 2020, assuming no policy maturities, are as follows:

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Three months ending December 31, 2015	$	7,315,000	$	412,000	$	7,727,000
2016		30,433,000		412,000		30,845,000
2017		33,390,000		412,000		33,802,000
2018		36,241,000		412,000		36,653,000
2019		40,520,000		412,000		40,932,000
2020		45,023,000		412,000		45,435,000
	$	192,922,000	$	2,472,000	$	195,394,000

Management anticipates funding the estimated premium payments as noted above with proceeds from the DZ Bank revolving credit facility and through additional debt and equity financing as well as from cash proceeds from maturities of life insurance policies. The proceeds of these capital sources are also intended to be used for the purchase, financing, and maintenance of additional life insurance policies among other things.

10

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(4) Fair value definition and hierarchy

ASC 820 establishes a hierarchal disclosure framework that prioritizes and ranks the level of market price observability used in measuring assets and liabilities at fair value. Market price observability is affected by a number of factors, including the type of investment, the characteristics specific to the investment and the state of the marketplace including the existence and transparency of transactions between market participants. Assets and liabilities with readily available active quoted prices or for which fair value can be measured from actively quoted prices in an orderly market generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. ASC 820 establishes a three-level valuation hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The hierarchy is broken down into three levels based on the observability of inputs as follows:

● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

● Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary by types of assets and liabilities and is affected by a wide variety of factors, including, for example, whether an instrument is established in the marketplace, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for assets and liabilities categorized in Level 3.

Level 3 Valuation Process

The estimated fair value of the Company’s life settlements are determined on a quarterly basis by the Company’s portfolio management committee, taking into consideration estimated premium payments, life expectancy assumptions, any changes in economic and other relevant conditions, and discount rate assumptions. The discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed in the secondary market, market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies. These inputs are then used to estimate the discounted cash flows using the MAPS probabilistic portfolio pricing model, which estimates the cash flows using various different probabilities and scenarios.  The valuation process includes a review by senior management as of each valuation date.  Management also engages a third party expert to independently test the accuracy of the valuations using the inputs provided by management.

Life insurance policies represent financial instruments recorded at fair value on a recurring basis. The following table reconciles the beginning and ending fair value of the Company’s Level 3 investments in life insurance policies for the three and nine-month periods ending September 30:

	Three month ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Beginning balance	$	301,499,000		$	267,896,000		$	282,883,000		$	234,673,000
Purchases		13,626,000			655,000			23,851,000			11,735,000
Maturities (cash in excess of carrying value)		(80,000	)		(931,000	)		(3,823,000	)		(999,000	)
Net change in fair value		14,517,000			8,762,000			26,651,000			30,973,000
Ending balance (September 30)	$	329,562,000		$	276,382,000		$	329,562,000		$	276,382,000

The fair value of a portfolio of life insurance policies is based on information available to the Company at the reporting date. Fair value is based upon a discounted cash flow model that incorporates life expectancy estimate assumptions. Life expectancy estimates are obtained from independent, third-party, widely accepted life expectancy estimate providers at policy acquisition. These life expectancy values are rolled down monthly through the passage of time by the MAPS actuarial software the Company uses for ongoing valuation of its portfolio of life insurance policies.

11

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

On September 15, 2014, 21st Services announced changes to its mortality tables primarily for insureds age 90 and older, as well as updated adjustment factors designed to better underwrite seniors with multiple impairments. These changes represent small portions of 21st Services’ historical underwritings. We expect medical-actuarial underwriting firms to continue improving and refining their underwriting methodology.

The fair value of life insurance policies is estimated using present value calculations of estimated cash flows based on the data specific to each individual life insurance policy. Estimated future policy premium payments are calculated based on the terms of the policy and the premium payment history. The following summarizes the unobservable inputs utilized in estimating the fair value of the portfolio of life insurance policies:

	As of September 30, 2015			As of December 31, 2014
Weighted average age of insured, years		82.6			82.8
Weighted average life expectancy, months		79.2			78.4
Average face amount per policy	$	2,562,000		$	2,677,000
Discount rate		11.07	%		11.43	%

These assumptions are, by their nature, inherently uncertain and the effect of changes in estimates may be significant. The techniques used in estimating the present value of estimated cash flows are derived from valuation techniques generally used in the industry that include inputs for the asset that are not based on observable market data. The extent to which the fair value could reasonably vary in the near term has been quantified by evaluating the effect of changes in significant underlying assumptions used to estimate the fair value. If the life expectancy estimates were increased or decreased by four and eight months on each outstanding policy and the discount rates were increased or decreased by 1% and 2%, while all other variables are held constant, the fair value of the investment in life insurance policies would increase or (decrease) by the amounts summarized below:

	Change in life expectancy estimates
	minus 8 months		minus 4 months		plus 4 months			plus 8 months
September 30, 2015	$	44,959,000	$	22,384,000	$	(21,842,000	)	$	(43,190,000	)
December 31, 2014	$	40,634,000	$	20,130,000	$	(19,664,000	)	$	(38,864,000	)

	Change in discount rate
	minus 2%		minus 1%		plus 1%			plus 2%
September 30, 2015	$	32,445,000	$	15,551,000	$	(14,348,000	)	$	(27,614,000	)
December 31, 2014	$	28,179,000	$	13,522,000	$	(12,502,000	)	$	(24,085,000	)

Other Fair Value Considerations

Carrying value of receivables, prepaid expenses, accounts payable and accrued expenses approximate fair value due to their short-term maturities and low credit risk. The estimated fair value of the Company’s Series I Secured Notes and L Bonds is approximately $273,507,000 based on a weighted-average market interest rate of 7.06% based on an income approach. The combined face value of these debt instruments is $271,471,000 as of September 30, 2015. The carrying value of the revolving credit facility reflects interest charged at the commercial paper rate plus an applicable margin. The margin represents our credit risk, and the strength of the portfolio of life insurance policies collateralizing the debt. The overall rate reflects market, and the carrying value of the revolving credit facility approximates fair value. All of the financial instruments are Level 3 fair value measurements.

12

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The Company has issued warrants to purchase common stock in connection with the issuance of its convertible, redeemable preferred stock. Warrants were determined by the Company to be permanent equity. The fair value measurements associated with the warrants, measured at issuance represent level 3 instruments.

As of September 30, 2015:

Month issued	Warrants issued		Fair value per share		Risk free rate			Volatility			Term
December 2011		68,937	$	0.22		0.42	%		25.25	%	5 years
March 2012		38,130	$	0.52		0.38	%		36.20	%	5 years
June 2012		161,840	$	1.16		0.41	%		47.36	%	5 years
July 2012		144,547	$	1.16		0.41	%		47.36	%	5 years
September 2012		2,500	$	0.72		0.31	%		40.49	%	5 years
September 2014		16,000	$	1.26		1.85	%		17.03	%	5 years
		431,954

Volatility is based upon the weekly percentage change in the stock price of selected comparable insurance companies. The percentage change is calculated on the average price of those selected stocks at the weekly close of business for the year preceding the balance sheet date. We compare annual volatility based on this weekly information.

(5) Credit facilities

Revolving credit facility – Autobahn Funding Company LLC

On July 15, 2008, DLP II and United Lending entered into a revolving credit facility pursuant to a Credit and Security Agreement (Agreement) with Autobahn Funding Company LLC (Autobahn), providing the Company with a maximum borrowing amount of $100,000,000. Autobahn is a commercial paper conduit that issues commercial paper to investors in order to provide funding to DLP II. DZ Bank AG Deutsche Zentral-Genossenschaftsbank (DZ Bank) acts as the agent for Autobahn. The original Agreement was to expire on July 15, 2013. On January 29, 2013, GWG Holdings, together with GWG Life and DLP II, entered into an Amended and Restated Credit and Security Agreement with Autobahn, extending the facility expiration date to December 31, 2014. On May 29, 2014, GWG Holdings, together with GWG Life and DLP II, entered into an Amendment No. 1 to Amended and Restated Credit and Security Agreement with Autobahn and DZ Bank (as committed lender and Agent). The amendment was entered into for the purpose of extending the maturity date for borrowings under the Agreement to December 31, 2016. Effective May 11, 2015, GWG Holdings, together with certain of its subsidiaries, entered into a Second Amended and Restated Credit and Security Agreement with Autobahn and DZ Bank. The Second Amended and Restated Credit and Security Agreement extends the maturity date of borrowings, under the credit facility to June 30, 2018. Advances under the credit facility made after May 11, 2015 will bear interest at the commercial paper rate of the lender at the time of the advance plus an applicable margin, which is less than under the previous Credit and Security Agreement executed on January 25, 2013. In addition to the extended term and decreased interest rate and borrowing cost, the Second Amended and Restated Credit and Security Agreement removes the requirement that the Company maintain a reserve for certain projected expenditures (including anticipated premium payments required to service its life insurance portfolio), thereby allowing for the Company’s full use of the credit facility up to its limit of $105,000,000.

In connection with the Second Amended and Restated Credit and Security Agreement, GWG Holdings and its subsidiaries entered into certain other agreements and amendments and restatements of earlier agreements entered into in connection with the original and renewal Credit and Security Agreements. Included among these other agreements was an Amended and Restated Performance Guaranty affirming the performance guaranty that GWG Holdings earlier provided in connection with the original and first Amended and Restated Credit and Security Agreements to DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as agent.The amount outstanding under this facility was $65,011,000 and $72,161,000 at September 30, 2015 and December 31, 2014, respectively.

The Agreement requires DLP II to pay, on a monthly basis, interest at the commercial paper rate plus an applicable margin, as defined in the Agreement. The effective rate was 5.43% at September 30, 2015 and 6.24% at December 31, 2014. The Agreement also requires payment of an unused line fee on the unfunded amount under the revolving credit facility. The weighted-average effective interest rate (excluding the unused line fee) was 5.42% and 6.23% for the three months ended September 30, 2015 and 2014, respectively, and 5.81% and 6.22% for the nine months ended September 30, 2015 and 2014, respectively. The note is secured by substantially all of DLP II’s and DLP III’s assets, which consist primarily of life insurance policies.

13

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The Agreement has certain financial and nonfinancial covenants. The Company was in compliance with these covenants at September 30, 2015 and December 31, 2014. The Agreement generally prohibits the Company from:

● changing its corporate name, offices, and jurisdiction of incorporation

● changing any deposit accounts or payment instructions to insurers;

● changing any operating policies and practices such that it would be reasonably likely to adversely affect the collectability of any asset in any material respect;

● merging or consolidating with, or selling all or substantially all of its assets to, any third party;

● selling any collateral or creating or permitting to exist any adverse claim upon any collateral;

● engaging in any other business or activity than that contemplated by the Agreement;

● incurring or guaranteeing any debt for borrowed money;

● amending the Company’s certificate of incorporation or bylaws, making any loans or advances to, investments in, or paying any dividends to, any person unless both before and after any such loan, advance, investment or dividend there exists no actual event of default, potential event of default or termination event;

● removing an independent director on the board of directors except for cause or with the consent of the lender; or

● making payment on or issuing any subsidiary secured notes or debentures, or amending any agreements respecting such notes or debentures, if an event of default, potential event of default or termination event exists or would arise from any such action.

In addition, the Company has agreed to maintain (i) a positive consolidated net income on a non-GAAP basis (as defined and calculated under the Agreement) for each complete fiscal year and (ii) a tangible net worth on a non-GAAP basis (again, as defined and calculated under the Agreement) of not less than $45 million, and (iii) maintain cash and eligible investments at $15 million or above.

Consolidated tangible net worth and net income as of and for the four quarters ended September 30, 2015, as calculated on non-GAAP basis under the Agreement, were $105,605,000 and $41,998,000, respectively.

Advances under the Agreement are subject to a borrowing base formula, which limits the availability of advances on the borrowing base calculation based on attributes of policies pledged to the facility. Over-concentration of policies by insurance carrier, over-concentration of policies by insurance carriers with ratings below a AA- rating, and the premiums and facility fees reserve are the three primary factors with the potential of limiting availability of funds on the facility. Total funds available for additional borrowings under the borrowing base formula criteria at September 30, 2015 and December 31, 2014, were $55,648,000 and $20,585,000 respectively.

On July 15, 2008, GWG Holdings delivered a performance guaranty in favor of Autobahn pursuant to which it guaranteed the obligations of GWG Life, in its capacity as the seller and master servicer, under the Credit and Security Agreement and related documents. On January 29, 2014 and in connection with the Amended and Restated Credit and Security Agreement, GWG Holdings delivered a reaffirmation of its performance guaranty. The obligations of GWG Holdings under the performance guaranty and subsequent reaffirmation do not extend to the principal and interest owed by DLP II and DLP III as the borrower under the credit facility.

(6) Series I Secured Notes

Series I Secured Notes are secured by assets of GWG Life and are subordinate to our revolving credit facility (see note 5). On June 14, 2011, the Company closed the offering to additional investors; however, existing investors may elect to continue advancing amounts outstanding upon maturity subject to the Company’s option to repay such notes. Series I Secured Notes have maturity dates ranging from nine months to seven years with fixed interest rates varying from 5.65% to 9.55% depending on the term of the note. Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note. At September 30, 2015 and December 31, 2014, the weighted-average interest rate of Series I Secured Notes was 8.47% and 8.37%, respectively. The notes are secured by the assets of GWG Life. The principal amount outstanding under these Series I Secured Notes was $23,918,000 and $28,047,000 at September 30, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the Series I Secured Notes and the carrying amount on the consolidated balance sheet is due to netting of unamortized deferred issuance costs. Overall, interest expense includes amortization of deferred financing and issuance costs of $49,000 and $260,000 for the three and nine months ended September 30, 2015, respectively, and $126,000 and $427,000 for the three and nine months ended September 30, 2014, respectively. Future expected amortization of deferred financing costs is $351,000 over the next six years.

14

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Future contractual maturities of Series I Secured Notes and future amortization of their deferred financing costs at September 30, 2015 are as follows:

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Three months ending December 31, 2015	$	1,776,000	$	8,000
2016		12,827,000		103,000
2017		6,154,000		129,000
2018		998,000		28,000
2019		347,000		7,000
Thereafter		1,816,000		76,000
	$	23,918,000	$	351,000

(7) L Bonds (formerly Renewable Secured Debentures)

In January 2015, we registered a $1.0 billion debt offering of our L Bonds with the SEC. The $1.0 billion L Bond offering is a follow-on to our $250.0 million debt offering of Renewable Secured Debentures (subsequently renamed L Bonds) which was registered with the SEC in January of 2012 and completed in January 2015. The Company is offering L Bonds on a continuous basis and there is no minimum amount that must be sold before the Company can use proceeds from the sale of L Bonds. The L Bonds are secured by the assets of GWG Holdings and GWG Life and are subordinate to our revolving credit facility (see note 5). L Bonds have maturity dates ranging from six months to seven years with fixed interest rates varying from 4.25% to 9.50% depending on the term of the L Bond. Interest is payable monthly, annually or at maturity depending on the terms of the L Bond. The Company plans to use the net proceeds from the offering of the L Bonds primarily to purchase and finance additional life insurance assets, and to service and retire other outstanding debt obligations. Emerson Equity LLC is serving as the managing broker-dealer for the offering, which is being sold through a network of participating dealers and licensed financial advisors and representatives in minimum increments of $25,000. At September 30, 2015 and December 31, 2014, the weighted-average interest rate of L Bonds was 7.21% and 7.45%, respectively. The amount outstanding under these L Bonds was $247,553,000 and $186,377,000 at September 30, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the L Bonds and the carrying amount on the consolidated balance sheets is due to netting of unamortized deferred issuance costs and cash receipts for new issuances in process. Amortization of deferred issuance costs was $1,892,000 and $4,232,000 for the three and nine months ended September 30, 2015, respectively, and $829,000 and $2,584,000 for the three and nine months ended September 30, 2014, respectively. Future expected amortization of deferred financing costs as of September 30, 2015 is $6,795,000 in total over the next seven years. 

The use of proceeds from the issuances of L Bonds is limited to the following: (1) payment of commissions on sales of L Bonds, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) payment of premiums on life insurance policies, (5) payment of principal and interest on L Bonds, (6) payment of portfolio operations expenses, and (7) general working capital.

15

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Future contractual maturities of L Bonds and future amortization of their deferred financing costs at September 30, 2015 are as follows:

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Three months ending December 31, 2015	$	22,691,000	$	47,000
2016		81,569,000		996,000
2017		52,228,000		1,642,000
2018		46,946,000		2,093,000
2019		13,642,000		483,000
Thereafter		30,477,000		1,534,000
	$	247,553,000	$	6,795,000

The Company entered into an Indenture effective October 19, 2011, as amended, with GWG Holdings as obligor, GWG Life as guarantor, and Bank of Utah as trustee for the benefit of the L Bond holders.  The Indenture has certain financial and nonfinancial covenants.  The Company was in compliance with these covenants at September 30, 2015 and December 31, 2014. 

(8) Convertible, redeemable preferred stock (Series A Preferred Stock)

The Company offered 3,333,333 shares of convertible redeemable preferred stock (Series A Preferred Stock) for sale to accredited investors in a private placement on July 31, 2011. The offering of Series A Preferred Stock concluded on September 2, 2012 and resulted in 3,278,000 shares being issued for gross consideration of $24,582,000. As of September 30, 2015, 349,000 shares have been issued as a result of the payment of $2,444,000 in dividends in the form of shares of Series A Preferred Stock and 693,000 shares have been converted to 520,000 shares of the Company’s common stock. The Series A Preferred Stock was sold at an offering price of $7.50 per share. Series A Preferred Stock has a preferred yield of 10% per annum, and each share has the right to convert into 0.75 shares of the Company’s common stock. Series A preferred stockholders also received three-year warrants to purchase, at an exercise price per share of $12.50, one share of common stock for every 40 shares of Series A Preferred Stock purchased. The warrants are exercisable immediately. Upon their original issuance, these warrants had a three-year exercise period. Effective August 1, 2014, the Board of Directors authorized the extension of the warrant exercise period for an additional two years.

In the Certificate of Designations for the Series A Preferred Stock dated July 31, 2011, the Company agreed to permit preferred stockholders to sell their shares back to the Company for the stated value of $7.50 per share, plus accrued dividends.

The Company’s obligation to redeem its Series A Preferred Stock terminated upon the Company completing a registration of its common stock with the SEC which occurred on September 24, 2014 (See note 11). As such, the convertible redeemable preferred stock was reclassified from temporary equity to permanent equity. The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time. As of September 30, 2015, the Company had redeemed an aggregate of 182,000 shares of Series A Preferred Stock. The Series A Preferred Stock shares (i) were convertible, at the election of the Company, into common stock of the Company in the event of either a registered offering of the Company’s common stock with the SEC aggregating gross proceeds of at least $5.0 million and at a price equal to or greater than $11.00 per share; (ii) remain convertible at the option of each holder; and (iii) are required to be converted upon the consent of stockholders holding at least a majority of the then-outstanding Series A Preferred Stock. In connection with the Company’s initial public offering, the Company elected to cause the conversion of 678,000 shares of preferred stock into 508,000 shares of common stock. As of September 30, 2015, the Company had 2,757,000 shares of Series A Preferred Stock outstanding with gross consideration of $20,624,000 (including cash proceeds, conversion of Series I Secured Notes and accrued interest on Series I, and conversion of preferred dividends payable). The Company incurred Series A Preferred Stock issuance costs of $2,838,000, which were amortized into additional paid-in-capital over the three-year redemption period. As of December 31, 2014, all of these costs had been fully amortized.

The Company determined that the grant date fair value of the outstanding warrants attached to the Series A Preferred Stock was $428,000 for warrants outstanding as of September 30, 2015. The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted-average sale price per share of common stock equals or exceeds $14.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption.

16

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Total warrants outstanding as of both September 30, 2015 and December 31, 2014, were 431,954 with a weighted-average remaining life of 1.68 and 2.43 years, respectively. As of September 30, 2015, none of these warrants have been exercised.

Dividends on the Series A Preferred Stock may be paid in either cash or additional shares of Series A Preferred Stock at the election of the holder and approval of the Company. The dividends are reported as an expense and included in the caption interest expense in the consolidated statements of operations. The Company declared and accrued dividends of $516,000 and $632,000 during the three months ended September 30, 2015 and 2014, respectively, and $1,548,000 and $1,912,000 during the nine months ended September 30, 2015 and 2014, respectively, pursuant to a board resolution declaring the dividend. 25,000 and 27,000 shares of Series A Preferred Stock were issued in lieu of cash dividends in the three-month periods ended September 30, 2015 and 2014, and 72,000 and 82,000 shares of Series A Preferred Stock were issued in lieu of cash dividends in the nine-month periods ended September 30, 2015 and 2014, respectively. The shares issued in lieu of cash dividends were issued at $7.00 per share.  As of September 30, 2015, GWG Holdings has $516,000 of accrued preferred dividends that were paid or converted to shares of Series A Preferred Stock on October 15, 2015.

(9) Redeemable Preferred Stock

The Company is offering 100,000 shares of Redeemable Preferred Stock for sale under a Form S-1 registration statement declared effective by the SEC on November 30, 2015. The per share offering price is $1,000 with a par value per share of $.001.

The Redeemable Preferred Stock ranks senior to our common stock, pari passu to our Series A Preferred Stock and senior or pari passu with all other classes and series of our preferred stock with respect to payment of dividends and rights upon liquidation dissolution or winding up. Redeemable Preferred Stock has a dividend yield of 7% per annum.

Subject to the limitations described below, holders of the Redeemable Preferred Stock will have the option to convert the Redeemable Preferred Stock they purchase from us and hold into common stock at a conversion price equal to the volume-weighted average price of our common stock for the 20 trading days immediately prior to the date of conversion, subject to a minimum conversion price of $15.00 (as the same may be adjusted). The right of holders to convert their Redeemable Preferred Stock is limited to 15% of the stated value of Redeemable Preferred Stock originally purchased by such holder from us and still held by such holder. For this purpose, shares of Redeemable Preferred Stock issued to holders in satisfaction of our dividend-payment obligations will not count as shares “originally purchased” from us.

Beginning one year from the date of original issuance of any shares of Redeemable Preferred Stock to be redeemed, a holder will have the opportunity to request once per calendar quarter that we redeem up to 25% of such holder’s Redeemable Preferred Stock originally purchased from us (plus any preferred shares issued in satisfaction of dividends thereon) at a redemption price equal to the stated value of such redeemed shares, plus any accrued but unpaid dividends thereon, less the applicable redemption fee (if any). As a percentage of the aggregate redemption price of a holder’s shares to be redeemed, the redemption fee shall be:

● 8% if the redemption is requested after the first anniversary and before the second anniversary of the original issuance of such shares.

● 5% if the redemption is requested after the second anniversary and before the third anniversary of the original issuance of such shares.

Beginning three years from the date of original issuance of such shares, no redemption fee shall be subtracted from the redemption price. Subject to certain restrictions and conditions, we will also redeem shares of Redeemable Preferred Stock of a holder who is a natural person (including an individual beneficial holder who holds our preferred shares through a custodian or nominee, such as a broker-dealer) upon his or her death, total disability or bankruptcy, within 60 days of our receipt of a written request from the holder or the holder’s estate at a redemption price equal to the Stated Value, plus accrued and unpaid dividends thereon.

17

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

After one year from the date of original issuance of shares of Redeemable Preferred Stock, we will have the right (but not the obligation) to call and redeem such shares of Redeemable Preferred Stock at 100% of their stated value, plus any accrued but unpaid dividends thereon.

We will not redeem or repurchase any preferred shares if we are restricted by applicable law or our Certificate of Incorporation, as amended, from making such redemption or to the extent any such redemption would cause or constitute a default under any borrowing agreements to which we or any of our subsidiaries are a party or otherwise bound. In addition, we will have no obligation to redeem preferred shares upon a redemption request made by a holder if we do not have sufficient funds available to fund that redemption. We will have discretion under the Certificate of Designation for the Redeemable Preferred Stock to determine whether to fund a redemption request.

(10) Income taxes

The Company has a no current income tax liability as of September 30, 2015 and December 31, 2014. The components of current and deferred income tax expense (benefit) for the three and nine months ended September 30, 2015 and income tax benefit for the three month ended September 30, 2014, consisted of the following:

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2015			2014			2015			2014
Income tax (benefit):
Current:
Federal	$	(141,000	)	$	-		$	-		$	-
State	$	(40,000	)	$	-		$	-		$	-
Total current tax benefit		(181,000	)		-			-			-
Deferred:
Federal	$	(1,488,000	)	$	(1,221,000	)	$	(504,000	)	$	(3,130,000	)
State	$	(429,000	)	$	(637,000	)	$	(161,000	)	$	(1,000,000	)
Total deferred tax benefit		(1,917,000	)		(1,858,000	)		(665,000	)		(4,130,000	)
Total income tax benefit		(2,098,000	)		(1,858,000	)		(665,000	)		(4,130,000	)

The primary differences between the Company’s September 30, 2015 effective tax rate and the statutory federal rate are the accrual of nondeductible preferred stock dividend expense of $516,000, state taxes, and other non-deductible expenses. The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

(11) Common Stock

On September 24, 2014, the Company consummated an initial public offering of its common stock that resulted in the sale of 800,000 shares of common stock at $12.50 per share. The sale resulted in net proceeds of approximately $8.6 million after the deduction of underwriting commissions, discounts and expense reimbursements. In connection with this offering, the Company listed its common stock on The NASDAQ Capital Market under the ticker symbol “GWGH” effective September 25, 2014. The Company used the net proceeds from the offering to promote and advertise the opportunities for consumers owning life insurance and investors to profit from participating in the secondary market for life insurance policies, purchase additional life insurance policies in the secondary market, pay premiums on the Company’s life insurance policy assets, fund its portfolio operations, and for working capital purposes.

Stock split — On June 24, 2014, the Company’s Board of Directors and majority stockholders approved a joint resolution to effect an amendment to the Company’s Certificate of Incorporation in the state of Delaware whereby the Company shall enact a reverse split of the common stock such that for every two (2) shares of common stock issued and outstanding immediately prior to the effective date shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) share of common stock. The effective date of the amendment and reverse stock split is June 24, 2014. In lieu of fractional shares, stockholders received cash payments in an amount equal to the fraction to which the stockholder would otherwise be entitled multiplied by the price of the common stock, as determined by the Board of Directors of the Company, but adjusted so as to give effect to the reverse stock split. The par value of the common stock remained at $0.001 per share.

18

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

On June 23, 2015, GWG issued 60,000 restricted shares of common stock at $9.70 per share, determined by closing market price, to a vendor as a form of payment for the services the vendor will provide to the Company in the next three years. The cost of the issued shares will be amortized over the next 12 months.

(12) Stock Incentive Plan

The Company adopted the GWG Holdings, Inc. 2013 Stock Incentive Plan on March 27, 2013. On April 23, 2015 the Board of Directors approved amendments to the plan that were subsequently approved by a majority of the Company’s stockholders at the annual meeting of stockholders on June 1, 2015. The plan is administered by the Compensation Committee of the Board of Directors of the Company. The Company’s Chief Executive Officer may, on a discretionary basis and without committee review or approval, grant incentives to new employees of the Company who are not officers of the Company. Incentives under the plan may be granted in one or a combination of the following forms: (a) incentive stock options and non-statutory stock options; (b) stock appreciation rights; (c) stock awards; (d) restricted stock; (e) restricted stock units; and (f) performance shares. Eligible participants include officers and employees of the Company, members of the Board of Directors, and consultants or other independent contractors. 2,000,000 shares are issuable under the plan. No person shall receive grants of stock options and SARs under the plan that exceed, in the aggregate 400,000 shares of common stock in any one year. The term of each stock option shall be determined by the committee but shall not exceed ten years. Vested stock options may be exercised in whole or part by the holder giving notice to the Company. The holder of the option may provide payment for the exercise price or surrender shares equal to the exercise price.

The Company issued stock options for 1,046,551 shares of common stock to employees, officers, and directors of the Company through September 30, 2015. Options for 449,274 shares have vested, and the remaining options will vest over three years. The options were issued with an exercise price between $8.20 and $10.18 for those owning more than 10% of the Company’s stock and between $6.73 and $10.25 for others, which is equal to the estimated market price of the shares on the date of grant valued using Black-Scholes binomial option pricing model. The expected volatility used in the Black-Scholes model valuation of options issued during the year was 17.03% annualized. The annual volatility rate is based on the standard deviation of the average continuously compounded rate of return of five selected comparable companies over the previous 52 weeks. Forfeiture rate of 15% is based on historical Company information and expected future trend. As of September 30, 2015, stock options for 166,499 shares were forfeited and stock options for 28,001 shares were exercised.

In September 2014, we entered into a stock option agreement with a new management employee granting the employee the right to purchase up to 318,000 shares of the Company’s common stock at an exercise price of $12.50. The grant of such rights to purchase the Company’s common stock was treated as an inducement grant and was issued outside the 2013 Stock Incentive Plan. The option agreement specifies that, among other things, options to purchase 159,000 common shares will vest ratably on the first, second and third anniversary of the date of the agreement. The remaining 159,000 options will vest quarterly using a formula based upon the closing price of the Company’s common stock on the last business day of such quarter. The maximum number of these remaining options that will vest is 53,000 in each successive one-year period beginning on the date of the option agreement. As of September 30, 2015, 53,000 of these options have been forfeited and 53,000 have vested.

Outstanding stock options:

	Vested			Un-vested			Total
Balance as of December 31, 2014		314,288			685,813			1,000,101
Granted during the year		61,000			239,950			300,950
Vested during the year		209,903			(209,903	)		-
Exercised during the year		(27,667	)		-			(27,667	)
Forfeited during the year		(55,250	)		(48,083	)		(103,333	)
Balance as of September 30, 2015		502,274			667,777			1,170,051

19

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Compensation expense related to un-vested options not yet recognized is $499,000. We expect to recognize this compensation expense over the next three years ($9,000 in 2015, $239,000 in 2016, $200,000 in 2017, and 51,000 in 2018). The Company issues new common stock for options exercised.

(13) Net loss per common share

The Company began issuing Series A Preferred Stock on September 1, 2011, as described in note 8. The Series A Preferred Stock and vested stock options are anti-dilutive to the net income (loss) per common share calculation for all three and nine-month periods ended September 30, 2015 and 2014. The Company has also issued warrants to purchase common stock in conjunction with the sale of the Series A Preferred Stock. The warrants are anti-dilutive for all described three and nine-month periods of 2015 and 2014 and have not been included in the fully diluted net income (loss) per common share calculation.

(14) Commitments

GWG Holdings entered into an office lease with U.S. Bank National Association as the landlord. The original lease was for 11,695 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The original lease agreement was effective April 22, 2012, amended on December 14, 2014, and expired on August 31, 2015. Effective September 14, 2015, GWG Holdings entered into a Second Amendment to the lease with U.S. Bank National Association (Second Amendment to Lease). The Second Amendment to Lease increases the office space area to 12,813 square feet and extends the lease expiration date by approximately ten years.

The Company is obligated to pay base rent plus common area maintenance and a share of the building operating costs. Rent expenses under this agreement were $193,000 and $157,000 during the nine-month periods ended September 30, 2015 and 2014, respectively, and $71,000 and $56,000 during the three-month periods ended September 30, 2015 and 2014, respectively.

Minimum lease payments under the Second Amendment to Lease are as follows:

Three months ending December 31, 2015	$	43,000
2016		173,000
2017		178,000
2018		185,000
2019		191,000
2020		198,000
2021		204,000
2022		210,000
2023		217,000
2024		223,000
2025		230,000
2026		38,000
	$	2,090,000

(15) Contingencies

Litigation - The Company is not currently subject to any current or ongoing litigation.

Opportunity Finance, LLC, owned by Jon Sabes and Steven Sabes, is subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments that may be deemed preference payments. Jon Sabes and Steve Sabes have pledged their stock ownership in GWG to holders of Series I Secured Notes and L Bonds. In addition, the Company loaned $1,000,000 to Opportunity Finance, LLC, and was repaid in full plus interest of $177,000. This investment amount may also be subject to clawback claims by the bankruptcy court.

20

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(16) Guarantees of secured debt by GWG Life

In January 2015, GWG registered a $1.0 billion debt offering of our L Bonds with the SEC. The $1.0 billion L Bond offering is a follow-on to our $250.0 million debt offering of Renewable Secured Debentures (subsequently renamed L Bonds) that was registered with the SEC and completed January 2015 as described in note 7. The L Bonds are secured by the assets of GWG Holdings as described in note 7 and a pledge of all the common stock held by the largest individual shareholders. Obligations under the L Bonds are guaranteed by GWG Life. This guarantee involves the grant of a security interest in all the assets of GWG Life. The payment of principal and interest on the L Bonds is fully and unconditional guaranteed by GWG Life. Substantially all of the Company’s life insurance policies are held by DLP II, DLP III and the Trust. The policies held by DLP II, DLPIII and the Trust are not collateral for the L Bond obligations as such policies serve as collateral for the revolving credit facility.

The consolidating financial statements are presented in lieu of separate financial statements and other related disclosures of the subsidiary guarantors and issuer because management does not believe that separate financial statements and related disclosures would be material to investors. There are currently no significant restrictions on the ability of GWG Holdings or GWG Life, the guarantor subsidiary, to obtain funds from its subsidiaries by dividend or loan, except as follows. DLP II and DLP III are borrowers under a credit agreement with Autobahn, as lender, and DZ Bank, as agent, as described in note 5. The significant majority of insurance policies owned by the Company are subject to a collateral arrangement with DZ Bank, as described in notes 2 and 5. Under this arrangement, collection and escrow accounts are used to fund premiums of the insurance policies and to pay interest and other charges under the revolving credit facility. DZ Bank and Autobahn must authorize all disbursements from these accounts, including any distributions to GWG Life. If the facility advance rate exceeds 50%, the distributions are limited to an amount that would result in the borrowers (DLP II, DLP III, GWG Life, and GWG Holdings) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by the agent. After such amount is reached, the credit agreement requires that excess funds be used for repayments of borrowings before any additional distributions may be made.

The following represents consolidating financial information as of September 30, 2015 and December 31, 2014, with respect to the financial position, and for the three and nine months ended September 30, 2015 and 2014 with respect to results of operations and cash flows of GWG Holdings and its subsidiaries. The parent column presents the financial information of GWG Holdings, the primary obligor of the L Bonds. The guarantor subsidiary column presents the financial information of GWG Life, the guarantor subsidiary of the L Bonds, presenting its investment in DLP II, DLP III and Trust under the equity method. The non-guarantor subsidiaries column presents the financial information of all non-guarantor subsidiaries including DLP II, DLP III and Trust.

21

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Balance Sheets

September 30, 2015	Parent			Guarantor Sub		Non-Guarantor Sub		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	26,354,110		$	1,948,399	$	150,164	$	-		$	28,452,673
Restricted cash		-			2,388,800		4,882,760		-			7,271,560
Policy benefits receivable		-			-		357,014		-			357,014
Investment in life settlements, at fair value		-			-		329,562,250		-			329,562,250
Other assets		2,918,013			1,732,640		1,232,070		-			5,882,723
Investment in subsidiaries		249,001,369			270,221,539		-		(519,222,908	)		-
TOTAL ASSETS	$	278,273,492		$	276,291,378	$	336,184,258	$	(519,222,908	)	$	371,526,220
L I A B I L I T I E S & S T O C K H O L D E R S' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	65,011,048	$	-		$	65,011,048
Series I Secured Notes		-			23,566,913		-		-			23,566,913
L Bonds		243,126,585			-		-		-			243,126,585
Interest payable		7,887,475			3,304,752		185,158		-			11,377,385
Accounts payable and other accrued expenses		1,879,138			568,509		616,348		-			3,063,995
Deferred taxes, net		4,608,650			-		-		-			4,608,650
TOTAL LIABILITIES		257,501,848			27,440,174		65,812,554		-			350,754,576
STOCKHOLDERS’ EQUITY
Member capital		-			248,851,204		270,371,704		(519,222,908	)		-
Convertible preferred stock		2,623,541			-		-		-			20,623,541
Common stock		5,942			-		-		-			5,942
Additional paid-in capital		17,163,249			-		-		-			17,163,249
Accumulated deficit		(17,021,088	)		-		-		-			(17,021,088	)
TOTAL STOCKHOLDERS’ EQUITY		20,771,644			248,851,204		270,371,704		(519,222,908	)		20,771,644
TOTAL LIABILITIES AND EQUITY	$	278,273,492		$	276,291,378	$	336,184,258	$	(519,222,908	)	$	371,526,220

22

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Balance Sheets (continued)

December 31, 2014	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	30,446,473		$	216,231	$	-	$	-		$	30,662,704
Restricted cash		-			82,500		4,213,553		-			4,296,053
Policy benefits receivable		-			-		1,750,000		-			1,750,000
Investment in life settlements, at fair value		-			-		282,883,010		-			282,883,010
Other assets		1,673,728			1,777,534		27,500		-			3,478,762
Investment in subsidiaries		185,636,417			215,124,779		-		(400,761,196	)		-
TOTAL ASSETS	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529
L I A B I L I T I E S & S T O C K H O L D E R S' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes		-			27,616,578		-		-			27,616,578
L Bonds		182,782,884			-		-		-			182,782,884
Interest payable		6,598,250			3,513,615		1,016,654		-			11,128,519
Accounts payable and other accrued expenses		711,993			434,433		571,583		-			1,718,009
Deferred taxes, net		5,273,555			-		-		-			5,273,555
TOTAL LIABILITIES		195,366,682			31,564,626		73,749,285		-			300,680,593
STOCKHOLDERS’ EQUITY
Member capital		-			185,636,418		215,124,778		(400,761,196	)		-
Convertible preferred stock		20,527,866			-		-		-			20,527,866
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,257,686			-		-		-			16,257,686
Accumulated deficit		(14,401,486	)		-		-		-			(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		22,389,936			185,636,418		215,124,778		(400,761,196	)		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529

23

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Operations

For the nine months ended September 30, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	2,022,774		$	-	$	(2,022,774	)	$	-
Gain on life settlements, net		-			-			33,446,556		-			33,446,556
Interest and other income		38,944			61,694			132,878		-			233,516
TOTAL REVENUE		38,944			2,084,468			33,579,434		(2,022,774	)		33,680,072
EXPENSES
Origination and servicing fees		-			-			2,022,774		(2,022,774	)		-
Employee compensation and benefits		4,671,183			1,509,703			-		-			6,180,886
Legal and professional fees		1,427,388			560,873			-		-			1,988,261
Interest expense		18,011,890			1,984,356			3,152,784		-			23,149,030
Other expenses		3,251,606			2,297,063			97,733		-			5,646,402
TOTAL EXPENSES		27,362,067			6,351,995			5,273,291		(2,022,774	)		36,964,579
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(27,323,123	)		(4,267,527	)		28,306,143		-			(3,284,507	)
EQUITY IN INCOME OF SUBSIDIARY		24,038,616			28,305,979			-		(52,344,595	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(3,284,507	)		24,038,452			28,306,143		(52,344,595	)		(3,284,507	)
INCOME TAX BENEFIT		(664,905	)		-			-		-			(664,905	)
NET INCOME (LOSS)	$	(2,619,602	)	$	24,038,452		$	28,306,143	$	(52,344,595	)	$	(2,619,602	)

For the nine months ended September 30, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	1,462,376		$	-	$	(1,462,376	)	$	-
Gain on life settlements, net		-			-			16,119,517		-			16,119,517
Interest and other income		17,501			229,348			5,218		(228,092	)		23,975
TOTAL REVENUE		17,501			1,691,724			16,124,735		(1,690,468	)		16,143,492
EXPENSES
Origination and servicing fees		-			-			1,462,376		(1,462,376	)		-
Employee compensation and benefits		1,992,554			1,531,720			-		-			3,524,274
Legal and professional fees		1,476,213			141,470			10,086		-			1,627,769
Interest expense		13,371,300			2,334,097			4,025,930		-			19,731,327
Other expenses		1,937,674			1,299,666			268,602		(228,092	)		3,277,850
TOTAL EXPENSES		18,777,741			5,306,953			5,766,994		(1,690,468	)		28,161,220
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(18,760,240	)		(3,615,229	)		10,357,741		-			(12,017,728	)
EQUITY IN INCOME OF SUBSIDIARY		6,742,512			10,357,741			-		(17,100,253	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(12,017,728	)		6,742,512			10,357,741		(17,100,253	)		(12,017,728	)
INCOME TAX BENEFIT		(4,129,670	)		-			-		-			(4,129,670	)
NET INCOME (LOSS)	$	(7,888,058	)	$	6,742,512		$	10,357,741	$	(17,100,253	)	$	(7,888,058	)

24

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Operations (continued)

For the three months ended September 30, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	1,004,024		$	-	$	(1,004,024	)	$	-
Gain on life settlements, net		-			-			8,189,261		-			8,189,261
Interest and other income		13,922			54,813			25,106		-			93,841
TOTAL REVENUE		13,922			1,058,837			8,214,367		(1,004,024	)		8,283,102
EXPENSES
Origination and servicing fees		-			-			1,004,024		(1,004,024	)		-
Employee compensation and benefits		1,759,589			548,657			-		-			2,308,246
Legal and professional fees		598,530			223,547			-		-			822,077
Interest expense		6,980,132			525,391			1,144,626		-			8,650,149
Other expenses		1,195,417			995,026			40,898		-			2,231,341
TOTAL EXPENSES		10,533,668			2,292,621			2,189,548		(1,004,024	)		14,011,813
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(10,519,746	)		(1,233,784	)		6,024,819		-			(5,728,711	)
EQUITY IN INCOME OF SUBSIDIARY		4,791,035			6,024,762			-		(10,815,797	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(5,728,711	)		4,790,978			6,024,819		(10,815,797	)		(5,728,711	)
INCOME TAX BENEFIT		(2,097,633	)		-			-		-			(2,097,633	)
NET INCOME (LOSS)	$	(3,631,078	)	$	4,790,978		$	6,024,819	$	(10,815,797	)	$	(3,631,078	)

For the three months ended September 30, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	153,470		$	-	$	(153,470	)	$	-
Gain on life settlements, net		-			-			5,118,423		-			5,118,423
Interest and other income		4,572			59,372			5,156		(58,871	)		10,229
TOTAL REVENUE		4,572			212,842			5,123,579		(212,341	)		5,128,652
EXPENSES
Origination and servicing fees		-			-			153,470		(153,470	)		-
Employee compensation and benefits		737,475			639,235			-		-			1,376,710
Legal and professional fees		734,024			16,020			10,086		-			760,130
Interest expense		4,679,311			761,828			1,355,597		-			6,796,736
Other expenses		850,122			587,745			74,371		(58,871	)		1,453,367
TOTAL EXPENSES		7,000,932			2,004,828			1,593,524		(212,341	)		10,386,943
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(6,996,360	)		(1,791,986	)		3,530,055		-			(5,258,291	)
EQUITY IN INCOME OF SUBSIDIARY		1,738,069			3,530,055			-		(5,268,124	)		-
NET INCOME BEFORE INCOME TAXES		(5,258,291	)		1,738,069			3,530,055		(5,268,124	)		(5,258,291	)
INCOME TAX BENEFIT		(1,858,100	)		-			-		-			(1,858,100	)
NET INCOME (LOSS)	$	(3,400,191	)	$	1,738,069		$	3,530,055	$	(5,268,124	)	$	(3,400,191	)

25

.

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Cash Flows

For the nine months ended September 30, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(2,619,602	)	$	24,038,452		$	28,306,143		$	(52,344,595	)	$	(2,619,602	)
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries		(24,038,617	)		(28,305,978	)		-			52,344,595			-
Gain on life settlements		-			-			(26,651,363	)		-			(26,651,363	)
Amortization of deferred financing and issuance costs		2,832,487			260,455			(1,201,170	)		-			1,891,772
Deferred income taxes		(664,905	)		-			-			-			(664,905	)
Convertible, redeemable preferred dividends payable		509,225			-			-			-			509,225
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			1,392,986						1,392,986
Other assets		(40,145,769	)		(26,745,888	)		-			66,117,118			(774,539	)
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses		4,503,624			123,222			(790,131	)		-			3,836,715
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(30,425,246	)		(30,629,737	)		1,056,465			66,117,118			(23,079,711	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(23,850,860	)		-			(23,850,860	)
Proceeds from settlement of life settlements		-			-			3,822,983			-			3,822,983
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(20,027,877	)		-			(20,027,877	)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility		-			-			(7,150,000	)		-			(7,150,000	)
Payments for redemption of Series I Secured Notes		-			(4,508,130	)		-			-			(4,508,130	)
Proceeds from issuance of L Bonds		87,620,483			-			-			-			87,620,483
Payments for redemption and issuance of L Bonds		(32,376,104	)		-			-			-			(32,376,104	)
Payments from restricted cash		-			(2,306,300	)		(669,207	)		-			(2,975,507	)
Issuance of common stock		582,000			-			-			-			582,000
Payments for redemption preferred stock		(295,185	)		-			-			-			(295,185	)
Issuance of member capital		-			39,176,335			26,940,783			(66,117,118	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		55,531,194			32,361,905			19,121,576			(66,117,118	)		40,897,557
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(4,092,363	)		1,732,168			150,164			-			(2,210,031	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		30,446,473			216,231			-			-			30,662,704
END OF THE PERIOD	$	26,354,110		$	1,948,399		$	150,164		$	-		$	28,452,673

26

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Consolidating Statements of Cash Flows (continued)

For the nine months ended September 30, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(7,888,058	)	$	6,742,512		$	10,357,741		$	(17,100,253	)	$	(7,888,058	)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
(Equity) of subsidiaries		(6,742,512	)		(10,357,741	)		-			17,100,253			-
Gain on life settlements		-			-			(30,973,250	)		-			(30,973,250	)
Amortization of deferred financing and issuance costs		2,125,269			427,187			18,425						2,570,881
Deferred income taxes		(4,129,670	)		-			-						(4,129,670	)
Convertible, redeemable preferred stock dividends payable		575,513			-			-			-			575,513
(Increase) in operating assets:
Other assets		(35,758,660	)		(29,984,534	)		-			63,647,054			(2,096,140	)
Increase in operating liabilities:
Accounts payable and accrued expenses		2,893,814			591,534			173,311			-			3,658,659
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(48,924,304	)		(32,851,042	)		(20,423,773	)		63,647,054			(38,282,065	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(11,559,435	)		-			(11,559,435	)
Proceeds from settlement of life settlements		-			-			999,125			-			999,125
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(10,560,310	)		-			(10,560,310	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(2,047,928	)		-			-			(2,047,928	)
Proceeds from issuance of L Bonds		48,516,296			-			-			-			48,516,296
Payments for redemption and issuance of L Bonds		(13,816,794	)		-			-			-			(13,816,794	)
Proceeds from restricted cash		-			1,420,000			2,268,236			-			3,688,236
Proceeds from sale of common stock		9,030,000			-			-			-			9,030,000
Payments for redemption preferred stock		(465,239	)		-			-			-			(465,239	)
Issuance of member capital		-			34,931,207			28,715,847			(63,647,054	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		43,264,263			34,303,279			30,984,083			(63,647,054	)		44,904,571
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(5,666,041	)		1,722,237			-			-			(3,937,804	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		32,711,636			738,157			-			-			33,449,793
END OF THE PERIOD	$	27,051,595		$	2,460,394		$	-		$	-		$	29,511,989

27

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Consolidating Statements of Cash Flows (continued)

For the three months ended September 30, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(3,631,078	)	$	4,790,978		$	6,024,819		$	(10,815,797	)	$	(3,631,078	)
Adjustments to reconcile net loss to net cash flows from operating activities:
(Equity) of subsidiaries		(4,791,035	)		(6,024,762	)		-			10,815,797			-
Gain on life settlements		-			-			(14,516,881	)		-			(14,516,881	)
Amortization of deferred financing and issuance costs		1,103,312			49,339			781,125			-			1,933,776
Deferred income taxes		(1,916,686	)		-			-			-			(1,916,686	)
Convertible, redeemable preferred stock dividends payable		173,993			-			-			-			173,993
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			2,142,986			-			2,142,986
Other assets		(22,146,946	)		(15,631,849	)		-			37,360,805			(417,990	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		2,010,129			(105,418	)		629,558			-			2,534,269
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(29,198,311	)		(16,921,712	)		(4,938,393	)		37,360,805			(13,697,611	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(13,626,842	)		-			(13,626,842	)
Proceeds from settlement of life settlements		-			-			80,000			-			80,000
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(13,546,842	)		-			(13,546,842	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(890,586	)		-			-			(890,586	)
Proceeds from issuance of L Bonds		37,122,127			-			-			-			37,122,127
Payments for redemption and issuance of L Bonds		(19,363,047	)		-			-			-			(19,363,047	)
Proceeds (payments) from restricted cash		-			(2,203,800	)		2,855,430			-			651,630
Issuance of member capital		-			21,730,944			15,629,861			(37,360,805	)		-
Payments for redemption preferred stock		(21,187	)		-			-			-			(21,187	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		17,737,893			18,636,558			18,485,291			(37,360,805	)		17,498,937
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(11,460,418	)		1,714,846			56			-			(9,363,047	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		37,814,528			233,553			150,108			-			38,198,189
END OF THE PERIOD	$	26,354,110		$	1,948,399		$	150,164		$	-		$	28,452,673

28

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Consolidating Statements of Cash Flows (continued)

For the three months ended September 30, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(3,400,191	)	$	1,738,069		$	3,530,055		$	(5,268,124	)	$	(3,400,191	)
Adjustments to reconcile net loss to cash:
(Equity) of subsidiaries		(1,738,069	)		(3,530,055	)		-			5,268,124			-
Gain on life settlements		-			-			(8,761,912	)		-			(8,761,912	)
Amortization of deferred financing and issuance costs		397,659			126,083			339,475			-			863,217
Deferred income taxes		(1,858,100	)		-			-			-			(1,858,100	)
Convertible, redeemable preferred stock dividends payable		186,182			-			-			-			186,182
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			300,000			-			300,000
Other assets		(9,136,310	)		(5,329,716	)		-			13,318,805			(1,147,221	)
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses		922,271			289,132			(720,907	)		-			490,496
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(14,626,558	)		(6,706,487	)		(5,313,289	)		13,318,805			(13,327,529	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(680,000	)		-			(680,000	)
Proceeds from settlement of life settlements		-			-			930,625			-			930,625
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			250,625			-			250,628
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(509,004	)		-			-			(509,004	)
Proceeds from issuance of L Bonds		15,281,809			-			-			-			15,281,809
Payments for redemption and issuance of L Bonds		(4,494,383	)		-			-			-			(4,494,383	)
Proceeds from restricted cash		-			565,000			100,699			-			665,699
Proceeds from sale of common stock		9,030,000			-			-			-			9,030,000
Issuance of member capital		-			8,356,840			4,961,965			(13,318,805	)		-
Payments for redemption preferred stock		(445,183	)		-			-			-			(445,183	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		19,372,243			8,412,836			5,062,664			(13,318,805	)		19,528,938
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		4,745,685			1,706,349			-			-			6,452,034
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		22,305,910			754,045			-			-			23,059,955
END OF THE PERIOD	$	27,051,595		$	2,460,394		$	-		$	-		$	29,511,989

29

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(17) Concentrations

GWG purchases life insurance policies written by life insurance companies having investment grade ratings by independent rating agencies. As a result there may be certain concentrations of contracts with life insurance companies. The following summarizes the face value of insurance contracts with specific life insurance companies exceeding 10% of the total face value held by the Company.

	September 30,		December 31,
	2015		2014
Life insurance company	%		%
AXA Equitable		14.27		14.55
John Hancock		12.98		11.48

The following summarizes the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company:

	September 30,		December 31,
	2015		2014
State of residence	%		%
California		27.11		28.87
Florida		18.66		18.56

(18) Subsequent events

Subsequent to September 30, 2015, the Company has issued approximately an additional $18.3 million in principal amount of L Bonds. 

30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

You should read the following discussion in conjunction with the consolidated financial statements and accompanying notes and the information contained in other sections of this report. This discussion and analysis is based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. The statements in this discussion and analysis concerning expectations regarding our future performance, liquidity and capital resources, as well as other non-historical statements, are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties. Our actual results could differ materially from those suggested or implied by any forward-looking statements. Please see the “Risk Relating to Forward-Looking Statements” caption below.

Overview

We are engaged in the emerging secondary market for life insurance. We acquire life insurance policy benefits in the secondary market from policy owners desiring to sell their policies at a discount to the face value of the insurance benefit. Once we purchase a policy, we continue paying the policy premiums to ultimately collect the face value of the insurance benefit. We generally seek to hold the individual policies to maturity, in order to ultimately collect the policy’s face value upon the insured’s mortality. Our strategy is to build a large, profitable portfolio of policies that is diversified in terms of insureds, insurance carriers and the medical conditions of insureds. We believe that diversification among insureds (by age and medical conditions), and insurance carriers will lower our overall risk exposure, and that a larger portfolio of individual policies (diversification in overall number) creates a portfolio of greater value by virtue of improved actuarial stability.

Business Update

GWG’s business model provides value-added services to consumers owning life insurance and investors seeking alternative investment opportunities related to the life insurance secondary market. To participate and compete in what we expect to be a growth market, we have spent and intend to continue to spend significant resources: (i) developing resources, strategies, and capabilities for investors to participate in a large portfolio of life insurance policies; and (ii) developing a robust operational platform, strategy, and systems for originating and purchasing life insurance benefits from consumers owning life insurance policies.

We continue to see increasing interest among investors and financial professionals participating in our $1.0 billion L Bond offering. The L Bond offers investors the opportunity to obtain a high yielding investment whose performance is not tied to the stock market, commodities, or real estate. We believe these features are growing in popularity due to i) the prospect of general market interest rates being “lower for longer”, ii) increased volatility in traditional financial market (stocks, bonds, real estate, commodities and currencies) and iii) the realization among investors and financial professionals that the life insurance secondary market and related longevity investments are becoming a more main-stream asset class.

We also expect that our recently effective $100,000,000 Redeemable Preferred Stock offering will appeal to investors and financial professionals for the same reasons enumerated above. We expect to continue growing our financial product distribution as awareness, understanding and interest in our asset class increases.

Our Redeemable Preferred Stock Offering is a key tool in strengthening our balance sheet and improving our capital structure. We believe that a successful offering of our Redeemable Preferred Stock will create a virtuous cycle within our capital structure and business. Our strengthened capital position will increase the equity value that is subordinated to our outstanding debt, which will in turn increase the attractiveness of the L Bond offering to financial advisors and investors seeking a high yielding, non-correlated return. These increased L Bond sale proceeds will allow us to grow our portfolio of life insurance and, ultimately, a large and actuarially diverse portfolio of life insurance policies should allow us to reduce our overall cost of capital and thereby enhance the value of the Company for its preferred and common stockholders.

A key strategic initiative of ours is to improve our origination protocols and practices for purchasing life insurance policy benefits. Historically, we have purchased policies in the secondary market through a network of life insurance agents, life insurance settlement brokers, and life settlement providers who assist policy owners in accessing the secondary market. Since the fourth quarter of 2014, we have been expanding our origination practices by marketing directly to consumers and by developing our unique Appointed Agent Program. We have engaged a strategic partner to assist us in the development of a specialized service center whose focus is sourcing qualified leads and processing life insurance policies directly for our purchase. We also recently began implementing (subject to state approval) the use of streamlined contracts and documents used in the purchase of policies, and have implemented the use of electronic signatures where permitted. In conjunction with these activities, we continue to refine the systems, processes and protocols, including a streamlined underwriting process for small face policies ($1,000,000 in face value policy benefits or less) in order to efficiently acquire life insurance policies from our direct origination channels. In that regard we have reached several milestones, most notably, the time in which it takes to complete a preliminary underwriting of a prospective insurance policy for pricing and communicating an offer. In the past, the process of obtaining medical records and additional underwriting data sufficient to review and value a life insurance policy typically took six or more weeks. This has been a historically challenging element of the business, both for purchasers such as the Company, financial advisors, and consumers seeking options for their life insurance. Through continued efforts, we have been able to reduce this elapsed time from approximately six weeks to two days for certain life insurance policy purchases. These processes and methodologies continue to utilize life expectancies received from third-party medical actuarial firms. In addition to obtaining third party life expectancies, we are rapidly working to deploy innovative and sophisticated underwriting techniques for our small face originations by applying advanced medical technologies and socio-economic factors into our underwriting methodology. We expect that these innovations will provide us with a competitive advantage in processing cases and purchasing life insurance policies. 

31

We continue to develop and expand our activities related to recruiting and supporting our Appointed Agent Program with new advanced marketing tools and resources. Our Appointed Agent Program empowers financial professionals to bring the life insurance secondary market’s value proposition directly to consumers owning life insurance. Central to the Appointed Agent Program is education, training, and marketing that support and empower financial professionals to offer clients significant value with a program that emphasizes regulatory compliance. Over the last three months, we have deployed new marketing efforts focused specifically on recruiting and expanding the number of financial professionals sourcing life insurance policies directly for us through our Appointed Agent Program. These efforts are being developed with the same strategic partner operating our specialized service center that is assisting us in processing qualified policy holder leads for our direct purchase.

Additionally, we continue to experience growing success in recruiting financial professionals into our Appoint Agent Program who also distribute our investment products. This dual offering enables financial professionals the opportunity to develop expertise in our business model and a specialization for their financial practice. In conjunction with these activities, we have continued to sharpen our service offerings and marketing tools for broker-dealers and financial advisors seeking to market our products and services. We believe these offerings have led to an increasing acceptance by the financial profession of our business model and industry since they address a growing need for post-retirement financial services to seniors owning life insurance.

While these efforts are all still relatively new and ongoing, the initial results and early outcomes from both our Appointed Agent Program and direct-to-consumer initiatives continue to be encouraging and are leading to a further focus on allocating resources to more fully realize the opportunity presented. In the past three months, we continue to experience increasing numbers of life insurance policies that are in our origination pipeline, with a portion of that increase being directly related to our direct origination efforts. All told, these direct origination efforts have accounted for approximately 30% of all new policy purchases during the quarter, up from nil previously, and now making up over 20% of all the life insurance policy benefits in our current origination pipeline as of November 11, 2015. Our origination pipeline includes all the life insurance policies we are currently gathering information, evaluating, bidding on, or in the process of closing a purchase. We expect to continue to work on these systems, including supporting marketing, technology, reporting, processing, and underwriting protocols through the balance of 2015.

We have also expanded our own footprint in the various states and jurisdictions where secondary market life settlement transactions are regulated. Of the 42 jurisdictions that require licensure, our wholly-owned subsidiaries GWG Life and GWG Life USA presently hold 35 licenses and have pending applications in another three jurisdictions.

As for the life insurance secondary market itself, we continue to see positive growth trends, evidenced by continued competition for policy purchases through traditional channels, continued consumer-direct marketing efforts by market participants, and a stable regulatory environment. One recent life insurance market development has been the notification from several life insurance carriers to policy owners of an increase in the cost of insurance (i.e., premiums) on select universal life insurance products. While the impacts of these increases are not yet known, nor is it known whether this trend will continue, the changes in cost of insurance have caused the industry to review its practices and pricing assumptions in relation to the specific products and insurance carriers involved. At this time, the Company has identified that it has potential exposure to a cost of insurance increase announced by AXA Equitable Life Insurance Company. Nevertheless, the impact, if any, on our consolidated financial results has yet to be quantified.

32

In the first nine months of 2015, we recognized $25.9 million of revenue from the receipt of $29.7 million in policy benefits. In addition, we recognized revenue from the change in fair value of our life insurance policies, net of premiums and carrying costs, of $7.5 million. In the first nine months of 2015, interest expense, including amortization of the deferred financing costs and preferred stock dividends, was $23.1 million, and selling, general and administrative expenses were $13.8 million. Income tax benefit for the first nine months of 2015 was $0.7 million. Our net income before interest, taxes and amortization was $19.9 million and our net loss after tax was $2.6 million for the first nine months of 2015.

In the first nine months of 2014, we recognized $2.3 million of revenue from the receipt of $3.3 million in policy benefits. In addition, we recognized revenue from the change in fair value of our life insurance policies, net of premiums and carrying costs, of $13.8 million. Interest expense, including amortization of the deferred financing costs and preferred stock dividends, was $19.7 million for the nine months ended September 30, 2014, and selling, general and administrative expenses were $8.4 million. Income tax benefit for the nine months ended September 30, 2014 was $4.1 million. Our net income before interest, taxes and amortization was $7.7 million and our net loss after tax was $7.9 million for the first nine months of 2014.

To date, we have financed our business principally through the issuance of debt, including our registered public offerings of L Bonds and debt incurred by our subsidiary DLP Funding II under a senior revolving credit facility provided by Autobahn/DZ Bank. See the “Liquidity and Capital Resources” caption below.

Critical Accounting Policies

Critical Accounting Estimates

The preparation of our consolidated financial statements in accordance with the Generally Accepted Accounting Principles (GAAP) requires us to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our judgments, estimates and assumptions on historical experience and on various other factors believed to be reasonable under the circumstances.  Actual results could differ materially from these estimates. We evaluate our judgments, estimates and assumptions on a regular basis and make changes accordingly. We believe that the judgments, estimates and assumptions involved in the accounting for the valuation of investments in life insurance policies have the greatest potential impact on our consolidated financial statements and accordingly believe these to be our critical accounting estimates. Below we discuss the critical accounting policies associated with these estimates as well as certain other critical accounting policies.

33

Ownership of Life Insurance Policies—Fair Value Option

Our primary business involves the purchasing and financing of life insurance policies. As such, we account for the purchase of life insurance policies in accordance with Financial Accounting Standards Board’s Accounting Standards Codification (FASB ASC) 325-30, Investments in Insurance Contracts, which requires us to use either the investment method or the fair value method. We have elected to account for these life insurance policies as investments using the fair value method.

We initially record our purchase of life insurance policies at the transaction price, which is the amount paid for the policy, inclusive of all fees and costs associated with the acquisition. The fair value of our investment in the portfolio of insurance policies is evaluated at the end of each reporting period. Changes in the fair value of the portfolio of life insurance policies are based on periodic evaluations and are recorded as changes in fair value of life insurance policies in our consolidated and combined statement of operations. The fair value is determined as the net present value of the life insurance portfolio’s future expected cash flows that incorporates current life expectancy estimates and discount rate assumptions.

In addition to reporting our results of operations and financial condition based on the fair value of our life insurance policies as required by GAAP, management also makes calculations based on the weighted average expected internal rate of return of the policies. See “Non-GAAP Financial Measures” below.

Valuation of Insurance Policies

Unobservable inputs, as discussed below, are a critical component of our estimate for the fair value of our investments in life insurance policies. We currently use a probabilistic method of estimating and valuing the projected cash flows of our portfolio of life insurance policies, which we believe to be the preferred and most prevalent valuation method in the industry. In this regard, the most significant assumptions we make are the life expectancy estimates of the insureds and the discount rate applied to the projected cash flows to be derived from our portfolio.

In determining life expectancy estimates, we generally use actuarial medical reviews from independent medical underwriters. These medical underwriters evaluate the health of the insured by reviewing historical and current medical records. This evaluation is performed to produce an estimate of the insured’s mortality—a life expectancy report. In the case of a small face policy ($1.0 million face value of policy benefits or less), we may use modified life expectancy methodologies that do not use actuarial medical reviews from independent medical underwriters. The life expectancy estimate represents a range of probabilities for the insured’s mortality against a group of cohorts with the same age, sex and smoking status. These mortality probabilities represent a mathematical curve known as an actuarial mortality curve, which is then used to generate a series of expected cash flows from the life insurance policy over the expected lifespan of the insured. A discount rate is used to calculate the net present value of the expected cash flows. The discount rate represents the internal rate of return we expect to earn on investments in a policy or in the portfolio as a whole at the stated fair value. The discount rate used to calculate fair value of our portfolio incorporates the guidance provided by ASC 820, Fair Value Measurements and Disclosures. Many of our current underwriting review processes, including our policy of obtaining actuarial medical reviews from independent medical underwriters as described above, are undertaken in satisfaction of obligations under our L Bond debt offerings and revolving credit facility. As a result, we may in the future modify our underwriting review processes if permitted under our borrowing arrangements.

The table below provides the discount rate used to estimate the fair value of the life insurance policies for the period ending:

September 30, 2015		December 31, 2014
	11.07%		11.43%

The discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed in the secondary market, market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies. The discount rate to arrive at the fair value of our portfolio assumes an orderly and arms-length transaction (i.e., a non-distressed transaction in which neither seller nor buyer is compelled to engage in the transaction).

We engaged a third party, Model Actuarial Pricing Systems (MAPS), to prepare a third-party valuation of our life settlement portfolio. MAPS owns and maintains the portfolio pricing software we use. MAPS processed policy data, future premium data, life expectancy estimate data, and other actuarial information we supply to calculate a net present value for our portfolio using the specified discount rate of 11.07%. MAPS independently calculated the net present value of our portfolio of 343 policies to be $329.6 million, which is the same fair value estimate we used on the balance sheet as of September 30, 2015, and furnished us with a letter documenting its calculation. A copy of such letter is filed as Exhibit 99.1 to this report.

34

JOBS Act

On April 5, 2012, the Jumpstart Our Business Startups Act of 2012, or JOBS Act, was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933 for complying with new or revised accounting standards. This means that an “emerging growth company” can make an election to delay the adoption of certain accounting standards until those standards would apply to private companies. We have elected to delay such adoption of new or revised accounting standards and, as a result, we may not comply with new or revised accounting standards at the same time as other public reporting companies that are not “emerging growth companies.” This exemption will apply for a period of five years following our first sale of common equity securities under an effective registration statement or until we no longer qualify as an “emerging growth company” as defined under the JOBS Act, whichever is earlier.

Deferred Income Taxes

FASB ASC 740, Income Taxes, requires us to recognize deferred tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. A valuation allowance is established for any portion of deferred tax assets that is not considered more likely than not to be realized.

We have provided a valuation allowance against the deferred tax asset related to a note receivable because we believe that, when realized for tax purposes, it will result in a capital loss that will not be utilized because we have no expectation of generating a capital gain within the applicable carryforward period. Therefore, we do not believe that it is more likely than not that the deferred tax asset will be realized.

We have also provided a valuation allowance against the deferred tax asset related to a tax basis capital loss generated with respect to its settlement and subsequent disposal of our investment in Athena Structured Funds PLC (see “Notes to Consolidated Financial Statements” Note 10). As we have no expectation of generating capital gains within the applicable carry-forward period, we do not believe that it is more likely than not that the deferred asset will be realized.

A valuation allowance is required to be recognized to reduce deferred tax assets to an amount that is more likely than not to be realized. Realization of deferred tax assets depends upon having sufficient past or future taxable income in periods to which the deductible temporary differences are expected to be recovered or within any applicable carryback or carryforward periods. We believe that it is more likely than not that we will be able to realize all of our deferred tax assets other than that which is expected to result in a capital loss.

Deferred Financing and Issuance Costs

Financing costs incurred to obtain financing under the revolving credit facility have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. The Series I Secured Note obligations are reported net of issuance costs, sales commissions, and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds are reported net of issuance costs, sales commissions, and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over a three-year redemption period. As of December 31, 2014 these costs have been fully amortized.

Risk Relating to Forward-Looking Statements

Certain matters discussed in this section of this report, and elsewhere in this report, are forward-looking statements.  We have based these forward-looking statements on our current expectations and projections about future events.  Nevertheless, these forward-looking statements are subject to risks, uncertainties and assumptions about our operations and the investments we make, including, among other things, the following:

● changes in the secondary market for life insurance;

● our limited operating history;

● the valuation of assets reflected on our financial statements;

● the reliability of our life expectancy estimates;

● the reliability of assumptions underlying our actuarial models;

● our reliance of debt financing;

● risks relating to the validity and enforceability of the life insurance policies we purchase;

● our reliance on information provided and obtained by third parties;

● federal and state regulatory matters;

35

● additional expenses, not reflected in our operating history, related to being a public reporting company;

● competition in the secondary life insurance market;

● the relative illiquidity of life insurance policies;

● life insurance company credit exposure;

● economic outlook;

● performance of our investments in life insurance policies;

● financing requirements;

● litigation risks;

● the impact of cost-of-insurance premium increases on our financial condition and results of operation; and

● restrictive covenants contained in borrowing agreements.

Forward-looking statements can generally be identified by the use of words like “believes,” “could,” “possibly,” “probably,” “anticipates,” “estimates,” “projects,” “expects,” “may,” “will,” “should,” “seek,” “intend,” “plan,” “expect” or “consider,” or the negative of these expressions or other variations, or by discussions of strategy that involve risks and uncertainties.  All forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual transactions, results, performance or achievements to be materially different from any future transactions, results, performance or achievements expressed or implied by such forward-looking statements.

Principal Revenue and Expense Items

We earn revenues from three primary sources as described below.

● Policy Benefits Realized. We recognize the difference between the death benefits and carrying values of the policy when an insured event has occurred and we determine that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. We generally collect the face value of the life insurance policy from the insurance company within 45 days of the insured’s mortality.

● Change in Fair Value of Life Insurance Policies.  We have elected to carry our investments in life insurance policies at fair value in accordance with ASC 325-30,  Investments in Life Insurance Contracts.  Accordingly, we value our investments in our portfolio of life insurance policies each reporting period in accordance with the fair value principles discussed herein, which includes the expected payment of premiums for future periods.

● Sale of a Life Insurance Policy or a Portfolio of Life Insurance Policies. In an event of a sale of a policy, we recognize gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Our main components of expense are summarized below.

● Selling, General and Administrative Expenses. We recognize and record expenses incurred in the operations of the purchasing and servicing of life insurance policies. These expenses include professional fees, salaries, and sales and marketing expenditures.  

● Interest Expense. We recognize and record interest expenses associated with the costs of financing our life insurance portfolio for the current period. These expenses include interest paid to our senior lender under our revolving credit facility, as well as all interest paid on our L Bonds and other outstanding indebtedness such as our subsidiary secured notes and dividends on convertible, redeemable preferred stock. When we issue long-term indebtedness, we amortize the issuance costs associated with such indebtedness over the outstanding term of the financing, and classify it as interest expense.

36

Results of Operations — Three and Nine Months Ended September 30, 2015 Compared to the Same Periods in 2014

The following is our analysis of the results of operations for the periods indicated below.  This analysis should be read in conjunction with our consolidated financial statements and related notes.

	Three Months Ended  September 30,				Nine Months  Ended  September 30,
	2015		2014		2015		2014
Revenue recognized from the receipt of policy benefits (1)	$	277,000	$	2,070,000	$	25,909,000	$	2,301,000
Revenue recognized from the change in fair value of life insurance policies, net of premiums and carrying costs (2)		7,912,000		3,049,000		7,538,000		13,819,000
Gain on life settlements, net	$	8,189,000	$	5,118,000	$	33,447,000	$	16,120,000
Number of policies matured		1		4		8		7
The change in fair value related to new policies acquired	$	7,423,000	$	964,000	$	12,546,000	$	7,523,000

(1) In the first nine months of 2015, we recognized $25.9 million of revenue from the receipt of $29.7 million in policy benefits. In the first nine months of 2014, we recognized $2.3 million of revenue from the receipt of $3.3 million in policy benefits.

(2) The change in the discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed by us in the life insurance secondary market, market interest rates, the credit exposure to the issuing insurance companies and our estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies. Because we use the discount rate to arrive at the fair value of our portfolio, the rate we choose necessarily assumes an orderly and arms-length transaction (i.e., a non-distressed transaction in which neither seller nor buyer is compelled to engage in the transaction). The discount rate applied to estimate the fair value of the portfolio of life insurance policies we own was 11.07% as of September 30, 2015, compared to 11.56% as of September 30, 2014. The decrease in discount rate was primarily due to an increase in prices our competitors were purchasing life insurance policies in the secondary market, an increase in the size and diversity of our portfolio that we believe results in a lower risk premium due to an increase in actuarial stability for any potential buyer. The carrying value of policies acquired during each quarterly reporting period are adjusted to their current fair value using the fair value discount rate applied to the entire portfolio as of that reporting date.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015		2014		Increase		2015		2014		Increase
Employee compensation and benefits (1)	$	2,308,000	$	1,377,000	$	931,000	$	6,181,000	$	3,524,000	$	2,657,000
Interest expense (including amortization of deferred financing costs and preferred stock dividends) (2)		8,650,000		6,797,000		1,853,000		23,149,000		19,731,000		3,418,000
Legal and professional expenses (3)		822,000		760,000		62,000		1,988,000		1,628,000		360,000
Other expenses (4)		2,232,000		1,453,000		779,000		5,646,000		3,278,000		2,368,000
Total expenses	$	14,012,000	$	10,387,000	$	3,625,000	$	36,964,000	$	28,161,000	$	8,803,000

(1)	We employed more staff and hired additional members to our sales, marketing and information technology teams.
(2)	The increase was due to the increase in the average debt outstanding.
(3)	Increase is due to increased compliance work and SEC filings related to securities offerings.
(4)	Marketing, recruiting and other expenses increased due to the continued development of a direct marketing campaign and related service center costs, increased activity related to our public offering of L Bonds and continued technology and infrastructure costs.

Income Tax Expense.  For the three and nine months ended September 30, 2015, we had a loss of $5,729,000 and $3,285,000, respectively before income taxes and we recorded income tax benefits of $2,098,000 and $665,000, respectively, or 36.6% and 20.2%, respectively.  In the same periods of 2014, we had a loss of $5,258,000 and $12,018,000 before income taxes and recorded income tax benefit of $1,858,000 and $4,130,000, respectively, or 35.3% and 34.4%, respectively.  The primary differences between our effective tax rate and the statutory federal rate are the accrual of preferred stock dividend expense, state taxes, and other non-deductible expenses.

37

The following table provides a reconciliation of our income tax expense at the statutory federal tax rate to our actual income tax expense:

	Three Months Ended					Nine Months Ended					Three Months Ended					Nine Months Ended
	September 30, 2015					September 30, 2015					September 30, 2014					September 30, 2014
Statutory federal income tax	$	(1,948,000	)	34.0	%	$	(1,117,000	)	34.0	%	$	(1,788,000	)	34.0	%	$	(4,086,000	)	34.0	%
State income taxes, net of federal benefit		(334,000	)	5.8	%		(105,000	)	3.2	%		(297,000	)	5.6	%		(649,000	)	5.4	%
Series A preferred stock dividends		175,000		(3.1	)%		526,000		(16.0	)%		216,000		(4.1	)%		650,000		(5.4	)%
Other permanent differences		9,000		(0.1	)%		31,000		(1.0	)%		11,000		(0.2	)%		(45,000	)	0.4	%
Total income tax expense	$	(2,098,000	)	36.6	%	$	665,000		20.2	%	$	(1,858,000	)	35.3	%	$	(4,130,000	)	34.4	%

The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

Liquidity and Capital Resources

We finance our business through a combination of policy benefit revenues, origination fees, equity offerings, debt offerings, and a credit facility. We have used our debt offerings and credit facility primarily for policy acquisition, policy servicing and portfolio related financing expenditures. We charge an intercompany origination fee in the amount of one to four percent of the face value of a life insurance policy’s benefit when we acquire the related life insurance policy. The origination fee we charge is included in the total purchase price we pay for a life insurance policy for purposes of our valuation and expected internal rate of return calculations, but is not netted against the purchase price we pay to a seller of an insurance policy. We generated cash flows $1.0 million and $2.0 million from origination fees during the three and nine months ended September 30, 2015, and $0.2 million and $1.5 million during the same periods in 2014. Profit from intra-company origination fees for life insurance policies retained by us are eliminated from our consolidated statements of operations. As such, the origination fees collected under our life insurance policy financing arrangements are reflected in our consolidated statements of cash flows as cash flows from financing activities as they are received form of borrowings used to finance the acquisition of life insurance policies.  Our borrowing agreements allow us to use net proceeds of the L Bonds for policy acquisition, which includes origination fees. If the policy acquisition is not financed, no fees are included in the consolidated cash flows. See “Cash Flows” below for further information. We determine the purchase price of life insurance policies in accordance with ASC 325-30, Investments in Insurance Contracts , using the fair value method. Under the fair value method, the initial investment is recorded at the transaction price. Because the origination fees are paid from a wholly owned subsidiary to the parent company, these fees are not included in the transaction price as reflected in our consolidated financial statements. For further discussion on our accounting policies for life settlements, please refer to note 1 to our consolidated financial statements.

As of September 30, 2015 and December 31, 2014, we had approximately $84.1 million and $51.2 million, respectively, in combined available cash and available borrowing base surplus capacity under our revolving credit facility for the purpose of purchasing additional life insurance policies, paying premiums on existing policies, paying portfolio servicing expenses, and paying principal and interest on our outstanding financing obligations.

On October 30, 2015, we began to publicly offer for sale 100,000 shares of Redeemable Preferred Stock under a Form S-1 registration statement declared effective by the SEC.

In January 2015, we began to publicly offer for sale $1.0 billion in principal amount of our L Bonds under a Form S-1 registration statement declared effective by the SEC. The $1.0 billion public offering of L Bonds is as a follow-on offering to our $250.0 million public offering of Renewable Secured Debentures (subsequently renamed L Bonds) that was registered with the SEC and completed January 2015. Through September 30, 2015, the total amount of these L Bonds sold, including renewals, was $376.8 million. As of September 30, 2015, we had approximately $247.6 million in principal amount of L Bonds outstanding. 

On September 24, 2014, we consummated an initial public offering of our common stock resulting in the sale of 800,000 shares of common stock at $12.50 per share and net proceeds of approximately $8.6 million after the deduction of underwriting commissions, discounts and expense reimbursements. We used the net proceeds from the offering to promote and advertise the opportunities for consumers owning life insurance and investors to profit from participating in the secondary market for life insurance policies, to purchase additional life insurance policies in the secondary market, to pay premiums on our life insurance policy assets, to fund our portfolio operations, and for working capital purposes.

In September 2012, we concluded a Series A Preferred Stock offering, having received an aggregate $24.6 million in subscriptions for our Series A Preferred Stock. These subscriptions consisted of $14.0 million in conversions of outstanding Series I Secured Notes and $10.6 million of new investments. We have used the proceeds from the sale of our Series A Preferred Stock to fund our operational expenditures.

38

In November 2009, we issued our first debt securities through our wholly owned subsidiary GWG Life commenced private placement of Series I Secured Notes to accredited investors only. This offering was closed in November 2011 and was followed-on by our first publicly registered $250.0 million debt offering of Renewable Secured Debentures (subsequently renamed L Bonds). As of September 30, 2015, we had approximately $23.9 million in principal amount of Series I Secured Notes outstanding.

The weighted-average interest rate of our outstanding Series I Secured Notes as of September 30, 2015 and December 31, 2014 was 8.47% and 8.37%, respectively, and the weighted-average maturity at those dates was 1.20 and 1.11 years, respectively. The Series I Secured Notes have renewal features. Since we first issued our Series I Secured Notes, we have experienced $148.3 million in maturities, of which as of September 30, 2015, $114.5 million has renewed for an additional term. This has provided us with an aggregate renewal rate of approximately 77% for investments in these securities.

The weighted-average interest rate of our outstanding L Bonds as of September 30, 2015 and December 31, 2014 was 7.21% and 7.45%, respectively, and the weighted-average maturity at those dates was 1.96 and 2.01 years, respectively. Our L Bonds have renewal features that provide that investors will remain in their investment with GWG unless they provide us with notice within 30 days of the maturity of their bond. Since we first issued our L Bonds, we have experienced $129.1 million in maturities, of which as of September 30, 2015, $80.1 million has renewed for an additional term. This has provided us with an aggregate renewal rate of approximately 62% for investments in these securities. Future contractual maturities of Series I Secured Notes and L Bonds at September 30, 2015 are:

Years Ending December 31,	Series I Secured Notes		L Bonds		Total
2015	$	1,776,000	$	22,691,000	$	24,467,000
2016		12,827,000		81,569,000		94,396,000
2017		6,154,000		52,228,000		58,382,000
2018		998,000		46,946,000		47,944,000
2019		347,000		13,642,000		13,989,000
Thereafter		1,816,000		30,477,000		32,293,000
	$	23,918,000	$	247,553,000	$	271,471,000

The L Bonds and Series I Secured Notes are secured by all our assets, and are subordinate to our revolving credit facility with Autobahn/DZ Bank. The L Bonds and Series I Secured Notes are pari passu with respect to a security interest in our assets pursuant to an intercreditor agreement (see notes 6 and 7 to our consolidated financial statements).

We maintain a $105 million revolving credit facility with Autobahn/DZ Bank through GWG Life’s wholly owned subsidiaries DLP II and DLP III. The revolving credit facility is used to pay the premium expenses related to GWG’s portfolio of life insurance policies. As of both September 30, 2015 and December 31, 2014, we had approximately $65.0 million and $72.2 million, respectively, outstanding under the revolving credit facility and maintained an available borrowing base surplus of $55.6 million and $20.6 million, respectively. Effective May 11, 2015, we amended and restated our credit facility to reduce the interest cost and extend the term of the facility to June 2018 (see note 5 to our condensed consolidated financial statements).

We expect to meet our ongoing operational capital needs through a combination of the receipt of policy benefit revenues and proceeds from financing transactions. We expect to meet our policy acquisition, servicing, and financing capital needs from the receipt of policy benefit revenues from our portfolio of life insurance policies, net proceeds from our offerings of L Bonds and Redeemable Preferred Stock, and from borrowings under our revolving credit facility to the extent available. Furthermore, we expect that policy benefit payments will increase as the average age of the insureds increase and mortality events occur at a greater rate over time, a trend which we experienced during periods in 2014-2015 and that we expect will reoccur with greater frequency in the future. As a result of the foregoing, we estimate that our liquidity and capital resources are sufficient for our current and projected financial needs. Nevertheless, if we are unable to continue for any reason to access the credit and capital markets through our offerings of L Bonds or Redeemable Preferred Stock, and we are unable to obtain capital from other sources, we expect that our business would be materially and adversely affected. In addition, our business would be materially and adversely affected if we did not receive the policy benefits we forecast and if holders of our L Bonds or Series I Secured Notes failed to renew with the frequency we have historically experienced. In such a case, we could be forced to sell our investments in life insurance policies to service or satisfy our debt-related obligations and continue to pay policy premiums.

Capital expenditures have historically not been material and we do not anticipate making material capital expenditures in 2015 or beyond.

39

Debt Financings Summary

We had the following outstanding debt balances as of September 30, 2015: 

Issuer/Borrower	Principal Amount Outstanding		Weighted Average Interest Rate
GWG Holdings, Inc. - L Bonds	$	247,553,000		7.21	%
GWG Life Settlements, LLC - Series I Secured Notes		23,918,000		8.47	%
GWG DLP Funding II, LLC - Revolving credit facility		65,011,000		5.43	%
Total	$	336,482,000		6.96	%

Our total credit facility and other indebtedness balance as of September 30, 2015 and December 31, 2014 was $336.5 million and $286.6 million, respectively. At September 30, 2015, the total outstanding face amount under our Series I Secured Notes outstanding was $23.9 million, less unamortized selling costs of $0.3 million, resulting in a carrying amount of $23.6 million. At December 31, 2014, the total outstanding face amount under our Series I Secured Notes outstanding was $28.0 million, less unamortized selling costs of $0.4 million, resulting in a carrying amount of $27.6 million. At September 30, 2015, the total outstanding face amount of L Bonds was $247.6 million plus $2.3 million of subscriptions in process, less unamortized selling costs of $6.8 million resulting in a carrying amount of $243.1 million. At December 31, 2014, the total outstanding face amount of L Bonds was $186.4 million plus $2.3 million of subscriptions in process, less unamortized selling costs of $5.9 million resulting in a carrying amount of $182.8 million. At September 30, 2015, the fair value of our investments in life insurance policies of $329.6 million plus our cash balance of $28.4 million and our restricted cash balance of $7.3 million, totaled $365.3 million, representing an excess of portfolio assets over secured indebtedness of $28.8 million. At December 31, 2014, the fair value of our investments in life insurance policies of $282.8 million plus our cash balance of $30.7 million and our restricted cash balance of $4.3 million, totaled $317.8 million, representing an excess of portfolio assets over secured indebtedness of $31.2 million. At September 30, 2015 our weighted average cost of capital was approximately 6.96%. The L Bonds and Series I Secured Notes are secured by all our assets and are subordinate to our revolving credit facility with Autobahn/DZ Bank. The L Bonds and Series I Secured Notes are pari passu with respect to a security interest in our asset pursuant to an intercreditor agreement.

The following forward-looking table seeks to illustrate the impact of the sale of our portfolio of life insurance assets at various discount rates in order to satisfy our debt obligations as of September 30, 2015. In all cases, the sale of the life insurance assets owned by DLP II and DLP III will be used first to satisfy all amounts owing under the revolving credit facility with Autobahn/ DZ Bank. The net sale proceeds remaining after satisfying all obligations under the revolving credit facility would be applied to L Bonds and Series I Secured Notes on a pari passu basis.

Portfolio Discount Rate	10%		11%		12%		13%		14%
Value of portfolio	$	346,250,000	$	330,610,000	$	316,182,000	$	302,844,000	$	290,486,000
Cash and cash equivalents		35,724,000		35,724,000		35,724,000		35,724,000		35,724,000
Total assets		381,974,000		366,334,000		351,906,000		338,568,000		326,210,000
Revolving credit facility Autobahn/DZ Bank		65,011,000		65,011,000		65,011,000		65,011,000		65,011,000
Net after revolving credit facility		316,963,000		301,323,000		286,895,000		273,557,000		261,199,000
Series I Secured Notes and L Bonds		271,471,000		271,471,000		271,471,000		271,471,000		271,471,000
Net after Series I Secured Notes and L Bonds		45,492,000		29,852,000		15,424,000		2,086,000		(10,272,000	)
Impairment to Series I Secured Notes and L Bonds		No impairment		No impairment		No impairment		No impairment		Impairment

The table illustrates that our ability to fully satisfy amounts owing under the L Bonds and Series I Secured Notes would likely be impaired upon the sale of all our life insurance assets at a price equivalent to a discount rate of approximately 13.16% or higher. At December 31, 2014 the impairment occurred at discount rate of approximately 14.09% or higher. The discount rates used to calculate the fair value of our portfolio for mark-to-market accounting were 11.07% and 11.43% as of September 30, 2015 and December 31, 2014, respectively.

The table does not include any allowance for transactional fees and expenses associated with a portfolio sale (which expenses and fees could be substantial), and is provided to demonstrate how various discount rates used to value our portfolio could affect our ability to satisfy amounts owing under our debt obligations, in light of our senior secured lender’s right to priority payments. You should read the above table in conjunction with the information contained in other sections of this report, including our discussion of discount rates included under the “— Critical Accounting Policies — Valuation of Insurance Policies” caption above. This discussion and analysis is based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. The forward-looking presentation above is subject to numerous risks and uncertainties. Our actual results could differ materially from those suggested or implied by the above table. Please see the caption “Risk Relating to Forward-Looking Statements” above.

40

Amended and Restated Credit Facility

Effective May 11, 2015, GWG Holdings, together with certain of its subsidiaries, entered into a Second Amended and Restated Credit and Security Agreement with Autobahn Funding Company LLC, as the conduit lender, and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as the committed lender and as the agent on behalf of secured parties under such agreement. The Second Amended and Restated Credit and Security Agreement extends the maturity date of borrowings made by the Company’s subsidiaries, DLP II and DLP III, to June 30, 2018. Advances under the credit facility made after May 11, 2015 will bear interest at the commercial paper rate of the lender at the time of the advance plus an applicable margin, which is less than under the previous Credit and Security Agreement executed on January 25, 2013. In addition to the extended term and decreased interest rate and borrowing cost, the Second Amended and Restated Credit and Security Agreement also removes the requirement that the Company maintain a reserve for certain projected expenditures (including anticipated premium payments required to service its life insurance portfolio), thereby allowing for the Company’s full use of the credit facility up to its limit of $105,000,000.

Cash Flows

The payment of premiums and servicing costs to maintain life insurance policies represents our most significant requirement for cash disbursement. When a policy is purchased, we are able to calculate the minimum premium payments required to maintain the policy in-force. Over time as the insured age, premium payments will increase; however, the probability of actually needing to pay the premiums decreases since mortality becomes more likely. These scheduled premiums and associated probabilities are factored into our expected internal rate of return and cash-flow modeling described herein. Beyond premiums, we incur policy servicing costs, including annual trustee and tracking costs, and debt servicing costs, including principal and interest payments. Until we receive a stable amount of proceeds from the policy benefits, we intend to pay these costs from our credit facility, when permitted, and through the issuance of debt securities, including the L Bonds.

The amount of payments for anticipated premiums and servicing costs that we will be required to make over the next five years to maintain our current portfolio, assuming no mortalities, is set forth in the table below.

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Nine months ending December 31, 2015	$	7,315,000	$	412,000	$	7,727,000
2016		30,433,000		412,000		30,845,000
2017		33,390,000		412,000		33,802,000
2018		36,241,000		412,000		36,653,000
2019		40,520,000		412,000		40,932,000
2020		45,023,000		412,000		45,435,000
	$	192,922,000	$	2,472,000	$	195,394,000

For the quarter end dates set forth below, the following table illustrates the total amount of face value of policy benefits owned, and the trailing 12 months of life insurance policy benefits collected and premiums paid on our portfolio. The trailing 12-month benefits/premium coverage ratio indicates the ratio of policy benefits received to premiums paid over the trailing 12-month period from our portfolio of life insurance policies.

41

Quarter End Date	Portfolio Face Amount		12-Month Trailing Benefits Collected		12-Month Trailing Premiums Paid		12-Month Trailing Benefits/Premium Coverage Ratio
March 31, 2012	$	482,455,000	$	4,203,000	$	14,977,000		28.06	%
June 30, 2012		489,255,000		8,703,000		15,412,000		56.47	%
September 30, 2012		515,661,000		7,833,000		15,837,000		49.46	%
December 31, 2012		572,245,000		7,350,000		16,597,000		44.28	%
March 31, 2013		639,755,000		11,350,000		18,044,000		62.90	%
June 30, 2013		650,655,000		13,450,000		19,182,000		70.11	%
September 30, 2013		705,069,000		18,450,000		20,279,000		90.98	%
December 31, 2013		740,648,000		16,600,000		21,733,000		76.38	%
March 31, 2014		771,940,000		12,600,000		21,930,000		57.46	%
June 30, 2014		784,652,000		6,300,000		22,598,000		27.88	%
September 30, 2014		787,964,000		4,300,000		23,121,000		18.60	%
December 31, 2014		779,099,000		18,050,000		23,265,000		77.58	%
March 31, 2015		754,942,000		46,675,000		23,786,000		196.23	%
June 30, 2015		806,274,000		47,125,000		24,348,000		193.55	%
September 30, 2015		878,882,000		44,482,000		25,313,000		175.72	%

We believe that the portfolio cash flow results set forth above are consistent with our general investment thesis: that the life insurance policy benefits we receive will continue to increase over time in relation to the premiums we are required to pay on the remaining polices in the portfolio. Nevertheless, we expect that our portfolio cash flow results on a period-to-period basis will remain inconsistent until such time as we achieve our goal of acquiring a larger, more diversified portfolio of life insurance policies in order to obtain more normalized actuarial results. As our receipt of life insurance policy benefits increases, we expect to begin servicing and paying down our outstanding indebtedness, or alternatively purchasing additional life insurance policies, from these cash flows.

The life insurance policies owned by DLP II and DLP III are subject to a collateral arrangement with the agent to our revolving credit lender, as described in note 5 to the consolidated financial statements. Under this arrangement, collection and escrow accounts are used to fund purchases and premiums of the insurance policies and to pay interest and other charges under our revolving credit facility. The lender and its agent must authorize all disbursements from these accounts, including any distributions to GWG Life or GWG Holdings. If the facility advance rate exceeds 50%, the distributions are limited to an amount that would result in the borrowers (DLP II, DLP III, GWG Life, and GWG Holdings) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by the agent. After such amount is reached, the credit agreement requires that excess funds be used for repayments of borrowings before any additional distributions may be made. In the future, these arrangements may restrict the cash flows available for payment of principal and interest on our debt obligations.

Inflation

Changes in inflation do not necessarily correlate with changes in interest rates. We presently do not foresee any material impact of inflation on our results of operations in the periods presented in our consolidated financial statements.

Off-Balance Sheet Arrangements

GWG Holdings entered into an office lease with U.S. Bank National Association as the landlord. The original lease was for 11,695 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The original lease agreement was effective April 22, 2012, amended on December 14, 2014 and expired on August 31, 2015. Effective September 14, 2015, GWG Holdings entered into a second amendment to the lease with U.S. Bank National Association (Second Amendment to Lease). The Second Amendment to Lease increases the office space area to 12,813 square feet and extends the lease expiration date by approximately ten years (see note 14 to our condensed consolidated financial statements).

Credit Risk

We review the credit risk associated with our portfolio of life insurance policies when estimating its fair value. In evaluating the policies’ credit risk we consider insurance company solvency, credit risk indicators, economic conditions, ongoing credit evaluations, and company positions. We attempt to manage our credit risk related to life insurance policies typically by purchasing policies issued only from companies with an investment grade credit rating by either Standard & Poor’s, Moody’s, or A.M. Best Company. As of September 30, 2015, 97.4% of our life insurance policies, by face value benefits, were issued by companies that maintained an investment grade rating (BBB or better) by Standard & Poor’s.

42

Interest Rate Risk

Our credit facility is floating-rate financing. In addition, our ability to offer interest rates that attract capital (including in the offer and sale of L Bonds) is generally impacted by prevailing interest rates. Furthermore, while our other indebtedness provides us with fixed-rate financing, our debt coverage ratio is calculated in relation to our total cost of financing. Therefore, fluctuations in interest rates impact our business by increasing our borrowing costs, and reducing availability under our debt financing arrangements. Furthermore, we calculate our portfolio earnings based upon the spread generated between the return on our life insurance portfolio and the cost of our financing. As a result, increases in interest rates will reduce the earnings we expect to achieve from our investments in life insurance policies.

Non-GAAP Financial Measures

We use non-GAAP financial measures when evaluating our financial results, for planning and forecasting purposes, and for maintaining compliance with covenants contained in our borrowing agreements. Non-GAAP financial measures disclosed by management are provided as additional information to investors in order to provide them with an alternative method for assessing our financial condition and operating results. These non-GAAP financial measures are not in accordance with GAAP and may be different from non-GAAP measures used by other companies, including other companies within our industry. This presentation of non-GAAP financial information is not meant to be considered in isolation or as a substitute for comparable amounts prepared in accordance with GAAP. See the notes to our consolidated financial statements and our audited financial statements contained herein.

We have elected to carry our investments in life insurance policies at fair value in accordance with ASC 325-30, Investments in Life Insurance Contracts . Accordingly, we value our investments in life insurance policies at the conclusion of each reporting period in accordance with GAAP fair value accounting principles. In addition to GAAP, we are required to report non-GAAP financial measures to Autobahn/DZ Bank under certain financial covenants made to that lender under our revolving credit facility. As indicated above, we also use non-GAAP financial reporting to manage and evaluate the financial performance of our business.

GAAP-based fair value requires us to mark-to-market our investments in life insurance policies, which by its nature, is based upon Level 3 measurements that are unobservable. As a result, this accounting treatment imports financial market volatility and subjective inputs into our financial reporting. We believe this type of accounting reporting is at odds with one of the key attractions for purchasing and owning a portfolio life insurance policies: the non-correlated nature of the returns to be derived from such policies. Therefore, in contrast to a GAAP-based fair valuation, we seek to measure the accrual of the actuarial gain occurring within the portfolio of life insurance policies at their expected internal rate of return based on statistical actuarial mortality probabilities for the insureds (using primarily the insured’s age, sex and smoking status). The expected internal rate of return tracks actuarial gain occurring within the policies according to a mortality table as the insureds’ age increases. By comparing the actuarial gain accruing within our portfolio of life insurance policies against our costs during the same period, we can estimate, manage and evaluate the overall financial profitability of our business without regard to mark-to-market volatility. We use this information to balance our life insurance policy purchasing and manage our capital structure, including the issuance of debt and utilization of our other sources of capital, and to monitor our compliance with borrowing covenants. We believe that these non-GAAP financial measures provide information that is useful for investors to understand period-over-period operating results separate and apart from fair value items that may, or could, have a disproportionately positive or negative impact on results in any particular period.

Our credit facility requires us to maintain a “positive net income” and “tangible net worth” each of which are calculated on an adjusted non-GAAP basis on the method described above, without regard to GAAP-based fair value measures. In addition, our revolving credit facility requires us to maintain an “excess spread,” which is the difference between (i) the weighted average of our expected internal rate of return of our portfolio of life insurance policies and (ii) the weighted average of our credit facility’s interest rate. These calculations are made using non-GAAP measures in the method described below, without regard to GAAP-based fair value measures.

In addition, our L Bonds and Series I Secured Notes require us to maintain a “debt coverage ratio” designed to ensure that the expected cash flows from our portfolio of life insurance policies is able to adequately service our total outstanding indebtedness. In addition, our L Bonds requires us to maintain a “subordination ratio” which limits the total amount of indebtedness that can be issued senior in rank to the L Bonds and Series I Secured Notes. These ratios are calculated using non-GAAP measures in the method described below, without regard to GAAP-based fair value measures.

43

Adjusted Non-GAAP Net Income. Our credit facility requires us to maintain a positive net income calculated on an adjusted non-GAAP basis. We calculate the adjusted net income by recognizing the actuarial gain accruing within our life insurance policies at the expected internal rate of return of the policies we own without regard to fair value. We net this actuarial gain against our costs during the same period to calculate our net income on a non-GAAP basis.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
GAAP net loss	$	(3,631,000	)	$	(3,400,000	)	$	(2,620,000	)	$	(7,888,000	)
Unrealized fair value gain (1)		(14,517,000	)		(8,762,000	)		(26,651,000	)		(30,973,000	)
Adjusted cost basis increase (2)		13,345,000			10,982,000			37,988,000			33,156,000
Accrual of unrealized actuarial gain (3)		9,201,000			8,082,000			21,417,000			23,209,000
Total adjusted non-GAAP net income (4)	$	4,398,000		$	6,902,000		$	30,134,000		$	17,504,000

(1)	Reversal of unrealized GAAP fair value gain of life insurance policies for current period.
(2)	Adjusted cost basis is increased to include those acquisition and servicing expenses that are not capitalized by GAAP.
(3)	Accrual of actuarial gain at the expected internal rate of return based on the investment cost basis for the period.
(4)	We must maintain an annual positive consolidated net income, calculated on a non-GAAP basis, to maintain compliance with our revolving credit facility with DZ Bank/Autobahn.

Adjusted Non-GAAP Tangible Net Worth. Our revolving credit facility requires us to maintain a tangible net worth in excess of $45 million calculated on an adjusted non-GAAP basis. We calculate the adjusted tangible net worth by recognizing the actuarial gain accruing within our life insurance policies at the expected internal rate of return of the policies we own without regard to fair value. We net this actuarial gain against our costs during the same period to calculate our tangible net worth on a non-GAAP basis.

	As of September 30, 2015			As of December 31, 2014
GAAP net worth (1)	$	20,772,000		$	22,390,000
Less intangible assets (2)		(11,239,000	)		(8,132,000	)
GAAP tangible net worth		9,533,000			14,258,000
Unrealized fair value gain (3)		(181,323,000	)		(154,672,000	)
Adjusted cost basis increase (4)		176,190,000			147,673,000
Accrual of unrealized actuarial gain (5)		101,205,000			80,122,000
Total adjusted non-GAAP tangible net worth (6)	$	105,605,000		$	87,381,000

(1)	Also referred to as GAAP book value.
(2)	Unamortized portion of deferred financing costs and pre-paid insurance.
(3)	Reversal of cumulative unrealized GAAP fair value gain or loss of life insurance policies.
(4)	Adjusted cost basis is increased by cumulative acquisition and servicing expenses which are not capitalized under GAAP.
(5)	Accrual of cumulative actuarial gain at expected internal rate of return based on investment cost basis.
(6)	We must maintain a total adjusted non-GAAP tangible net worth of $45 million to maintain compliance with our revolving credit facility with DZ Bank/Autobahn.

Excess Spread. Our revolving credit facility requires us to maintain a 2.00% “excess spread” between our expected internal rate of return of our portfolio of life insurance policies and the credit facility’s interest rate. A presentation of our excess spread and our total excess spread is set forth below. Management uses the “total excess spread” to gauge expected profitability of our investments, and uses the “excess spread” to monitor compliance with our borrowing.

44

	As of September 30, 2015			As of December 31, 2014
Expected IRR (1)		11.22	%		11.78	%
Weighted-average revolving credit facility interest rate (2)		5.43	%		6.24	%
Excess spread (3)		5.79	%		5.54	%
Total weighted-average interest rate on indebtedness for borrowed money (4)		6.96	%		7.24	%
Total excess spread (5)		4.26	%		4.54	%

(1) This represents the weighted-average expected internal rate of return of the life insurance policies as of the measurement date based upon our investment cost basis of the insurance policies and the expected cash flows from the life insurance portfolio. Our investment cost basis is calculated as our cash investment in the life insurance policies, without regard to GAAP-based fair value measurements, and is set forth below:

Investment Cost Basis	As of September 30, 2015			As of December 31, 2014
GAAP fair value	$	329,562,000		$	282,883,000
Unrealized fair value gain (A)		(181,323,000	)		(154,672,000	)
Adjusted cost basis increase (B)		176,190,000			147,673,000
Investment cost basis (C)	$	324,429,000		$	275,884,000

(A)	This represents the reversal of cumulative unrealized GAAP fair value gain of life insurance policies.
(B)	Adjusted cost basis is increased to include those acquisition and servicing expenses that are not capitalized by GAAP.
(C)	This is the full investment cost basis in life insurance policies from which our expected internal rate of return is calculated.

(2)	This is the weighted-average revolving credit relating to our revolving credit facility interest rate as of the measurement date.
(3)	We must maintain an excess spread of 2.00% relating to our revolving credit facility to maintain compliance under such facility.
(4)	Represents the weighted-average interest rate paid on all outstanding indebtedness as of the measurement date, determined as follows:

Outstanding Indebtedness	As of September 30, 2015		As of December 31, 2014
Revolving credit facility	$	65,011,000	$	72,161,000
Series I Secured Notes		23,918,000		28,047,000
L Bonds		247,553,000		186,377,000
Total	$	336,482,000	$	286,585,000

Interest Rates on Indebtedness
Revolving credit facility	5.43	%	6.24	%
Series I Secured Notes	8.47	%	8.37	%
L Bonds	7.21	%	7.45	%
Weighted-average interest rates on indebtedness	6.96	%	7.24	%

(5) Calculated as expected IRR (1) minus the weighted-average interest rate on indebtedness for borrowed money (4).

Debt Coverage Ratio and Subordination Ratio. Our L Bonds and Series I Secured Notes require us to maintain a “debt coverage ratio” of less than 90%. The “debt coverage ratio” is calculated by dividing the sum of our total indebtedness by the sum of our cash and cash equivalents and the net present value of the life insurance portfolio. The “subordination ratio” for our L Bonds is calculated by dividing the total indebtedness that is senior to L Bonds and Series I Secured Notes by the sum of the Company’s cash and cash equivalents and the net present value of the life insurance portfolio. The “subordination ratio” must be less than 50%. For purposes of both ratio calculations, the net present value of the life insurance portfolio is calculated using a discount rate equal to the weighted average interest rate of all indebtedness.

45

	As of September 30, 2015			As of December 31, 2014
Life insurance portfolio policy benefits	$	878,882,000		$	779,099,000
Discount rate of future cash flows		6.96	%		7.24	%
Net present value of Life insurance portfolio policy benefits	$	402,811,000		$	347,786,000
Cash and cash equivalents		35,724,000			34,959,000
Total Coverage		438,535,000			382,745,000
Revolving credit facility		65,011,000			72,161,000
Series I Secured Notes		23,918,000			28,047,000
L Bonds		247,553,000			186,377,000
Total Indebtedness	$	336,482,000		$	286,585,000
Debt Coverage Ratio		76.73	%		74.88	%
Subordination Ratio		14.82	%		18.85	%

As of September 30, 2015, we were in compliance with both the debt coverage ratio and the subordination ratio as required under our related financing agreements for L Bonds and Series I Secured Notes.

Non-GAAP Net Asset Value. The non-GAAP net asset value attempts to measure the economic value of the Company’s common equity by netting interest-bearing debt and the redemption/liquidation value of the Company’s outstanding Series A Preferred Stock against the value of the Company’s portfolio of life insurance (discounted at our weighted-average cost of capital ⁽¹⁾) and cash and cash equivalents at the end of the measurement period. Management believes this is a useful way to view the common equity value attributable to the current yield spread in the Company’s portfolio of life insurance.

	As of September 30, 2015			As of December 31, 2014
Discount rate of future cash flows		6.96	%		7.24	%
Net present value of life insurance policy benefits	$	402,811,000		$	347,786,000
Cash and cash equivalents	$	35,724,000		$	34,959,000
Interest bearing debt	$	(336,482,000	)	$	(286,585,000	)
Preferred stock redemption value	$	(22,742,000	)	$	(22,596,000	)
Net asset value	$	79,311,000		$	73,564,000
Per share	$	13.35		$	12.53
Shares outstanding (basic)		5,941,790			5,870,193

(1) The weighted average cost of capital discount rate used in this calculation is separate and distinct from the discount rate used to determine the GAAP fair value of the portfolio of life insurance policies as described in our most recent form 10-K.

Our Portfolio

Our portfolio of life insurance policies, owned by our subsidiaries as of September 30, 2015, is summarized below:

Life Insurance Portfolio Summary

Total portfolio face value of policy benefits	$	878,882,000
Average face value per policy	$	2,562,000
Average face value per insured life	$	2,808,000
Average age of insured (yrs.) *		82.6
Average life expectancy estimate (yrs.) *		6.60
Total number of policies		343
Number of unique lives		313
Demographics		70% Males; 30% Females
Number of smokers		7
Largest policy as % of total portfolio		1.14	%
Average policy as % of total portfolio		0.29	%
Average Annual Premium as % of face value		3.41	%

*  Averages presented in the table are weighted averages.

46

Our portfolio of life insurance policies, owned by our subsidiaries as of September 30, 2015, organized by the insured’s current age and the associated policy benefits, is summarized below:

Distribution of Policy Benefits by Current Age of Insured

Min Age	Max Age	Policy Benefits		Weighted Average Life Expectancy (yrs.)		Distribution
90	94	$	66,395,000		3.00		7.56	%
85	89		229,163,000		4.91		26.07	%
80	84		314,401,000		6.71		35.77	%
75	79		189,843,000		8.37		21.60	%
70	74		58,057,000		9.85		6.61	%
66	69		21,023,000		9.86		2.39	%
Total		$	878,882,000		6.60		100.00	%

Our portfolio of life insurance policies, owned by our subsidiaries as of September 30, 2015, organized by the insured’s current age and number of policies owned, is summarized below:

Distribution of Policies by Current Age of Insured

Min Age	Max Age	Policies		Weighted Average Life Expectancy (yrs.)		Distribution
90	94		27		3.00		7.56	%
85	89		99		4.91		26.07	%
80	84		113		6.71		35.77	%
75	79		63		8.37		21.60	%
70	74		29		9.85		6.61	%
66	69		12		9.86		2.39	%
Total			343		6.60		100.00	%

Our portfolio of life insurance policies, owned by our subsidiaries as of September 30, 2015, organized by the insured’s estimated life expectancy estimates and associated policy benefits, is summarized below:

Distribution of Policy Benefits by Current Life Expectancies of Insured

Min LE (Months)	Max LE (Months)	Policy Benefits		Distribution
8	47	$	155,430,000		17.69	%
48	71		232,897,000		26.50	%
72	95		225,287,000		25.63	%
96	119		161,284,000		18.35	%
120	143		57,865,000		6.58	%
144	188		46,119,000		5.25	%
Total		$	878,882,000		100.00	%

We track concentrations of pre-existing medical conditions among insured individuals within our portfolio based on information contained in life expectancy reports. We track these medical conditions with ten primary disease categories: (1) cardiovascular, (2) cerebrovascular, (3) dementia, (4) cancer, (5) diabetes, (6) respiratory disease, (7) neurological disorders, (8) other, no disease, or multiple. Our primary disease categories are summary generalizations based on the ICD-9 codes we track on each insured individuals within our portfolio. ICD-9 codes, published by the World Health Organization, are used worldwide for medical diagnoses and treatment systems, as well as morbidity and mortality statistics. Currently, cardiovascular is the only primary disease category within our portfolio that represents a concentration over 10%.

47

Our portfolio of life insurance policies, owned by our subsidiaries as of September 30, 2015, organized by the primary disease categories of the insured and associated policy benefits, is summarized below:

Distribution of Policy Benefits by Primary Disease Category

Primary Disease Category	Policy Benefits		Distribution
Cancer	$	61,000,000		6.94	%
Cardiovascular		182,091,000		20.72	%
Cerebrovascular		35,212,000		4.01	%
Dementia		65,544,000		7.46	%
Diabetes		64,117,000		7.29	%
Multiple		205,020,000		23.33	%
Neurological Disorders		25,774,000		2.93	%
No Disease		97,641,000		11.11	%
Other		101,033,000		11.49	%
Respiratory Diseases		41,450,000		4.72	%
Total Policy Benefits	$	878,882,000		100.00	%

The primary disease category represents a general category of impairment. Within the primary disease category, there are a multitude of sub-categorizations defined more specifically by ICD-9 codes. For example, a primary disease category of cardiovascular includes subcategorizations such as atrial fibrillation, heart valve replacement, coronary atherosclerosis, etc. In addition, individuals may have more than one ICD-9 code describing multiple medical conditions within one or more primary disease categories. Where an individual’s ICD-9 codes indicate medical conditions in more than one primary disease categories, we categorize the individual as having multiple primary disease categories. We expect to continue to develop and refine our identification and tracking on the insured individuals medical conditions as we manage our portfolio of life insurance policies.

Portfolio Credit Risk Management

The life insurance assets in which we invest represent obligations of third-party life insurance companies to pay the benefits under the relevant policy. We rely on the payment of policy benefits by life insurance companies as our sole source of revenue collection. Accordingly, the possible insolvency of a life insurance company is a significant risk to our business. To manage this risk, we seek to invest in life insurance assets that are issued by insurance companies with investment-grade ratings from either A.M. Best, Moody’s or Standard & Poor’s. To further mitigate risk, we seek to have no more than 20% of our aggregate face value of policy benefits in our portfolio issued by any one life insurance company. In addition, to assure diversity and stability in our portfolio, we regularly review the various metrics of our portfolio relating to credit risk. We track industry rating agency reports and industry journals and articles in order to gain insight into possible financial problems of life insurance companies. Finally, we only invest in those life insurance policies that meet the underwriting standards established in the indenture governing our debt securities, as applicable.

As of September 30, 2015, 91.8% of insurance companies in our portfolio hold an investment-grade rating by Standard & Poor’s (BBB- or better), and the face value of policy benefits issued by one life insurance company with in the portfolio was 14.27%. Of the 49 insurance companies that insure the policies we own, ten companies insure approximately 72.57% of total face value of insurance benefits and the remaining 39 insurance companies insure the remaining approximately 27.47% of total face value of insurance benefits. The concentration risk of our ten largest insurance company holdings as of September 30, 2015 is set forth in the table below.

Rank	Policy Benefits		Percentage of Policy Benefit Amt.			Insurance Company	Ins. Co. S&P Rating
1	$	125,380,000		14.27	%	AXA Equitable Life Insurance Company	A+
2	$	114,055,000		12.98	%	John Hancock Life Insurance Company (U.S.A)	AA-
3	$	80,822,000		9.20	%	Transamerica Life Insurance Company	AA-
4	$	62,475,000		7.11	%	Voya Retirement Insurance and Annuity Company	A
5	$	58,769,000		6.69	%	Jefferson-Pilot Life Insurance Company	AA-
6	$	44,750,000		5.09	%	American General Life Insurance Company	A+
7	$	43.750,000		4.98	%	Massachusetts Mutual Life Insurance Company	AA+
8	$	36,046,000		4.10	%	Metropolitan Life Insurance Company	AA-
9	$	35,932,000		4.09	%	Lincoln National Life Insurance Company	AA-
10	$	35,500,000		4.04	%	West Coast Life Insurance Company	AA-

48

Life Insurance Portfolio Detail

(as of September 30, 2015) 

	Face Amount		Gender	Age (ALB)	LE (mo.)	Insurance Company	S&P Rating
1	$	1,100,000	Male	95	29.4	Voya Retirement Insurance and Annuity Company	A
2	$	4,000,000	Male	94	35.0	MetLife Investors USA Insurance Company	AA-
3	$	1,500,000	Female	94	32.8	Aviva Life Insurance Company	A-
4	$	3,200,000	Male	94	27.5	West Coast Life Insurance Company	AA-
5	$	1,000,000	Female	93	38.7	Transamerica Life Insurance Company	AA-
6	$	264,000	Female	93	25.1	Lincoln Benefit Life Company	BBB+
7	$	3,500,000	Male	92	40.5	Voya Retirement Insurance and Annuity Company	A
8	$	500,000	Male	92	13.5	John Hancock Life Insurance Company (U.S.A)	AA-
9	$	2,000,000	Female	92	11.9	Pruco Life Insurance Company	AA-
10	$	250,000	Male	92	22.5	Transamerica Life Insurance Company	AA-
11	$	1,682,773	Female	91	49.4	Hartford Life and Annuity Insurance Company	BBB+
12	$	3,000,000	Male	91	42.5	West Coast Life Insurance Company	AA-
13	$	5,000,000	Female	91	51.4	American General Life Insurance Company	A+
14	$	5,000,000	Female	91	30.6	John Hancock Life Insurance Company (U.S.A)	AA-
15	$	300,000	Female	91	30.3	West Coast Life Insurance Company	AA-
16	$	3,845,000	Female	91	46.2	Pacific Life Insurance Company	A+
17	$	5,000,000	Male	90	31.8	John Hancock Life Insurance Company (U.S.A)	AA-
18	$	3,500,000	Female	90	55.4	John Hancock Life Insurance Company (U.S.A)	AA-
19	$	3,100,000	Female	90	32.6	Lincoln Benefit Life Company	BBB+
20	$	1,500,000	Female	90	67.7	Jefferson-Pilot Life Insurance Company	AA-
21	$	3,000,000	Female	90	32.1	Jefferson-Pilot Life Insurance Company	AA-
22	$	5,000,000	Female	90	38.8	Voya Retirement Insurance and Annuity Company	A
23	$	5,000,000	Female	90	16.8	Lincoln National Life Insurance Company	AA-
24	$	1,000,000	Male	90	8.1	Voya Retirement Insurance and Annuity Company	A
25	$	1,203,520	Male	90	42.7	Columbus Life Insurance Company	AA
26	$	1,350,000	Female	90	34.5	Jefferson-Pilot Life Insurance Company	AA-
27	$	600,000	Female	90	20.2	Columbus Life Insurance Company	AA
28	$	5,000,000	Female	89	49.5	Massachusetts Mutual Life Insurance Company	AA+
29	$	2,500,000	Female	89	46.8	American General Life Insurance Company	A+
30	$	2,500,000	Male	89	55.0	Pacific Life Insurance Company	A+
31	$	1,000,000	Female	89	49.4	United of Omaha Life Insurance Company	AA-
32	$	1,103,922	Female	89	59.4	Sun Life Assurance Company of Canada (U.S.)	AA-
33	$	1,000,000	Female	89	63.5	Transamerica Life Insurance Company	AA-
34	$	250,000	Female	89	63.5	Transamerica Life Insurance Company	AA-
35	$	2,500,000	Female	89	5.8	AXA Equitable Life Insurance Company	A+
36	$	2,500,000	Female	89	5.8	AXA Equitable Life Insurance Company	A+
37	$	715,000	Female	89	59.2	Jefferson-Pilot Life Insurance Company	AA-
38	$	2,225,000	Female	89	83.6	Transamerica Life Insurance Company	AA-
39	$	3,500,000	Female	89	39.3	Lincoln National Life Insurance Company	AA-
40	$	500,000	Female	88	65.9	Sun Life Assurance Company of Canada (U.S.)	AA-
41	$	250,000	Male	88	70.4	Metropolitan Life Insurance Company	AA-

49

42	$	4,000,000	Female	88	70.0	Transamerica Life Insurance Company	AA-
43	$	5,000,000	Male	88	51.6	AXA Equitable Life Insurance Company	A+
44	$	1,500,000	Male	88	42.3	John Hancock Life Insurance Company (U.S.A)	AA-
45	$	1,500,000	Male	88	42.3	John Hancock Life Insurance Company (U.S.A)	AA-
46	$	1,050,000	Male	88	43.5	John Hancock Life Insurance Company (U.S.A)	AA-
47	$	1,000,000	Male	88	53.6	AXA Equitable Life Insurance Company	A+
48	$	500,000	Male	88	60.1	Lincoln National Life Insurance Company	AA-
49	$	4,785,380	Female	88	44.3	John Hancock Life Insurance Company (U.S.A)	AA-
50	$	1,803,455	Female	88	47.6	Metropolitan Life Insurance Company	AA-
51	$	1,529,270	Female	88	47.6	Metropolitan Life Insurance Company	AA-
52	$	800,000	Male	88	68.8	Lincoln National Life Insurance Company	AA-
53	$	5,000,000	Male	88	50.4	John Hancock Life Insurance Company (U.S.A)	AA-
54	$	3,000,000	Female	88	80.0	Massachusetts Mutual Life Insurance Company	AA+
55	$	200,000	Male	88	46.9	Lincoln Benefit Life Company	BBB+
56	$	4,445,467	Male	88	57.0	Penn Mutual Life Insurance Company	A+
57	$	1,500,000	Male	88	44.8	Union Central Life Insurance Company	A+
58	$	7,500,000	Male	88	48.5	Jefferson-Pilot Life Insurance Company	AA-
59	$	3,600,000	Female	88	56.0	AXA Equitable Life Insurance Company	A+
60	$	3,000,000	Male	88	42.1	Jefferson-Pilot Life Insurance Company	AA-
61	$	2,000,000	Male	88	45.2	John Hancock Life Insurance Company (U.S.A)	AA-
62	$	100,000	Female	88	54.2	American General Life Insurance Company	A+
63	$	100,000	Female	88	54.2	American General Life Insurance Company	A+
64	$	396,791	Male	88	35.2	Lincoln National Life Insurance Company	AA-
65	$	1,500,000	Male	88	105.9	Transamerica Life Insurance Company	AA-
66	$	3,000,000	Male	88	31.4	American General Life Insurance Company	A+
67	$	1,000,000	Male	87	59.5	John Hancock Life Insurance Company (U.S.A)	AA-
68	$	2,000,000	Male	87	59.5	John Hancock Life Insurance Company (U.S.A)	AA-
69	$	5,000,000	Male	87	47.7	Jefferson-Pilot Life Insurance Company	AA-
70	$	5,000,000	Female	87	33.0	Transamerica Life Insurance Company	AA-
71	$	3,000,000	Male	87	47.7	Transamerica Life Insurance Company	AA-
72	$	1,200,000	Male	87	72.8	Transamerica Life Insurance Company	AA-
73	$	6,000,000	Female	87	54.7	Sun Life Assurance Company of Canada (U.S.)	AA-
74	$	3,000,000	Male	87	78.9	AXA Equitable Life Insurance Company	A+
75	$	1,000,000	Female	87	34.4	New York Life Insurance Company	AA+
76	$	10,000,000	Female	87	70.1	West Coast Life Insurance Company	AA-
77	$	2,500,000	Male	87	46.5	Transamerica Life Insurance Company	AA-
78	$	1,000,000	Female	87	48.9	West Coast Life Insurance Company	AA-
79	$	2,000,000	Female	87	48.9	West Coast Life Insurance Company	AA-
80	$	500,000	Female	87	52.9	Beneficial Life Insurance Company	N/A
81	$	800,000	Male	87	53.6	National Western Life Insurance Company	A
82	$	5,000,000	Male	87	79.0	Lincoln National Life Insurance Company	AA-
83	$	1,000,000	Female	87	26.7	John Hancock Life Insurance Company (U.S.A)	AA-
84	$	4,513,823	Female	87	22.5	Aviva Life Insurance Company	A-
85	$	2,000,000	Male	87	93.9	Voya Retirement Insurance and Annuity Company	A
86	$	2,000,000	Male	87	93.9	Voya Retirement Insurance and Annuity Company	A

50

87	$	2,000,000	Male	87	93.9	Voya Retirement Insurance and Annuity Company	A
88	$	2,000,000	Female	87	74.2	U.S. Financial Life Insurance Company	A+
89	$	1,365,000	Female	86	92.8	Transamerica Life Insurance Company	AA-
90	$	1,000,000	Female	86	82.6	Voya Retirement Insurance and Annuity Company	A
91	$	200,000	Female	86	84.3	Lincoln National Life Insurance Company	AA-
92	$	1,000,000	Male	86	38.0	Massachusetts Mutual Life Insurance Company	AA+
93	$	1,000,000	Female	86	22.8	State Farm Life Insurance Company	AA-
94	$	2,000,000	Male	86	82.7	Transamerica Life Insurance Company	AA-
95	$	8,500,000	Male	86	79.3	Massachusetts Mutual Life Insurance Company	AA+
96	$	2,328,547	Male	86	42.6	Metropolitan Life Insurance Company	AA-
97	$	2,000,000	Male	86	42.6	Metropolitan Life Insurance Company	AA-
98	$	1,000,000	Male	86	24.6	Transamerica Life Insurance Company	AA-
99	$	500,000	Male	86	79.8	Metropolitan Life Insurance Company	AA-
100	$	2,000,000	Male	86	59.9	Jefferson-Pilot Life Insurance Company	AA-
101	$	3,000,000	Female	86	68.9	Transamerica Life Insurance Company	AA-
102	$	347,211	Male	86	40.9	Prudential Life Insurance Company	AA-
103	$	1,800,000	Male	86	51.7	John Hancock Variable Life Insurance Company	AA-
104	$	2,000,000	Male	86	61.7	AXA Equitable Life Insurance Company	A+
105	$	1,750,000	Male	86	61.7	AXA Equitable Life Insurance Company	A+
106	$	4,000,000	Male	86	50.4	Metropolitan Life Insurance Company	AA-
107	$	2,000,000	Male	86	33.0	Transamerica Life Insurance Company	AA-
108	$	1,425,000	Male	86	77.4	John Hancock Life Insurance Company (U.S.A)	AA-
109	$	1,500,000	Male	85	47.5	Transamerica Life Insurance Company	AA-
110	$	1,500,000	Female	85	106.0	Lincoln Benefit Life Company	BBB+
111	$	3,750,000	Male	85	74.4	AXA Equitable Life Insurance Company	A+
112	$	1,000,000	Male	85	58.4	John Hancock Life Insurance Company (U.S.A)	AA-
113	$	2,000,000	Female	85	82.4	AXA Equitable Life Insurance Company	A+
114	$	1,000,000	Male	85	52.3	Voya Retirement Insurance and Annuity Company	A
115	$	3,000,000	Female	85	80.8	Sun Life Assurance Company of Canada (U.S.)	AA-
116	$	829,022	Female	85	23.0	Hartford Life and Annuity Insurance Company	BBB+
117	$	1,500,000	Male	85	76.8	AXA Equitable Life Insurance Company	A+
118	$	5,000,000	Male	85	86.4	Voya Retirement Insurance and Annuity Company	A
119	$	1,500,000	Male	85	47.3	Voya Retirement Insurance and Annuity Company	A
120	$	1,500,000	Male	85	47.3	Voya Retirement Insurance and Annuity Company	A
121	$	5,000,000	Male	85	71.0	Voya Retirement Insurance and Annuity Company	A
122	$	500,000	Male	85	39.9	Genworth Life Insurance Company	BBB-
123	$	1,000,000	Male	85	45.2	John Hancock Life Insurance Company (U.S.A)	AA-
124	$	4,000,000	Female	85	48.7	Voya Retirement Insurance and Annuity Company	A
125	$	5,000,000	Female	85	89.9	American General Life Insurance Company	A+
126	$	3,500,000	Female	85	104.5	Lincoln Benefit Life Company	BBB+
127	$	5,000,000	Female	84	97.8	AXA Equitable Life Insurance Company	A+
128	$	1,000,000	Female	84	80.5	John Hancock Life Insurance Company (U.S.A)	AA-
129	$	6,000,000	Female	84	107.8	American General Life Insurance Company	A+
130	$	5,000,000	Male	84	63.6	AXA Equitable Life Insurance Company	A+
131	$	1,433,572	Male	84	53.5	Security Mutual Life Insurance Company of NY	N/A

51

132	$	2,000,000	Male	84	38.4	National Life Insurance Company	A
133	$	1,000,000	Female	84	42.7	Metropolitan Life Insurance Company	AA-
134	$	2,147,816	Female	84	117.4	John Hancock Life Insurance Company (U.S.A)	AA-
135	$	4,200,000	Female	84	115.7	Transamerica Life Insurance Company	AA-
136	$	750,000	Male	84	86.6	West Coast Life Insurance Company	AA-
137	$	4,000,000	Male	84	35.1	John Hancock Life Insurance Company (U.S.A)	AA-
138	$	1,000,000	Male	84	75.8	John Hancock Life Insurance Company (U.S.A)	AA-
139	$	2,000,000	Female	84	95.7	Lincoln Benefit Life Company	BBB+
140	$	5,000,000	Male	84	72.5	Jefferson-Pilot Life Insurance Company	AA-
141	$	2,700,000	Male	84	59.4	John Hancock Life Insurance Company (U.S.A)	AA-
142	$	2,400,000	Male	84	35.8	Genworth Life Insurance Company	BBB-
143	$	7,600,000	Female	84	96.7	Transamerica Life Insurance Company	AA-
144	$	250,000	Male	84	50.6	Transamerica Life Insurance Company	AA-
145	$	2,500,000	Female	84	62.7	American General Life Insurance Company	A+
146	$	2,500,000	Male	84	57.2	AXA Equitable Life Insurance Company	A+
147	$	3,000,000	Male	84	57.2	Lincoln National Life Insurance Company	AA-
148	$	2,000,000	Male	84	83.7	Pacific Life Insurance Company	A+
149	$	3,000,000	Female	84	41.7	AXA Equitable Life Insurance Company	A+
150	$	1,703,959	Male	84	65.4	Jefferson-Pilot Life Insurance Company	AA-
151	$	3,000,000	Male	84	59.4	Metropolitan Life Insurance Company	AA-
152	$	500,000	Male	84	17.2	Great Southern Life Insurance Company	N/A
153	$	1,000,000	Male	84	55.8	Hartford Life and Annuity Insurance Company	BBB+
154	$	400,000	Male	84	48.3	Transamerica Life Insurance Company	AA-
155	$	10,000,000	Female	84	57.3	American National Insurance Company	A
156	$	500,000	Male	84	24.2	West Coast Life Insurance Company	AA-
157	$	3,500,000	Female	83	90.2	Jefferson-Pilot Life Insurance Company	AA-
158	$	500,000	Male	83	98.3	Metropolitan Life Insurance Company	AA-
159	$	1,000,000	Male	83	67.2	Lincoln National Life Insurance Company	AA-
160	$	3,000,000	Male	83	39.5	U.S. Financial Life Insurance Company	A+
161	$	1,900,000	Male	83	64.3	American National Insurance Company	A
162	$	500,000	Male	83	44.8	New York Life Insurance Company	AA+
163	$	500,000	Male	83	44.8	New York Life Insurance Company	AA+
164	$	5,000,000	Male	83	71.6	AXA Equitable Life Insurance Company	A+
165	$	385,000	Male	83	72.2	Metropolitan Life Insurance Company	AA-
166	$	500,000	Male	83	72.2	Metropolitan Life Insurance Company	AA-
167	$	10,000,000	Male	83	72.9	Lincoln National Life Insurance Company	AA-
168	$	250,000	Male	83	31.2	Jackson National Life Insurance Company	AA
169	$	1,500,000	Male	83	74.4	Jefferson-Pilot Life Insurance Company	AA-
170	$	3,500,000	Female	83	86.1	AXA Equitable Life Insurance Company	A+
171	$	5,000,000	Female	83	74.5	Sun Life Assurance Company of Canada (U.S.)	AA-
172	$	3,000,000	Female	83	91.4	MetLife Investors USA Insurance Company	AA-
173	$	750,000	Male	83	80.2	John Hancock Life Insurance Company (U.S.A)	AA-
174	$	4,500,000	Male	83	72.0	AXA Equitable Life Insurance Company	A+
175	$	1,250,000	Female	83	59.3	Columbus Life Insurance Company	AA
176	$	2,275,000	Male	83	91.2	Voya Retirement Insurance and Annuity Company	A

52

177	$	10,000,000	Male	83	82.4	AXA Equitable Life Insurance Company	A+
178	$	2,300,000	Male	83	21.0	American General Life Insurance Company	A+
179	$	3,500,000	Male	83	70.7	AXA Equitable Life Insurance Company	A+
180	$	6,217,200	Female	83	103.8	Phoenix Life Insurance Company	B+
181	$	2,500,000	Female	83	70.3	Voya Retirement Insurance and Annuity Company	A
182	$	5,000,000	Female	83	55.4	Massachusetts Mutual Life Insurance Company	AA+
183	$	1,500,000	Male	83	24.4	Pacific Life Insurance Company	A+
184	$	2,000,000	Female	83	95.4	Jefferson-Pilot Life Insurance Company	AA-
185	$	5,000,000	Male	83	82.2	Jefferson-Pilot Life Insurance Company	AA-
186	$	3,000,000	Male	82	67.2	Protective Life Insurance Company	AA-
187	$	1,500,000	Male	82	67.2	American General Life Insurance Company	A+
188	$	2,000,000	Female	82	114.6	Transamerica Life Insurance Company	AA-
189	$	1,500,000	Male	82	56.8	Pacific Life Insurance Company	A+
190	$	5,000,000	Male	82	108.6	American General Life Insurance Company	A+
191	$	250,000	Male	82	147.5	Voya Retirement Insurance and Annuity Company	A
192	$	1,995,000	Female	82	78.5	Transamerica Life Insurance Company	AA-
193	$	4,000,000	Male	82	55.5	Jefferson-Pilot Life Insurance Company	AA-
194	$	10,000,000	Male	82	79.7	New York Life Insurance Company	AA+
195	$	5,000,000	Male	82	74.3	Transamerica Life Insurance Company	AA-
196	$	2,000,000	Male	82	70.1	Ohio National Life Assurance Corporation	AA-
197	$	1,000,000	Male	82	70.1	Ohio National Life Assurance Corporation	AA-
198	$	350,000	Male	82	35.3	Reassure America Life Insurance Company	AA
199	$	5,000,000	Male	81	91.8	AXA Equitable Life Insurance Company	A+
200	$	8,000,000	Male	81	84.9	AXA Equitable Life Insurance Company	A+
201	$	550,000	Male	81	103.5	Genworth Life Insurance Company	BBB-
202	$	500,000	Male	81	64.2	West Coast Life Insurance Company	AA-
203	$	1,680,000	Female	81	68.9	AXA Equitable Life Insurance Company	A+
204	$	1,000,000	Female	81	96.5	Jefferson-Pilot Life Insurance Company	AA-
205	$	1,250,000	Male	81	100.9	Metropolitan Life Insurance Company	AA-
206	$	1,000,000	Male	81	66.1	AXA Equitable Life Insurance Company	A+
207	$	1,250,000	Female	81	74.7	Principal Life Insurance Company	A+
208	$	1,000,000	Male	81	57.2	AXA Equitable Life Insurance Company	A+
209	$	700,000	Male	81	102.3	Banner Life Insurance Company	AA-
210	$	3,000,000	Male	81	99.1	John Hancock Life Insurance Company (U.S.A)	AA-
211	$	2,000,000	Male	81	41.0	Jefferson-Pilot Life Insurance Company	AA-
212	$	10,000,000	Male	81	70.2	Hartford Life and Annuity Insurance Company	BBB+
213	$	1,750,000	Male	81	83.4	AXA Equitable Life Insurance Company	A+
214	$	5,000,000	Male	81	73.1	AXA Equitable Life Insurance Company	A+
215	$	300,000	Female	81	73.7	Hartford Life and Annuity Insurance Company	BBB+
216	$	250,000	Male	81	80.6	American General Life Insurance Company	A+
217	$	2,502,000	Male	81	151.5	Transamerica Life Insurance Company	AA-
218	$	10,000,000	Male	81	114.0	John Hancock Life Insurance Company (U.S.A)	AA-
219	$	1,210,000	Male	81	66.7	Lincoln National Life Insurance Company	AA-
220	$	3,000,000	Female	81	106.5	West Coast Life Insurance Company	AA-
221	$	7,000,000	Male	81	87.2	Genworth Life Insurance Company	BBB-

53

222	$	3,000,000	Male	80	92.5	Voya Retirement Insurance and Annuity Company	A
223	$	4,000,000	Male	80	82.6	Jefferson-Pilot Life Insurance Company	AA-
224	$	3,000,000	Male	80	151.4	Metropolitan Life Insurance Company	AA-
225	$	5,000,000	Male	80	92.6	John Hancock Life Insurance Company (U.S.A)	AA-
226	$	800,000	Male	80	80.7	North American Company for Life And Health Insurance	A+
227	$	2,000,000	Male	80	28.9	Metropolitan Life Insurance Company	AA-
228	$	6,000,000	Male	80	124.6	AXA Equitable Life Insurance Company	A+
229	$	320,987	Female	80	106.6	John Hancock Life Insurance Company (U.S.A)	AA-
230	$	130,000	Male	80	52.5	Genworth Life Insurance Company	BBB-
231	$	1,000,000	Male	80	125.7	Empire General Life Assurance Corporation	AA-
232	$	2,000,000	Female	80	90.1	Pacific Life Insurance Company	A+
233	$	4,300,000	Female	80	111.6	American National Insurance Company	A
234	$	200,000	Male	80	68.8	Kansas City Life Insurance Company	N/A
235	$	2,000,000	Female	80	88.8	Transamerica Life Insurance Company	AA-
236	$	1,000,000	Male	80	58.6	Pacific Life Insurance Company	A+
237	$	3,000,000	Male	80	112.7	Principal Life Insurance Company	A+
238	$	200,000	Male	80	47.8	Prudential Life Insurance Company	AA-
239	$	500,000	Male	80	49.3	Transamerica Life Insurance Company	AA-
240	$	3,000,000	Male	79	44.3	Pacific Life Insurance Company	A+
241	$	3,000,000	Male	79	44.3	Minnesota Life Insurance Company	A+
242	$	3,000,000	Male	79	44.2	Prudential Life Insurance Company	AA-
243	$	5,000,000	Male	79	100.0	Pacific Life Insurance Company	A+
244	$	5,000,000	Male	79	100.0	Pacific Life Insurance Company	A+
245	$	3,601,500	Male	79	96.1	Transamerica Life Insurance Company	AA-
246	$	1,000,000	Male	79	98.5	Sun Life Assurance Company of Canada (U.S.)	AA-
247	$	5,000,000	Male	79	91.1	John Hancock Life Insurance Company (U.S.A)	AA-
248	$	5,000,000	Male	79	131.4	Principal Life Insurance Company	A+
249	$	1,009,467	Male	79	61.0	John Hancock Life Insurance Company (U.S.A)	AA-
250	$	7,000,000	Male	79	88.1	Lincoln Benefit Life Company	BBB+
251	$	100,000	Male	79	66.1	North American Company for Life And Health Insurance	A+
252	$	5,000,000	Male	79	58.8	John Hancock Life Insurance Company (U.S.A)	AA-
253	$	476,574	Male	79	74.3	Transamerica Life Insurance Company	AA-
254	$	2,250,000	Male	79	96.5	Massachusetts Mutual Life Insurance Company	AA+
255	$	775,000	Male	79	126.8	Lincoln National Life Insurance Company	AA-
256	$	1,000,000	Female	79	125.9	John Hancock Life Insurance Company (U.S.A)	AA-
257	$	1,000,000	Male	79	112.8	Metropolitan Life Insurance Company	AA-
258	$	6,000,000	Male	79	109.5	AXA Equitable Life Insurance Company	A+
259	$	5,000,000	Female	79	118.9	Voya Retirement Insurance and Annuity Company	A
260	$	750,000	Male	79	71.9	Lincoln National Life Insurance Company	AA-
261	$	5,000,000	Male	79	184.8	West Coast Life Insurance Company	AA-
262	$	3,000,000	Male	79	97.9	Principal Life Insurance Company	A+
263	$	5,000,000	Male	78	121.1	Jefferson-Pilot Life Insurance Company	AA-
264	$	3,000,000	Male	78	88.4	American General Life Insurance Company	A+
265	$	5,000,000	Male	78	81.1	John Hancock Life Insurance Company (U.S.A)	AA-
266	$	500,000	Male	78	69.4	John Hancock Life Insurance Company (U.S.A)	AA-

54

267	$	1,000,000	Male	78	117.3	Metropolitan Life Insurance Company	AA-
268	$	4,000,000	Male	78	52.3	MetLife Investors USA Insurance Company	AA-
269	$	2,500,000	Male	78	90.3	Massachusetts Mutual Life Insurance Company	AA+
270	$	2,500,000	Male	78	90.3	Massachusetts Mutual Life Insurance Company	AA+
271	$	500,000	Female	78	118.9	Columbus Life Insurance Company	AA
272	$	1,750,000	Male	78	65.4	John Hancock Life Insurance Company (U.S.A)	AA-
273	$	5,000,000	Male	78	106.5	Transamerica Life Insurance Company	AA-
274	$	3,750,000	Male	78	61.5	AXA Equitable Life Insurance Company	A+
275	$	2,000,000	Female	78	59.2	Transamerica Life Insurance Company	AA-
276	$	2,840,000	Male	77	101.6	Transamerica Life Insurance Company	AA-
277	$	4,000,000	Male	77	71.1	Massachusetts Mutual Life Insurance Company	AA+
278	$	1,000,000	Female	77	78.3	John Hancock Life Insurance Company (U.S.A)	AA-
279	$	2,000,000	Male	77	110.5	Genworth Life Insurance Company	BBB-
280	$	490,620	Male	77	90.4	Ameritas Life Insurance Corporation	A+
281	$	600,000	Male	77	87.6	Protective Life Insurance Company	AA-
282	$	5,000,000	Male	76	153.6	Prudential Life Insurance Company	AA-
283	$	3,000,000	Male	76	101.4	Prudential Life Insurance Company	AA-
284	$	5,000,000	Male	76	147.1	Massachusetts Mutual Life Insurance Company	AA+
285	$	5,000,000	Male	76	147.1	Massachusetts Mutual Life Insurance Company	AA+
286	$	3,000,000	Male	76	107.9	Protective Life Insurance Company	AA-
287	$	2,000,000	Female	76	123.9	Aviva Life Insurance Company	A-
288	$	7,000,000	Female	76	126.8	Pacific Life Insurance Company	A+
289	$	850,000	Male	76	72.3	New York Life Insurance Company	AA+
290	$	1,000,000	Male	76	87.2	Pacific Life Insurance Company	A+
291	$	2,000,000	Male	76	123.8	Transamerica Life Insurance Company	AA-
292	$	150,000	Male	76	110.1	Genworth Life Insurance Company	BBB-
293	$	5,000,000	Male	76	63.2	West Coast Life Insurance Company	AA-
294	$	250,000	Male	75	108.7	Midland National Life Insurance Company	A+
295	$	3,000,000	Male	75	59.4	Aviva Life Insurance Company	A-
296	$	200,000	Male	75	74.6	Voya Retirement Insurance and Annuity Company	A
297	$	3,000,000	Male	75	118.4	John Hancock Life Insurance Company (U.S.A)	AA-
298	$	5,000,000	Male	75	118.4	John Hancock Life Insurance Company (U.S.A)	AA-
299	$	8,000,000	Male	75	108.1	Metropolitan Life Insurance Company	AA-
300	$	4,000,000	Female	75	148.8	American General Life Insurance Company	A+
301	$	5,000,000	Male	75	36.4	Lincoln Benefit Life Company	BBB+
302	$	3,000,000	Female	75	121.0	General American Life Insurance Company	AA-
303	$	1,000,000	Male	74	106.1	Transamerica Life Insurance Company	AA-
304	$	500,000	Male	74	114.0	United of Omaha Life Insurance Company	AA-
305	$	300,000	Male	74	20.1	Lincoln National Life Insurance Company	AA-
306	$	2,000,000	Male	74	104.1	American General Life Insurance Company	A+
307	$	10,000,000	Female	74	145.2	Voya Retirement Insurance and Annuity Company	A
308	$	500,000	Male	73	41.6	Midland National Life Insurance Company	A+
309	$	3,000,000	Male	73	80.2	AXA Equitable Life Insurance Company	A+
310	$	2,500,000	Male	73	113.7	John Hancock Life Insurance Company (U.S.A)	AA-
311	$	500,000	Male	73	145.4	Prudential Life Insurance Company	AA-

55

312	$	500,000	Male	72	132.8	Ameritas Life Insurance Corporation	A+
313	$	370,000	Male	72	132.8	Ameritas Life Insurance Corporation	A+
314	$	500,000	Male	72	138.8	Metropolitan Life Insurance Company	AA-
315	$	2,500,000	Male	72	115.0	American General Life Insurance Company	A+
316	$	300,000	Male	72	121.5	New England Life Insurance Company	AA-
317	$	1,167,000	Male	72	32.3	Transamerica Life Insurance Company	AA-
318	$	1,500,000	Male	72	118.5	Metropolitan Life Insurance Company	AA-
319	$	10,000,000	Male	72	128.6	AXA Equitable Life Insurance Company	A+
320	$	3,000,000	Male	71	82.8	John Hancock Life Insurance Company (U.S.A)	AA-
321	$	2,000,000	Male	71	109.2	New York Life Insurance Company	AA+
322	$	2,000,000	Male	71	109.2	New York Life Insurance Company	AA+
323	$	5,000,000	Male	71	138.4	John Hancock Life Insurance Company (U.S.A)	AA-
324	$	2,500,000	Male	71	124.5	Lincoln National Life Insurance Company	AA-
325	$	2,500,000	Male	71	124.5	John Hancock Life Insurance Company (U.S.A)	AA-
326	$	600,000	Male	71	92.6	AXA Equitable Life Insurance Company	A+
327	$	420,000	Male	71	132.7	RiverSource Life Insurance Company	A+
328	$	650,000	Female	70	81.2	Voya Retirement Insurance and Annuity Company	A
329	$	1,250,000	Male	70	109.5	West Coast Life Insurance Company	AA-
330	$	500,000	Male	70	100.3	Transamerica Life Insurance Company	AA-
331	$	500,000	Male	70	100.3	North American Company for Life And Health Insurance	A+
332	$	2,000,000	Male	68	121.8	Transamerica Life Insurance Company	AA-
333	$	1,000,000	Male	68	121.8	Genworth Life Insurance Company	BBB-
334	$	1,000,000	Male	68	68.9	Protective Life Insurance Company	AA-
335	$	156,538	Female	68	114.8	New York Life Insurance Company	AA+
336	$	2,000,000	Male	68	56.5	MetLife Investors USA Insurance Company	AA-
337	$	2,000,000	Male	68	56.5	MetLife Investors USA Insurance Company	AA-
338	$	5,616,468	Male	67	191.2	John Hancock Life Insurance Company (U.S.A)	AA-
339	$	3,000,000	Male	66	110.0	Voya Retirement Insurance and Annuity Company	A
340	$	2,000,000	Male	66	110.0	AXA Equitable Life Insurance Company	A+
341	$	1,000,000	Male	66	53.7	Lincoln National Life Insurance Company	AA-
342	$	1,000,000	Male	66	86.7	Transamerica Life Insurance Company	AA-
343	$	250,000	Male	66	173.6	Prudential Life Insurance Company	AA-
	$	878,881,882

(1)	The insured’s age is current as of the measurement date.
(2)	The insured’s life expectancy estimate, other than for a small face value insurance policy benefit, is the average of two life expectancy estimates provided by independent third-party medical actuarial underwriting firms actuarially adjusted through the measurement date.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in our reports filed pursuant to the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance the objectives of the control system are met.

56

As of September 30, 2015, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of our disclosure controls and procedures as such term is defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934, as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with management's evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Securities Exchange Act of 1934 during the period covered by this report that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management's Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f).  Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only with proper authorizations; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management, under the supervision of and with the participation of the Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of September 30, 2015 based on criteria for effective control over financial reporting set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), 2013 framework in “Internal Control—Integrated Framework.” Based on this assessment, our management concluded that, as of the evaluation date, we maintained effective internal control over financial reporting.

57

PART II.  OTHER INFORMATION

ITEM 6. EXHIBITS

Exhibit
31.1	Section 302 Certification of the Chief Executive Officer (filed herewith).
31.2	Section 302 Certification of the Chief Financial Officer (filed herewith).
32	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. §1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ( filed herewith ).
99.1	Letter from Model Actuarial Pricing Systems, dated October 29, 2015 (filed herewith).
101.INS	XBRL Instance Document (filed herewith).
101.SCH	XBRL Schema Document (filed herewith).
101.CAL	XBRL Calculation Linkbase Document (filed herewith).
101.DEF	XBRL Definition Linkbase Document (filed herewith).
101.LAB	XBRL Label Linkbase Document (filed herewith).
101.PRE	XBRL Presentation Linkbase Document (filed herewith).

58

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	GWG HOLDINGS, INC.
Date:  November 12, 2015	By:	/s/ Jon R. Sabes
		Chief Executive Officer
Date:  November 12, 2015	By:	/s/ William B. Acheson
		Chief Financial Officer

59

EX-31.1

Exhibit 31.1

SECTION 302 CERTIFICATION

I, Jon R. Sabes, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GWG Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 12, 2015	/s/ Jon R. Sabes
	Chief Executive Officer

EX-31.2

Exhibit 31.2

SECTION 302 CERTIFICATION

I, William B. Acheson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GWG Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 12, 2015	/s/ William B. Acheson
	Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of GWG Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jon R. Sabes, Chief Executive Officer of the Company, and I, William B. Acheson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 12, 2015	/s/ Jon R. Sabes
	Jon R. Sabes
	Chief Executive Officer
November 12, 2015	/s/ William B. Acheson
	William B. Acheson
	Chief Financial Officer

EX-99.1

Exhibit 99.1

 

October 29, 2015

Steven Sabes

Chief Operating Officer

GWG Life

220 South Sixth Street, Suite 1200

Minneapolis, MN 55402

Steven:

You have asked that we prepare a quarterly valuation of a GWG portfolio of life insurance settlements. The valuations were prepared under the assumptions described below, which you provided in phone conversations and e-mails. We utilized the revised policy portfolio data you provided on 10/19/2015 to project potential cash flows monthly following the 9/30/2015 valuation date, based on the premiums and other values in the policy records provided.

Data Reliance

In preparing these valuations, we relied upon:

● Policy Data – We have relied on the portfolio data file as provided to us by GWG Life. This file and the policy data contained in it are assumed to have been prepared accurately and reflect current company supported product performance. The 9/30/2015 file had 343 policies with total face amounts of $878,881,882, a net increase of 29 policies and net increase of $72,608,026 in face amount over the prior quarter. The 6/30/2015 file had 314 policies with total face amounts of $806,273,856.

● Future Premiums Data – We have relied on GWG Life’s data regarding the future premiums to be paid on each policy. It is our understanding that GWG Life uses the MAPS software package along with data gathered from the actual premium payments to the life insurance carriers for each policy for projecting future minimum premium streams.

● Life Expectancy, Values, plus any adjustments – We have relied on the life expectancy values provided by GWG Life. It is our understanding that GWG Life obtained these LE values using the following industry experts: 21^st Services, AVS Underwriting, EMSI, Fasano Associates, and/or ISC Services.

Results

Using the assumptions stated below, we calculated the net present values as of the valuation dates using the

specified discount rates of 11.07% and 6.96%. These results will be e-mailed to you in the Excel reports generated, including a Portfolio Summary and List of Policies, from the MAPS Portfolio valuation model.

	GWG Portfolio as of 9/30/2015
Number of Policies		343
Total Net Death Benefit ($)		878,881,882
Discount Rate		11.07	%	6.96	%	12.00	%	15.00	%
Expected Net Present Value ($)		329,562,255		402,811,328		316,182,329		279,013,081
Stochastic Analysis – 10,000 Scenarios
95th Percentile Net Present Value ($)		298,954,898		371,705,405		285,555,404		249,035,028
95% CTE Net Present Value ($)		290,964,722		290,964,722		277,804,842		241,460,881

The Expected Net Present Value is the probabilistic average value of the portfolio. These values are calculated actuarially; assuming that the amount of premiums paid and death benefits received are proportional to the probabilities of survival. Since death will occur at an unknown discrete point in time, the actual return for a policy, and a portfolio of policies, may vary significantly from the Expected Value.

Model Actuarial Pricing Systems, LP

The Stochastic analysis can return information about the range of values that might be achieved along with probabilities that the results might be better or worse than the Expected or a specified level. The Stochastic analysis creates random scenarios where a discrete date of death is independently projected for each life based on its mortality curve. The net present value of the portfolio for each scenario is calculated as the present value of projected death benefits minus the present value of projected premiums. The scenarios are ranked by value. The 95th Percentile Net Present Value is the portfolio value exceeded by 95% of the stochastic scenarios. The 95% CTE is the Contingent Tail Expectation for the 95th percentile, and is the average of the 5% of scenarios with the lowest net present value.

The valuations (1) do not include premiums paid before the valuation date, and (2) assume that the insured remains alive at the valuation date. The valuations also assume that the policy COIs and policy expense charges remain at current levels in the future. If these charges are increased, the projected values would decrease. The above values do not consider any federal income or other taxes.

Summary of MAPS Model Settings and Assumptions

We used the following assumptions as discussed with you:

● Insurance Policy Characteristics: Per portfolio data file as provided.

● Policy Issue Date: Per portfolio data file as provided.

● Insured Date of Birth and Gender: Per portfolio data file as provided.

● Extended Death Benefit After Policy Maturity Age: Per portfolio data file as provided.

● Optimized Premium Levels and Timing: Monthly premiums unadjusted per the portfolio data file as provided.

● Per Policy and Portfolio Administrative Expenses: None, per the portfolio data file as provided.

● Collection of Death Benefit Delay: 0 months, with 0.00% statutory interest credited.

● Mortality: 2008 VBT Select & Ultimate Primary tables, by Age, Sex, and Tobacco Use.

● Age Basis: Age Nearest Birthday.

● Mortality Improvement: None.

● Life Expectancy: One blended LE and corresponding UW effective date per life in the portfolio data file as provided.

● Adjustment Applied to Stated LE: None.

● Improvement Used by Underwriters: No.

● Valuation Discount Interest Rates: 11.07% and 6.96% as specified, plus 12% and 15%.

● Number of Stochastic Scenarios: 10,000.

● Stochastic Random Seed input: 1234567

● Stochastic Percentile Ranks and Contingent Tail Expectations: 95%, with additional reporting at 75%, 85%, 90%, 97%, and 99%.

Notice on Mortality and Volatility

Parties engaged in life settlements commonly obtain and use "life expectancies" in their considerations. While life expectancies are provided for individuals, they are developed from expected patterns of mortality of large groups of similar individuals. No one knows exactly when any one individual will die, nor is a life expectancy intended to suggest the time until death will be near the life expectancy. Any one individual may live much longer than his or her estimated life expectancy or that projected by applying a mortality rating to any particular mortality table. Even for a large group of lives, the actual mortality for the group may be less than expected for a variety of reasons (such as improvements in medical technology, unanticipated general mortality improvement, or incorrect estimation of the life expectancy). Stochastic simulation and sensitivity testing can help to quantify these risks, but such tests should not be interpreted as a guarantee of any particular financial outcome. Investors will earn less than expected on the policy of any individual who lives longer than his life expectancy.

Model Actuarial Pricing Systems, LP

2

 

Background

Model Actuarial Pricing Systems, LP is a subsidiary of Cantor Fitzgerald (a leading global financial services firm) providing life settlement software and services worldwide to a variety of customers including life settlement brokers, providers, consultants and investors.

Since its inception in late 1990s, the MAPS Single Policy Valuation Model has been the industry standard life settlement valuation model for both single life and joint life insurance contracts. Incorporating sophisticated analysis and valuation algorithms, the MAPS Model transformed the life settlements industry by providing actuarially correct valuation of the premium and death benefit cash flows associated with a life settlement transaction.

Very truly yours,

/s/ Brad McGee

Brad McGee

Model Actuarial Pricing Systems, LP

Model Actuarial Pricing Systems, LP

3

XML

Investment in Life Insurance Policies(Details 2)	Sep. 30, 2015 USD ($)
Summary of estimated expected premium payments to maintain the above life insurance policies assuming no mortalities
Six months ending December 31 ,2015	$ 7,727,000
2016	30,845,000
2017	33,802,000
2018	36,653,000
2019	40,932,000
2020	45,435,000
Estimated expected premium payments	195,394,000
Premiums [Member]
Summary of estimated expected premium payments to maintain the above life insurance policies assuming no mortalities
Six months ending December 31 ,2015	7,315,000
2016	30,433,000
2017	33,390,000
2018	36,241,000
2019	40,520,000
2020	45,023,000
Estimated expected premium payments	192,922,000
Servicing [Member]
Summary of estimated expected premium payments to maintain the above life insurance policies assuming no mortalities
Six months ending December 31 ,2015	412,000
2016	412,000
2017	412,000
2018	412,000
2019	412,000
2020	412,000
Estimated expected premium payments	$ 2,472,000

XML

Income Taxes (Detail Textual)	Sep. 30, 2015 USD ($)
Income Taxes (Textual)
Federal net operating loss carryforwards	$ 516,000

XML

Series I Secured Notes (Details Textual) - USD ($)		3 Months Ended		9 Months Ended
	Jun. 14, 2011	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Series I Secured Notes Payable (Textual)
Weighted average market interest rate of Secured notes payable		7.06%		7.06%
Amortization of deferred financing and issuance costs		$ 457,000	$ 89,000	$ 757,000	$ 268,000
Series I Secured Notes Payable [Member]
Series I Secured Notes Payable (Textual)
Interest rate on secured notes, Minimum	5.65%
Interest rate on secured notes, Maximum	9.55%
Description of interest payment				Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note.
Weighted average market interest rate of Secured notes payable		8.47%		8.47%		8.37%
Principal amount outstanding under Series I Secured notes		$ 23,918,000		$ 23,918,000		$ 28,047,000
Amortization of deferred financing and issuance costs		$ 49,000	$ 126,000	260,000	$ 427,000
Future expected amortization of deferred financing costs				$ 351,000
Minimum maturity period of secured notes	9 months
Maximum maturity period of secured notes	7 years
Amortizatoin period of deferred financing cost				6 years

XML

Common Stock (Details) - USD ($)			1 Months Ended	3 Months Ended	9 Months Ended
	Jun. 23, 2015	Sep. 24, 2014	Jun. 24, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2015	Dec. 31, 2014
Common Stock (Textual)
Common stock, par value						$ 0.001	$ 0.001
Net proceeds				$ 9,030,000	$ 9,030,000
Reverse stock split			The company shall enact a reverse split of the common stock such that for every two (2) shares of common stock issued and outstanding immediately prior to the effective date shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) share of common stock.
GWG (Member)
Common Stock (Textual)
Restricted Common stock issued	60,000	800,000
Common stock, par value	$ 9.70	$ 12.50
Net proceeds		$ 8,600,000

XML

Credit Facilities (Details) - USD ($)		3 Months Ended		9 Months Ended
	Jul. 15, 2008	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Credit Facilities (Textual)
Maximum borrowing amount under line of credit facility	$ 100,000,000
Expiry date of line of credit	Jul. 15, 2013
Amount outstanding under line of credit facility		$ 65,011,000		$ 65,011,000		$ 72,161,000
Effective rate of interest		5.43%		5.43%		6.24%
Total funds available for additional borrowings under the borrowing base formula criteria		$ 55,648,000		$ 55,648,000		$ 20,585,000
Weighted average effective interest rate		5.42%	6.23%	5.81%	6.22%
Minimum tangible net worth to be maintained by company				$ 45,000,000
Minimum cash and eligible investments				15,000,000
Consolidated tangible net worth under credit and security agreement				105,605,000
Consolidated net income under credit and security agreement				$ 41,998,000
Credit facility up to limit	$ 105,000,000

XML

Guarantees of Secured Debt by GWG Life (Tables)

9 Months Ended

Sep. 30, 2015

Guarantees of Secured Debt by GWG Life [Abstract]

Condensed consolidating balance sheets

September 30, 2015	Parent			Guarantor Sub		Non-Guarantor Sub		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	26,354,110		$	1,948,399	$	150,164	$	-		$	28,452,673
Restricted cash		-			2,388,800		4,882,760		-			7,271,560
Policy benefits receivable		-			-		357,014		-			357,014
Investment in life settlements, at fair value		-			-		329,562,250		-			329,562,250
Other assets		2,918,013			1,732,640		1,232,070		-			5,882,723
Investment in subsidiaries		249,001,369			270,221,539		-		(519,222,908	)		-
TOTAL ASSETS	$	278,273,492		$	276,291,378	$	336,184,258	$	(519,222,908	)	$	371,526,220
L I A B I L I T I E S & S T O C K H O L D E R S' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	65,011,048	$	-		$	65,011,048
Series I Secured Notes		-			23,566,913		-		-			23,566,913
L Bonds		243,126,585			-		-		-			243,126,585
Interest payable		7,887,475			3,304,752		185,158		-			11,377,385
Accounts payable and other accrued expenses		1,879,138			568,509		616,348		-			3,063,995
Deferred taxes, net		4,608,650			-		-		-			4,608,650
TOTAL LIABILITIES		257,501,848			27,440,174		65,812,554		-			350,754,576
STOCKHOLDERS’ EQUITY
Member capital		-			248,851,204		270,371,704		(519,222,908	)		-
Convertible preferred stock		2,623,541			-		-		-			20,623,541
Common stock		5,942			-		-		-			5,942
Additional paid-in capital		17,163,249			-		-		-			17,163,249
Accumulated deficit		(17,021,088	)		-		-		-			(17,021,088	)
TOTAL STOCKHOLDERS’ EQUITY		20,771,644			248,851,204		270,371,704		(519,222,908	)		20,771,644
TOTAL LIABILITIES AND EQUITY	$	278,273,492		$	276,291,378	$	336,184,258	$	(519,222,908	)	$	371,526,220

December 31, 2014	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	30,446,473		$	216,231	$	-	$	-		$	30,662,704
Restricted cash		-			82,500		4,213,553		-			4,296,053
Policy benefits receivable		-			-		1,750,000		-			1,750,000
Investment in life settlements, at fair value		-			-		282,883,010		-			282,883,010
Other assets		1,673,728			1,777,534		27,500		-			3,478,762
Investment in subsidiaries		185,636,417			215,124,779		-		(400,761,196	)		-
TOTAL ASSETS	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529
L I A B I L I T I E S & S T O C K H O L D E R S' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes		-			27,616,578		-		-			27,616,578
L Bonds		182,782,884			-		-		-			182,782,884
Interest payable		6,598,250			3,513,615		1,016,654		-			11,128,519
Accounts payable and other accrued expenses		711,993			434,433		571,583		-			1,718,009
Deferred taxes, net		5,273,555			-		-		-			5,273,555
TOTAL LIABILITIES		195,366,682			31,564,626		73,749,285		-			300,680,593
STOCKHOLDERS’ EQUITY
Member capital		-			185,636,418		215,124,778		(400,761,196	)		-
Convertible preferred stock		20,527,866			-		-		-			20,527,866
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,257,686			-		-		-			16,257,686
Accumulated deficit		(14,401,486	)		-		-		-			(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		22,389,936			185,636,418		215,124,778		(400,761,196	)		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529

Condensed consolidating statements of operations

For the nine months ended September 30, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	2,022,774		$	-	$	(2,022,774	)	$	-
Gain on life settlements, net		-			-			33,446,556		-			33,446,556
Interest and other income		38,944			61,694			132,878		-			233,516
TOTAL REVENUE		38,944			2,084,468			33,579,434		(2,022,774	)		33,680,072
EXPENSES
Origination and servicing fees		-			-			2,022,774		(2,022,774	)		-
Employee compensation and benefits		4,671,183			1,509,703			-		-			6,180,886
Legal and professional fees		1,427,388			560,873			-		-			1,988,261
Interest expense		18,011,890			1,984,356			3,152,784		-			23,149,030
Other expenses		3,251,606			2,297,063			97,733		-			5,646,402
TOTAL EXPENSES		27,362,067			6,351,995			5,273,291		(2,022,774	)		36,964,579
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(27,323,123	)		(4,267,527	)		28,306,143		-			(3,284,507	)
EQUITY IN INCOME OF SUBSIDIARY		24,038,616			28,305,979			-		(52,344,595	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(3,284,507	)		24,038,452			28,306,143		(52,344,595	)		(3,284,507	)
INCOME TAX BENEFIT		(664,905	)		-			-		-			(664,905	)
NET INCOME (LOSS)	$	(2,619,602	)	$	24,038,452		$	28,306,143	$	(52,344,595	)	$	(2,619,602	)

For the nine months ended September 30, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	1,462,376		$	-	$	(1,462,376	)	$	-
Gain on life settlements, net		-			-			16,119,517		-			16,119,517
Interest and other income		17,501			229,348			5,218		(228,092	)		23,975
TOTAL REVENUE		17,501			1,691,724			16,124,735		(1,690,468	)		16,143,492
EXPENSES
Origination and servicing fees		-			-			1,462,376		(1,462,376	)		-
Employee compensation and benefits		1,992,554			1,531,720			-		-			3,524,274
Legal and professional fees		1,476,213			141,470			10,086		-			1,627,769
Interest expense		13,371,300			2,334,097			4,025,930		-			19,731,327
Other expenses		1,937,674			1,299,666			268,602		(228,092	)		3,277,850
TOTAL EXPENSES		18,777,741			5,306,953			5,766,994		(1,690,468	)		28,161,220
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(18,760,240	)		(3,615,229	)		10,357,741		-			(12,017,728	)
EQUITY IN INCOME OF SUBSIDIARY		6,742,512			10,357,741			-		(17,100,253	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(12,017,728	)		6,742,512			10,357,741		(17,100,253	)		(12,017,728	)
INCOME TAX BENEFIT		(4,129,670	)		-			-		-			(4,129,670	)
NET INCOME (LOSS)	$	(7,888,058	)	$	6,742,512		$	10,357,741	$	(17,100,253	)	$	(7,888,058	)

For the three months ended September 30, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	1,004,024		$	-	$	(1,004,024	)	$	-
Gain on life settlements, net		-			-			8,189,261		-			8,189,261
Interest and other income		13,922			54,813			25,106		-			93,841
TOTAL REVENUE		13,922			1,058,837			8,214,367		(1,004,024	)		8,283,102
EXPENSES
Origination and servicing fees		-			-			1,004,024		(1,004,024	)		-
Employee compensation and benefits		1,759,589			548,657			-		-			2,308,246
Legal and professional fees		598,530			223,547			-		-			822,077
Interest expense		6,980,132			525,391			1,144,626		-			8,650,149
Other expenses		1,195,417			995,026			40,898		-			2,231,341
TOTAL EXPENSES		10,533,668			2,292,621			2,189,548		(1,004,024	)		14,011,813
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(10,519,746	)		(1,233,784	)		6,024,819		-			(5,728,711	)
EQUITY IN INCOME OF SUBSIDIARY		4,791,035			6,024,762			-		(10,815,797	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(5,728,711	)		4,790,978			6,024,819		(10,815,797	)		(5,728,711	)
INCOME TAX BENEFIT		(2,097,633	)		-			-		-			(2,097,633	)
NET INCOME (LOSS)	$	(3,631,078	)	$	4,790,978		$	6,024,819	$	(10,815,797	)	$	(3,631,078	)

For the three months ended September 30, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	153,470		$	-	$	(153,470	)	$	-
Gain on life settlements, net		-			-			5,118,423		-			5,118,423
Interest and other income		4,572			59,372			5,156		(58,871	)		10,229
TOTAL REVENUE		4,572			212,842			5,123,579		(212,341	)		5,128,652
EXPENSES
Origination and servicing fees		-			-			153,470		(153,470	)		-
Employee compensation and benefits		737,475			639,235			-		-			1,376,710
Legal and professional fees		734,024			16,020			10,086		-			760,130
Interest expense		4,679,311			761,828			1,355,597		-			6,796,736
Other expenses		850,122			587,745			74,371		(58,871	)		1,453,367
TOTAL EXPENSES		7,000,932			2,004,828			1,593,524		(212,341	)		10,386,943
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(6,996,360	)		(1,791,986	)		3,530,055		-			(5,258,291	)
EQUITY IN INCOME OF SUBSIDIARY		1,738,069			3,530,055			-		(5,268,124	)		-
NET INCOME BEFORE INCOME TAXES		(5,258,291	)		1,738,069			3,530,055		(5,268,124	)		(5,258,291	)
INCOME TAX BENEFIT		(1,858,100	)		-			-		-			(1,858,100	)
NET INCOME (LOSS)	$	(3,400,191	)	$	1,738,069		$	3,530,055	$	(5,268,124	)	$	(3,400,191	)

Condensed consolidating statements of cash flows

For the nine months ended September 30, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(2,619,602	)	$	24,038,452		$	28,306,143		$	(52,344,595	)	$	(2,619,602	)
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries		(24,038,617	)		(28,305,978	)		-			52,344,595			-
Gain on life settlements		-			-			(26,651,363	)		-			(26,651,363	)
Amortization of deferred financing and issuance costs		2,832,487			260,455			(1,201,170	)		-			1,891,772
Deferred income taxes		(664,905	)		-			-			-			(664,905	)
Convertible, redeemable preferred dividends payable		509,225			-			-			-			509,225
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			1,392,986						1,392,986
Other assets		(40,145,769	)		(26,745,888	)		-			66,117,118			(774,539	)
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses		4,503,624			123,222			(790,131	)		-			3,836,715
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(30,425,246	)		(30,629,737	)		1,056,465			66,117,118			(23,079,711	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(23,850,860	)		-			(23,850,860	)
Proceeds from settlement of life settlements		-			-			3,822,983			-			3,822,983
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(20,027,877	)		-			(20,027,877	)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility		-			-			(7,150,000	)		-			(7,150,000	)
Payments for redemption of Series I Secured Notes		-			(4,508,130	)		-			-			(4,508,130	)
Proceeds from issuance of L Bonds		87,620,483			-			-			-			87,620,483
Payments for redemption and issuance of L Bonds		(32,376,104	)		-			-			-			(32,376,104	)
Payments from restricted cash		-			(2,306,300	)		(669,207	)		-			(2,975,507	)
Issuance of common stock		582,000			-			-			-			582,000
Payments for redemption preferred stock		(295,185	)		-			-			-			(295,185	)
Issuance of member capital		-			39,176,335			26,940,783			(66,117,118	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		55,531,194			32,361,905			19,121,576			(66,117,118	)		40,897,557
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(4,092,363	)		1,732,168			150,164			-			(2,210,031	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		30,446,473			216,231			-			-			30,662,704
END OF THE PERIOD	$	26,354,110		$	1,948,399		$	150,164		$	-		$	28,452,673

For the nine months ended September 30, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(7,888,058	)	$	6,742,512		$	10,357,741		$	(17,100,253	)	$	(7,888,058	)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
(Equity) of subsidiaries		(6,742,512	)		(10,357,741	)		-			17,100,253			-
Gain on life settlements		-			-			(30,973,250	)		-			(30,973,250	)
Amortization of deferred financing and issuance costs		2,125,269			427,187			18,425						2,570,881
Deferred income taxes		(4,129,670	)		-			-						(4,129,670	)
Convertible, redeemable preferred stock dividends payable		575,513			-			-			-			575,513
(Increase) in operating assets:
Other assets		(35,758,660	)		(29,984,534	)		-			63,647,054			(2,096,140	)
Increase in operating liabilities:
Accounts payable and accrued expenses		2,893,814			591,534			173,311			-			3,658,659
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(48,924,304	)		(32,851,042	)		(20,423,773	)		63,647,054			(38,282,065	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(11,559,435	)		-			(11,559,435	)
Proceeds from settlement of life settlements		-			-			999,125			-			999,125
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(10,560,310	)		-			(10,560,310	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(2,047,928	)		-			-			(2,047,928	)
Proceeds from issuance of L Bonds		48,516,296			-			-			-			48,516,296
Payments for redemption and issuance of L Bonds		(13,816,794	)		-			-			-			(13,816,794	)
Proceeds from restricted cash		-			1,420,000			2,268,236			-			3,688,236
Proceeds from sale of common stock		9,030,000			-			-			-			9,030,000
Payments for redemption preferred stock		(465,239	)		-			-			-			(465,239	)
Issuance of member capital		-			34,931,207			28,715,847			(63,647,054	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		43,264,263			34,303,279			30,984,083			(63,647,054	)		44,904,571
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(5,666,041	)		1,722,237			-			-			(3,937,804	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		32,711,636			738,157			-			-			33,449,793
END OF THE PERIOD	$	27,051,595		$	2,460,394		$	-		$	-		$	29,511,989

For the three months ended September 30, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(3,631,078	)	$	4,790,978		$	6,024,819		$	(10,815,797	)	$	(3,631,078	)
Adjustments to reconcile net loss to net cash flows from operating activities:
(Equity) of subsidiaries		(4,791,035	)		(6,024,762	)		-			10,815,797			-
Gain on life settlements		-			-			(14,516,881	)		-			(14,516,881	)
Amortization of deferred financing and issuance costs		1,103,312			49,339			781,125			-			1,933,776
Deferred income taxes		(1,916,686	)		-			-			-			(1,916,686	)
Convertible, redeemable preferred stock dividends payable		173,993			-			-			-			173,993
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			2,142,986			-			2,142,986
Other assets		(22,146,946	)		(15,631,849	)		-			37,360,805			(417,990	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		2,010,129			(105,418	)		629,558			-			2,534,269
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(29,198,311	)		(16,921,712	)		(4,938,393	)		37,360,805			(974,383	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(13,626,842	)		-			(13,626,842	)
Proceeds from settlement of life settlements		-			-			80,000			-			80,000
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(13,546,842	)		-			(13,546,842	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(890,586	)		-			-			(890,586	)
Proceeds from issuance of L Bonds		37,122,127			-			-			-			37,122,127
Payments for redemption and issuance of L Bonds		(19,363,047	)		-			-			-			(19,363,047	)
Proceeds (payments) from restricted cash		-			(2,203,800	)		2,855,430			-			651,630
Issuance of member capital		-			21,730,944			15,629,861			(37,360,805	)		-
Payments for redemption preferred stock		(21,187	)		-			-			-			(21,187	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		17,737,893			18,636,558			18,485,291			(37,360,805	)		17,498,937
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(11,460,418	)		1,714,846			56			-			(9,363,047	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		37,814,528			233,553			150,108			-			38,198,189
END OF THE PERIOD	$	26,354,110		$	1,948,399		$	150,164		$	-		$	28,452,673

For the three months ended September 30, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(3,400,191	)	$	1,738,069		$	3,530,055		$	(5,268,124	)	$	(3,400,191	)
Adjustments to reconcile net loss to cash:
(Equity) of subsidiaries		(1,738,069	)		(3,530,055	)		-			5,268,124			-
Gain on life settlements		-			-			(8,761,912	)		-			(8,761,912	)
Amortization of deferred financing and issuance costs		397,659			126,083			339,475			-			863,217
Deferred income taxes		(1,858,100	)		-			-			-			(1,858,100	)
Convertible, redeemable preferred stock dividends payable		186,182			-			-			-			186,182
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			300,000			-			300,000
Other assets		(9,136,310	)		(5,329,716	)		-			13,318,805			(1,147,221	)
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses		922,271			289,132			(720,907	)		-			490,496
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(14,626,558	)		(6,706,487	)		(5,313,289	)		13,318,805			(13,327,529	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(680,000	)		-			(680,000	)
Proceeds from settlement of life settlements		-			-			930,625			-			930,625
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			250,625			-			250,628
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(509,004	)		-			-			(509,004	)
Proceeds from issuance of L Bonds		15,281,809			-			-			-			15,281,809
Payments for redemption and issuance of L Bonds		(4,494,383	)		-			-			-			(4,494,383	)
Proceeds from restricted cash		-			565,000			100,699			-			665,699
Proceeds from sale of common stock		9,030,000			-			-			-			9,030,000
Issuance of member capital		-			8,356,840			4,961,965			(13,318,805	)		-
Payments for redemption preferred stock		(445,183	)		-			-			-			(445,183	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		19,372,243			8,412,836			5,062,664			(13,318,805	)		19,528,938
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		4,745,685			1,706,349			-			-			6,452,034
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		22,305,910			754,045			-			-			23,059,955
END OF THE PERIOD	$	27,051,595		$	2,460,394		$	-		$	-		$	29,511,989

XML

Stock Incentive Plan (Details Textual) - USD ($)		1 Months Ended	9 Months Ended
	Mar. 27, 2013	Sep. 30, 2014	Sep. 30, 2015
Stock Incentive Plan (Textual)
Number of shares issued to employees, officers and directors			300,950
Options vesting period			3 years
Forfeited during the year			(103,333)
Compensation expense related to un-vested options not yet recognized			$ 499,000
Compensation expense related to un-vested options, period of recognition			3 years
Ownership Percentage			10.00%
Compensation Expense in 2015			$ 9,000
Compensation Expense in 2016			239,000
Compensation Expense in 2017			200,000
Compensation Expense in 2018			$ 51,000
Exercised during the year			(27,667)
Share-based options, forfeited			53,000
Share-based options, vested			53,000
Maximum [Member]
Stock Incentive Plan (Textual)
Exercise Price			$ 10.18
Minimum [Member]
Stock Incentive Plan (Textual)
Exercise Price			$ 8.20
Common Stock [Member]
Stock Incentive Plan (Textual)
Number of shares issued to employees, officers and directors			1,046,551
Number of options vested			449,274
Others [Member] | Maximum [Member]
Stock Incentive Plan (Textual)
Exercise Price			$ 10.25
Others [Member] | Minimum [Member]
Stock Incentive Plan (Textual)
Exercise Price			$ 6.73
2013 Stock Incentive Plan [Member]
Stock Incentive Plan (Textual)
Number of shares issuable	2,000,000
Stock based compensation, Method used			The annual volatility rate is based on the standard deviation of the average continuously compounded rate of return of five selected comparable companies over the previous 52 weeks.
Expected volatility rate			17.03%
2013 Stock Incentive Plan [Member] | Maximum [Member]
Stock Incentive Plan (Textual)
Stock option period	10 years
2013 Stock Incentive Plan [Member] | Employee Stock Option [Member]
Stock Incentive Plan (Textual)
Maximum number of shares for an employee		53,000
Employee granting right purchase of common stock		318,000
Number of options vested		159,000
Exercise Price		$ 12.50
Options vesting period		1 year
2013 Stock Incentive Plan [Member] | Common Stock [Member]
Stock Incentive Plan (Textual)
Maximum number of shares for an employee	400,000
Forfeited during the year			166,499
Forfeited during the year, Percent			15.00%
Exercised during the year			28,001

XML

Nature of Business and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2015

Nature of Business and Summary of Significant Accounting Policies [Abstract]

Use of estimates

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1) the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Cash and cash equivalents

Cash and cash equivalents - The Company considers cash in demand deposit accounts and temporary investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains its cash and cash equivalents with highly rated financial institutions. From time to time, the Company’s balances in its bank accounts exceed Federal Deposit Insurance Corporation limits. The Company periodically evaluates the risk of exceeding insured levels and may transfer funds as it deems appropriate. The Company has not experienced any losses with regards to balances in excess of insured limits or as a result of other concentrations of credit risk.

Life settlements

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1)	Receipt of death notice or verified obituary of insured
2)	Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. In an event of a sale of a policy, the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company. Such deposits and direct cost advances were $31,000 and $27,000 at September 30, 2015 and December 31, 2014, respectively.

Deferred financing and issuance costs

Deferred financing and issuance costs – Costs incurred to obtain financing under the revolving credit facility, as described in note 5, have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. Amortization of deferred financing costs was $457,000 and $89,000 for the three-month periods ended September 30, 2015 and 2014, and $757,000 and $268,000 for the nine-month periods ended September 30, 2015 and 2014, respectively. Future amortization is expected to be $1,096,000 for the next seven months ending April 30, 2016.  The Series I Secured Notes, as described in note 6, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock, as described in note 8, was also reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which were amortized into additional paid-in-capital over the three-year redemption period. As of December 31, 2014, all of these costs had been fully amortized.

Earnings (loss) per share

Earnings (loss) per share - Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period. Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock, and outstanding warrants, and stock options.

Subsequent events

Subsequent events - Subsequent events are events or transactions that occur after the balance sheet date but before consolidated financial statements are issued. The Company recognizes in the consolidated financial statements the effects of all subsequent events that provide additional evidence about conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing the consolidated financial statements. The Company’s consolidated financial statements do not recognize subsequent events that provide evidence about conditions that did not exist at the date of the balance sheet but arose after the balance sheet date and before the consolidated financial statements are available to be issued. The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are filed for potential recognition or disclosure.

Recently adopted pronouncements

Recently adopted pronouncements - On April 7, 2015 the FASB issued Accounting Standards Update (ASU) No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs,” as part of its simplification initiative. The ASU changes the presentation of debt issuance costs in financial statements. Under the ASU, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. For public business entities, the guidance in the ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. For entities other than public business entities, the guidance is effective for fiscal years beginning after December 15, 2015, and interim periods beginning after December 15, 2016. Early adoption is allowed for all entities for financial statements that have not been previously issued. Entities would apply the new guidance retrospectively to all prior periods (i.e., the balance sheet for each period is adjusted). The impact of the new ASU on the Company’s balance sheet would be a reduction of approximately $3,195,000 to assets and a corresponding reduction to liabilities. There would be no impact on the Company’s statements of operations.

XML

L Bonds (Formerly Renewable Secured Debentures) (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Jan. 31, 2015	Dec. 31, 2014
Renewable Secured Debentures (Textual)
Debentures offer for sale	$ 271,471,000		$ 271,471,000
Weighted average market interest rate of secured notes payable	7.06%		7.06%
Renewable Secured Debentures [Member]
Renewable Secured Debentures (Textual)
Debentures offer for sale	$ 250,000,000		$ 250,000,000		$ 1,000,000,000
Interest rates, minimum			4.25%
Interest rates, maximum			9.50%
Description of interest payment			Interest is payable monthly, annually or at maturity depending on the terms of the debenture.
Weighted average market interest rate of secured notes payable	7.21%		7.21%			7.45%
Amount outstanding under L Bonds	$ 247,553,000		$ 247,553,000			$ 186,377,000
Amortization of deferred issuance costs	$ 1,892,000	$ 829,000	42,320,000	$ 2,584,000
Future expected amortization of deferred financing costs			$ 6,795,000
Maturity period of debentures, Minimum			6 months
Maturity period of debentures, Maximum			7 years
Conditions for proceed from issuance of debenture			(1) payment of commissions on sales of L Bonds, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) payment of premiums on life insurance policies, (5) payment of principal and interest on L Bonds, (6) payment of portfolio operations expenses, and (7) general working capital.
Publicly registered L Bond offering			$ 1,000,000,000
Minimum increments			$ 25,000

XML

Fair Value Definition and Hierarchy (Details 1) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Summary of inputs utilized in estimating the fair value
Discount rate	11.07%	11.43%
Life insurance policies [Member]
Summary of inputs utilized in estimating the fair value
Weighted average age of insured	82 years 7 months 6 days	82 years 9 months 18 days
Weighted average life expectancy, months*	79 years 2 months 12 days	78 years 4 months 24 days
Average face amount per policy	$ 2,562,000	$ 2,677,000
Discount rate	11.07%	11.43%

XML

Investment in Life Insurance Policies (Details)	Sep. 30, 2015 USD ($) Contract	Dec. 31, 2014 USD ($) Contract
Summary of Company's life insurance policies accounted for under fair value method and their estimated maturity dates, based on remaining life expectancy
Number of Contracts, 2015 | Contract		3
Number of Contracts, 2016 | Contract	5	7
Number of Contracts, 2017 | Contract	14	17
Number of Contracts, 2018 | Contract	26	30
Number of Contracts, 2019 | Contract	50	45
Number of Contracts, 2020 | Contract	47	41
Number of Contracts, 2021 | Contract	51	36
Number of Contracts, Thereafter | Contract	150	112
Life Settlement Contracts, Number of Contracts, Total | Contract	343	291
Estimated Fair Value, 2015		$ 5,063,000
Estimated Fair Value, 2016	$ 7,399,000	8,144,000
Estimated Fair Value, 2017	14,484,000	21,916,000
Estimated Fair Value, 2018	39,188,000	41,994,000
Estimated Fair Value, 2019	55,126,000	47,303,000
Estimated Fair Value, 2020	52,173,000	43,429,000
Estimated Fair Value, 2021	47,957,000	29,789,000
Estimated Fair Value, Thereafter	113,235,000	85,245,000
Life Settlement Contracts, Estimated Fair Value, Total	$ 329,562,000	282,883,000
Face Value, 2015		6,000,000
Face Value, 2016	$ 8,500,000	11,550,000
Face Value, 2017	19,557,000	35,542,000
Face Value, 2018	63,114,000	76,206,000
Face Value, 2019	109,625,000	106,973,000
Face Value, 2020	111,187,000	102,614,000
Face Value, 2021	129,006,000	90,921,000
Face Value, Thereafter	437,893,000	349,293,000
Life Settlement Contracts, Face Value, Total	$ 878,882,000	$ 779,099,000

XML

Redeemable Preferred Stock (Details) - Series A 7% redeemable preferred stocks [Member]	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Subsidiary, Sale of Stock [Line Items]
Company offering shares of convertible redeemable preferred stock | shares	100,000
Offering price of series redeemable preferred stock	$ 10,000
Redeemable preferred stock par value per share	$ 0.001
Dividend rate of convertible redeemable preferred stock	7.00%

XML

Concentrations (Details Textual)	9 Months Ended
	Sep. 30, 2015
Concentration (Textual)
Description of issuance contracts with specific life insurance companies and contracts held in specific states	Exceeding 10% of the total face value

XML

Guarantees of Secured Debt by GWG Life (Details) - USD ($)	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Dec. 31, 2013
A S S E T S
Cash and cash equivalents	$ 28,452,673	$ 38,198,189	$ 30,662,704	$ 29,511,989	$ 23,059,955	$ 33,449,793
Restricted cash	7,271,560		4,296,053
Policy benefits receivable	357,014		1,750,000
Investment in life settlements, at fair value	329,562,250		282,883,010
Other assets	$ 5,882,723		$ 3,478,762
Investment in subsidiaries
TOTAL ASSETS	$ 371,526,220		$ 323,070,529
LIABILITIES
Revolving credit facility	65,011,048		72,161,048
Series I Secured Notes	23,566,913		27,616,578
L Bonds	243,126,585		182,782,884
Interest payable	11,377,385		11,128,519
Accounts payable and other accrued expenses	3,063,995		1,718,009
Deferred taxes, net	4,608,650		5,273,555
TOTAL LIABILITIES	$ 350,754,576		$ 300,680,593
STOCKHOLDERS' EQUITY
Member capital
Convertible preferred stock	$ 20,623,541		$ 20,527,866
Common stock	5,942		5,870
Additional paid-in capital	17,163,249		16,257,686
Accumulated deficit	(17,021,088)		(14,401,486)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	20,771,644		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	371,526,220		323,070,529
Parent [Member]
A S S E T S
Cash and cash equivalents	$ 26,354,110	37,814,528	$ 30,446,473	27,051,595	22,305,910	32,711,636
Restricted cash
Policy benefits receivable
Investment in life settlements, at fair value
Other assets	$ 2,918,013		$ 1,673,728
Investment in subsidiaries	249,001,369		185,636,417
TOTAL ASSETS	$ 278,273,492		$ 217,756,618
LIABILITIES
Revolving credit facility
Series I Secured Notes
L Bonds	$ 243,126,585		$ 182,782,884
Interest payable	7,887,475		6,598,250
Accounts payable and other accrued expenses	1,879,138		711,993
Deferred taxes, net	4,608,650		5,273,555
TOTAL LIABILITIES	$ 257,501,848		$ 195,366,682
STOCKHOLDERS' EQUITY
Member capital
Convertible preferred stock	$ 2,623,541		$ 20,527,866
Common stock	5,942		5,870
Additional paid-in capital	17,163,249		16,257,686
Accumulated deficit	(17,021,088)		(14,401,486)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	20,771,644		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	278,273,492		217,756,618
Guarantor Sub [Member]
A S S E T S
Cash and cash equivalents	1,948,399	233,553	216,231	$ 2,460,394	$ 754,045	$ 738,157
Restricted cash	$ 2,388,800		$ 82,500
Policy benefits receivable
Investment in life settlements, at fair value
Other assets	$ 1,732,640		$ 1,777,534
Investment in subsidiaries	270,221,539		215,124,779
TOTAL ASSETS	$ 276,291,378		$ 217,201,044
LIABILITIES
Revolving credit facility
Series I Secured Notes	$ 23,566,913		$ 27,616,578
L Bonds
Interest payable	$ 3,304,752		$ 3,513,615
Accounts payable and other accrued expenses	$ 568,509		$ 434,433
Deferred taxes, net
TOTAL LIABILITIES	$ 27,440,174		$ 31,564,626
STOCKHOLDERS' EQUITY
Member capital	$ 248,851,204		$ 185,636,418
Convertible preferred stock
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	$ 248,851,204		$ 185,636,418
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	276,291,378		$ 217,201,044
Non-Guarantor Sub [Member]
A S S E T S
Cash and cash equivalents	150,164	$ 150,108
Restricted cash	4,882,760		$ 4,213,553
Policy benefits receivable	357,014		1,750,000
Investment in life settlements, at fair value	329,562,250		282,883,010
Other assets	$ 1,232,070		$ 27,500
Investment in subsidiaries
TOTAL ASSETS	$ 336,184,258		$ 288,874,063
LIABILITIES
Revolving credit facility	$ 65,011,048		$ 72,161,048
Series I Secured Notes
L Bonds
Interest payable	$ 185,158		$ 1,016,654
Accounts payable and other accrued expenses	$ 616,348		$ 571,583
Deferred taxes, net
TOTAL LIABILITIES	$ 65,812,554		$ 73,749,285
STOCKHOLDERS' EQUITY
Member capital	$ 270,371,704		$ 215,124,778
Convertible preferred stock
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	$ 270,371,704		$ 215,124,778
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 336,184,258		$ 288,874,063
Eliminations [Member]
A S S E T S
Cash and cash equivalents
Restricted cash
Policy benefits receivable
Investment in life settlements, at fair value
Other assets
Investment in subsidiaries	$ (519,222,908)		$ (400,761,196)
TOTAL ASSETS	$ (519,222,908)		$ (400,761,196)
LIABILITIES
Revolving credit facility
Series I Secured Notes
L Bonds
Interest payable
Accounts payable and other accrued expenses
Deferred taxes, net
TOTAL LIABILITIES
STOCKHOLDERS' EQUITY
Member capital	$ (519,222,908)		$ (400,761,196)
Convertible preferred stock
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	$ (519,222,908)		$ (400,761,196)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ (519,222,908)		$ (400,761,196)

XML

Series I Secured Notes (Details) - Series I Secured Notes Payable [Member]	Sep. 30, 2015 USD ($)
Summary of future contractual maturities of notes payable
2015	$ 1,776,000
2016	12,827,000
2017	6,154,000
2018	998,000
2019	347,000
Thereafter	1,816,000
Total	23,918,000
Summary of amortization of deferred financing costs of notes payable
2015	8,000
2016	103,000
2017	129,000
2018	28,000
2019	7,000
Thereafter	76,000
Total	$ 351,000

XML

Investment in Life Insurance Policies

9 Months Ended

Sep. 30, 2015

Investment in Life Insurance Policies [Abstract]

Investment in life insurance policies

(3) Investment in life insurance policies

The life insurance policies (Level 3 fair value measurements) are valued based on unobservable inputs that are significant to the overall fair value measurement. Changes in the fair value of these instruments are recorded in gain or loss on life insurance policies in the consolidated statements of operations (net of the cash premiums paid on the policies). The fair value is determined on a discounted cash flow basis that incorporates life expectancy assumptions.  Life expectancy reports have been obtained from widely accepted life expectancy providers. The discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed in the secondary market, market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies. As a result of management’s analysis, discount rates of 11.07% and 11.43% were applied to the portfolio as of September 30, 2015 and December 31, 2014, respectively.

A summary of the Company’s life insurance policies accounted for under the fair value method and their estimated maturity dates, based on remaining life expectancy is as follows:

	As of September 30, 2015						As of December 31, 2014
Years Ending December 31,	Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2015		-	$	-	$	-		3	$	5,063,000	$	6,000,000
2016		5		7,399,000		8,500,000		7		8,144,000		11,550,000
2017		14		14,484,000		19,557,000		17		21,916,000		35,542,000
2018		26		39,188,000		63,114,000		30		41,994,000		76,206,000
2019		50		55,126,000		109,625,000		45		47,303,000		106,973,000
2020		47		52,173,000		111,187,000		41		43,429,000		102,614,000
2021		51		47,957,000		129,006,000		36		29,789,000		90,921,000
Thereafter		150		113,235,000		437,893,000		112		85,245,000		349,293,000
Totals		343		329,562,000		878,882,000		291	$	282,883,000	$	779,099,000

The Company realized policy benefits of $357,000 and $3,000,000 during the three-month periods ended September 30, 2015 and 2014, respectively, related to policies with a carrying value of $80,000 and $931,000, respectively. The Company recorded realized gains of $277,000 and $2,069,000 on such policies. The Company recognized policy benefits of $29,732,000 and $3,300,000 during the nine-month periods ended September 30, 2015 and 2014, respectively, related to policies with a carrying value of $3,823,000 and $999,000, respectively.  The Company recorded realized gains of $25,909,000 and $2,301,000, respectively on such policies. Subsequent to September 30, 2015, one policy with insurance benefits of $1,500,000 has matured.

Reconciliation of gain on life settlements:

	Three Months Ended  September 30,						Nine Months Ended  September 30,
	2015			2014			2015			2014
Change in fair value	$	14,517,000		$	8,762,000		$	26,651,000		$	30,973,000
Premiums and other annual fees		(6,605,000	)		(5,713,000	)		(19,114,000	)		(17,155,000	)
Policy maturities		277,000			2,069,000			25,909,000			2,301,000
Gain on life settlements, net	$	8,189,000		$	5,118,000		$	33,446,000		$	16,119,000

The estimated expected premium payments to maintain the above life insurance policies in force through 2020, assuming no policy maturities, are as follows:

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Three months ending December 31, 2015	$	7,315,000	$	412,000	$	7,727,000
2016		30,433,000		412,000		30,845,000
2017		33,390,000		412,000		33,802,000
2018		36,241,000		412,000		36,653,000
2019		40,520,000		412,000		40,932,000
2020		45,023,000		412,000		45,435,000
	$	192,922,000	$	2,472,000	$	195,394,000

Management anticipates funding the estimated premium payments as noted above with proceeds from the DZ Bank revolving credit facility and through additional debt and equity financing as well as from cash proceeds from maturities of life insurance policies. The proceeds of these capital sources are also intended to be used for the purchase, financing, and maintenance of additional life insurance policies among other things.

XML

Guarantees of Secured Debt by GWG Life (Details 1) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
REVENUE
Origination and servicing income
Gain on life settlements, net	$ 8,189,261	$ 5,118,423	$ 33,446,556	$ 16,119,517
Interest and other income	93,841	10,229	233,516	23,975
TOTAL REVENUE	$ 8,283,102	$ 5,128,652	$ 33,680,072	$ 16,143,492
EXPENSES
Origination and servicing fees
Employee compensation and benefits	$ 2,308,246	$ 1,376,710	$ 6,180,886	$ 3,524,274
Legal and professional fees	822,077	760,130	1,988,261	1,627,769
Interest expense	8,650,149	6,796,736	23,149,030	19,731,327
Other expenses	2,231,341	1,453,367	5,646,402	3,277,850
TOTAL EXPENSES	14,011,813	10,386,943	36,964,579	28,161,220
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	$ (5,728,711)	$ (5,258,291)	$ (3,284,507)	$ (12,017,728)
EQUITY IN INCOME OF SUBSIDIARY
NET INCOME (LOSS) BEFORE INCOME TAXES	$ (5,728,711)	$ (5,258,291)	$ (3,284,507)	$ (12,017,728)
INCOME TAX BENEFIT	(2,097,633)	(1,858,100)	(664,905)	(4,129,670)
NET INCOME (LOSS)	$ (3,631,078)	$ (3,400,191)	$ (2,619,602)	$ (7,888,058)	$ (5,962,909)
Parent [Member]
REVENUE
Origination and servicing income
Gain on life settlements, net
Interest and other income	$ 13,922	$ 4,572	$ 38,944	$ 17,501
TOTAL REVENUE	$ 13,922	$ 4,572	$ 38,944	$ 17,501
EXPENSES
Origination and servicing fees
Employee compensation and benefits	$ 1,759,589	$ 737,475	$ 4,671,183	$ 1,992,554
Legal and professional fees	598,530	734,024	1,427,388	1,476,213
Interest expense	6,980,132	4,679,311	18,011,890	13,371,300
Other expenses	1,195,417	850,122	3,251,606	1,937,674
TOTAL EXPENSES	10,533,668	7,000,932	27,362,067	18,777,741
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	(10,519,746)	(6,996,360)	(27,323,123)	(18,760,240)
EQUITY IN INCOME OF SUBSIDIARY	(4,791,035)	(1,738,069)	(24,038,617)	(6,742,512)
NET INCOME (LOSS) BEFORE INCOME TAXES	(5,728,711)	(5,258,291)	(3,284,507)	(12,017,728)
INCOME TAX BENEFIT	(2,097,633)	(1,858,100)	(664,905)	(4,129,670)
NET INCOME (LOSS)	(3,631,078)	(3,400,191)	(2,619,602)	(7,888,058)
Guarantor Sub [Member]
REVENUE
Origination and servicing income	$ 1,004,024	$ 153,470	$ 2,022,774	$ 1,462,376
Gain on life settlements, net
Interest and other income	$ 54,813	$ 59,372	$ 61,694	$ 229,348
TOTAL REVENUE	$ 1,058,837	$ 212,842	$ 2,084,468	$ 1,691,724
EXPENSES
Origination and servicing fees
Employee compensation and benefits	$ 548,657	$ 639,235	$ 1,509,703	$ 1,531,720
Legal and professional fees	223,547	16,020	560,873	141,470
Interest expense	525,391	761,828	1,984,356	2,334,097
Other expenses	995,026	587,745	2,297,063	1,299,666
TOTAL EXPENSES	2,292,621	2,004,828	6,351,995	5,306,953
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	(1,233,784)	(1,791,986)	(4,267,527)	(3,615,229)
EQUITY IN INCOME OF SUBSIDIARY	(6,024,762)	(3,530,055)	(28,305,978)	(10,357,741)
NET INCOME (LOSS) BEFORE INCOME TAXES	$ 4,790,978	$ 1,738,069	$ 24,038,452	$ 6,742,512
INCOME TAX BENEFIT
NET INCOME (LOSS)	$ 4,790,978	$ 1,738,069	$ 24,038,452	$ 6,742,512
Non-Guarantor Sub [Member]
REVENUE
Origination and servicing income
Gain on life settlements, net	$ 8,189,261	$ 5,118,423	$ 33,446,556	$ 16,119,517
Interest and other income	25,106	5,156	132,878	5,218
TOTAL REVENUE	8,214,367	5,123,579	33,579,434	16,124,735
EXPENSES
Origination and servicing fees	$ 1,004,024	$ 153,470	$ 2,022,774	$ 1,462,376
Employee compensation and benefits
Legal and professional fees		$ 10,086
Interest expense	$ 1,144,626	1,355,597	$ 3,152,784	$ 10,086
Other expenses	40,898	74,371	97,733	4,025,930
TOTAL EXPENSES	2,189,548	1,593,524	5,273,291	268,602
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	$ 6,024,819	$ 3,530,055	$ 28,306,143	$ 5,766,994
EQUITY IN INCOME OF SUBSIDIARY
NET INCOME (LOSS) BEFORE INCOME TAXES	$ 6,024,819	$ 3,530,055	$ 28,306,143
INCOME TAX BENEFIT				$ 10,357,741
NET INCOME (LOSS)	$ 6,024,819	$ 3,530,055	$ 28,306,143	10,357,741
Eliminations [Member]
REVENUE
Origination and servicing income	$ (1,004,024)	$ (153,470)	$ (2,022,774)	$ (1,462,376)
Gain on life settlements, net
Interest and other income		$ (58,871)		$ (228,092)
TOTAL REVENUE	$ (1,004,024)	(212,341)	$ (2,022,774)	(1,690,468)
EXPENSES
Origination and servicing fees	$ (1,004,024)	$ (153,470)	$ (2,022,774)	$ (1,462,376)
Employee compensation and benefits
Legal and professional fees
Interest expense
Other expenses		$ (58,871)		$ (228,092)
TOTAL EXPENSES	$ (1,004,024)	$ (212,341)	$ (2,022,774)	$ (1,690,468)
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES
EQUITY IN INCOME OF SUBSIDIARY	$ 10,815,797	$ 5,268,124	$ (52,344,595)	$ 17,100,253
NET INCOME (LOSS) BEFORE INCOME TAXES	$ (10,815,797)	$ (5,268,124)	$ (52,344,595)	$ (17,100,253)
INCOME TAX BENEFIT
NET INCOME (LOSS)	$ (10,815,797)	$ (5,268,124)	$ (52,344,595)	$ (17,100,253)

XML

Fair Value Definition and Hierarchy (Details 2) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Plus 8 months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	$ (431,905,000)	$ (19,664,000)
Minus 8 months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	449,592,000	40,634,000
Plus 4 Months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(218,420,000)	(38,864,000)
Minus 4 Months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	22,384,000	20,130,000
Plus 2% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(27,614,000)	(24,085,000)
Minus 2% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	32,445,000	28,179,000
Plus 1% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(14,348,000)	(12,502,000)
Minus 1% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	$ 15,551,000	$ 13,522,000

XML

L Bonds (Formerly Renewable Secured Debentures) (Tables)

9 Months Ended

Sep. 30, 2015

Credit Facilities / Series I Secured Notes / L Bonds (formerly Renewable Secured Debentures) [Abstract]

Schedule of future contractual maturities of L Bonds

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Three months ending December 31, 2015	$	22,691,000	$	47,000
2016		81,569,000		996,000
2017		52,228,000		1,642,000
2018		46,946,000		2,093,000
2019		13,642,000		483,000
Thereafter		30,477,000		1,534,000
	$	247,553,000	$	6,795,000

XML

Series I Secured Notes (Tables)

9 Months Ended

Sep. 30, 2015

Credit Facilities / Series I Secured Notes / L Bonds (formerly Renewable Secured Debentures) [Abstract]

Future contractual maturities of series I secured notes payable

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Three months ending December 31, 2015	$	1,776,000	$	8,000
2016		12,827,000		103,000
2017		6,154,000		129,000
2018		998,000		28,000
2019		347,000		7,000
Thereafter		1,816,000		76,000
	$	23,918,000	$	351,000

XML

Stock Incentive Plan (Details)	9 Months Ended
	Sep. 30, 2015 shares
Outstanding stock options
Beginning Balance	1,000,101
Granted during the year	300,950
Vested during the year
Exercised during the year	(27,667)
Forfeited during the year	(103,333)
Ending Balance	1,170,051
Vested [Member]
Outstanding stock options
Beginning Balance	314,288
Granted during the year	61,000
Vested during the year	209,903
Exercised during the year	(27,667)
Forfeited during the year	(55,250)
Ending Balance	502,274
Un-vested [Member]
Outstanding stock options
Beginning Balance	685,813
Granted during the year	239,950
Vested during the year	(209,903)
Exercised during the year
Forfeited during the year	(48,083)
Ending Balance	667,777

XML

Fair value definition and hierarchy (Details 3) - Level 3 [Member]	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued	431,954
December 2011 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Month issued	Dec. 31, 2011
Warrants issued	68,937
Fair value per share | $ / shares	$ 0.22
Risk free rate	0.42%
Volatility	25.25%
Term	5 years
March 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Month issued	Mar. 31, 2012
Warrants issued	38,130
Fair value per share | $ / shares	$ 0.52
Risk free rate	0.38%
Volatility	36.20%
Term	5 years
June 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Month issued	Jun. 30, 2012
Warrants issued	161,840
Fair value per share | $ / shares	$ 1.16
Risk free rate	0.41%
Volatility	47.36%
Term	5 years
July 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Month issued	Jul. 31, 2012
Warrants issued	144,547
Fair value per share | $ / shares	$ 1.16
Risk free rate	0.41%
Volatility	47.36%
Term	5 years
September 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Month issued	Sep. 30, 2012
Warrants issued	2,500
Fair value per share | $ / shares	$ 0.72
Risk free rate	0.31%
Volatility	40.49%
Term	5 years
September 2014 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Month issued	Sep. 30, 2014
Warrants issued	16,000
Fair value per share | $ / shares	$ 1.26
Risk free rate	1.85%
Volatility	17.03%
Term	5 years

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2015

Income Taxes [Abstract]

Components of deferred income tax expense

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2015			2014			2015			2014
Income tax (benefit):
Current:
Federal	$	(141,000	)	$	-		$	-		$	-
State	$	(40,000	)	$	-		$	-		$	-
Total current tax benefit		(181,000	)		-			-			-
Deferred:
Federal	$	(1,488,000	)	$	(1,221,000	)	$	(504,000	)	$	(3,130,000	)
State	$	(429,000	)	$	(637,000	)	$	(161,000	)	$	(1,000,000	)
Total deferred tax benefit		(1,917,000	)		(1,858,000	)		(665,000	)		(4,130,000	)
Total income tax benefit		(2,098,000	)		(1,858,000	)		(665,000	)		(4,130,000	)

XML

Stock Incentive Plan (Tables)

9 Months Ended

Sep. 30, 2015

Stock Incentive Plan [Abstract]

Schedule of outstanding stock options

	Vested			Un-vested			Total
Balance as of December 31, 2014		314,288			685,813			1,000,101
Granted during the year		61,000			239,950			300,950
Vested during the year		209,903			(209,903	)		-
Exercised during the year		(27,667	)		-			(27,667	)
Forfeited during the year		(55,250	)		(48,083	)		(103,333	)
Balance as of September 30, 2015		502,274			667,777			1,170,051

XML

Restrictions on Cash

9 Months Ended

Sep. 30, 2015

Restrictions on Cash [Abstract]

Restrictions on cash

(2) Restrictions on cash

The Company is required by its lenders to maintain collection and escrow accounts. These accounts are used to fund the acquisition, pay annual premiums of insurance policies, pay interest and other charges under the revolving credit facility, and collect policy benefits. DZ Bank AG, as agent for Autobahn Funding Company, LLC, the lender for the revolving credit facility as described in note 5, authorizes the disbursements from these accounts. At September 30, 2015 and December 31, 2014, there was a balance of $7,272,000, and $4,296,000, respectively, maintained in these restricted cash accounts.

XML

Commitments (Tables)

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies [Abstract]

Schedule of minimum lease payments under the second amendment to lease

Three months ending December 31, 2015	$	43,000
2016		173,000
2017		178,000
2018		185,000
2019		191,000
2020		198,000
2021		204,000
2022		210,000
2023		217,000
2024		223,000
2025		230,000
2026		38,000
	$	2,090,000

XML

Investment in Life Insurance Policies (Details Textual) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Investment in Life Insurance Policies (Textual)
Benefit recognized from insurance policy	$ 357,000	$ 3,000,000	$ 29,732,000	$ 3,300,000
Carrying value of life insurance policy	80,000	931,000	3,823,000	999,000
Realized gains from life insurance policy	$ 277,000	$ 2,069,000	$ 25,909,000	2,301,000
Discount rate applied to portfolio			11.07%		11.43%
Insurance benefits of policy matured				$ 1,500,000
Life insurance policies [Member]
Investment in Life Insurance Policies (Textual)
Discount rate applied to portfolio			11.07%		11.43%

XML

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Current:
Federal	$ (141,000)
State	(40,000)
Total current tax (benefit)	(181,000)
Deferred:
Federal	(1,488,000)	$ (1,221,000)	$ (504,000)	$ (3,130,000)
State	(429,000)	(637,000)	(161,000)	(1,000,000)
Total deferred tax (benefit)	(1,917,000)	(1,858,000)	(665,000)	(4,130,000)
Total income tax (benefit)	$ (2,097,633)	$ (1,858,100)	$ (664,905)	$ (4,129,670)

XML

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
A S S E T S
Cash and cash equivalents	$ 28,452,673	$ 30,662,704
Restricted cash	7,271,560	4,296,053
Policy benefits receivable	357,014	1,750,000
Investment in life settlements, at fair value	329,562,250	282,883,010
Other assets	5,882,723	3,478,762
TOTAL ASSETS	371,526,220	323,070,529
LIABILITIES
Revolving credit facility	65,011,048	72,161,048
Series I Secured Notes	23,566,913	27,616,578
L Bonds	243,126,585	182,782,884
Interest payable	11,377,385	11,128,519
Accounts payable and accrued expenses	3,063,995	1,718,009
Deferred taxes, net	4,608,650	5,273,555
TOTAL LIABILITIES	350,754,576	300,680,593
STOCKHOLDERS' EQUITY
CONVERTIBLE PREFERRED STOCK (par value $0.001; shares authorized 40,000,000; shares outstanding 2,756,549 and 2,738,966; liquidation preference of $20,674,000 and $20,542,000, respectively)	20,623,541	20,527,866
COMMON STOCK Common stock (par value $0.001: shares authorized 210,000,000; shares issued and outstanding is 5,941,790 and 5,870,193 on September 30, 2015 and December 31, 2014, respectively)	5,942	5,870
Additional paid-in capital	17,163,249	16,257,686
Accumulated deficit	(17,021,088)	(14,401,486)
TOTAL STOCKHOLDERS' EQUITY	20,771,644	22,389,936
TOTAL LIABILITIES & EQUITY	$ 371,526,220	$ 323,070,529

XML

Fair Value Definition and Hierarchy (Details Textual)	9 Months Ended
	Sep. 30, 2015 USD ($)
Fair Value Definition and Hierarchy (Textual)
Estimated fair value of series I secured notes payable	$ 273,507,000
Weighted average market interest rate of secured notes payable	7.06%
Debt instruments face value	$ 271,471,000
Description for change in discount factor	If the life expectancy estimates were increased or decreased by four and eight months on each outstanding policy and the discount factors were increased or decreased by 1% and 2%, while all other variables are held constant.
Increase decrease in life expectancy	Four and eight months
Increase decrease in discount rate	1% and 2

XML

Condensed Consolidated Statement of Stockholders' Equity - USD ($)		Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance at Dec. 31, 2013		$ (5,492,015)		$ 4,562	$ 2,942,000	$ (8,438,577)
Begining balance, Shares at Dec. 31, 2013				4,562,000
Net loss		(5,962,909)				$ (5,962,909)
Issuance of common stock		8,643,790		$ 800	$ 8,642,990
Issuance of common stock, Share				800,000
Series A Preferred Stock conversion to common stock		4,957,099		$ 508	$ 4,956,591
Series A Preferred Stock conversion to common stock, Shares				508,193
Reclassification of preferred stock from temporary equity to permanent equity due to initial public offering (*)	[1]	20,326,605	$ 20,326,605
Reclassification of preferred stock from temporary equity to permanent equity due to initial public offering (*), Shares	[1]		2,710,214
Issuance of preferred stock		201,261	$ 201,261
Issuance of preferred stock, Shares			28,752
Issuance of stock options		122,412			$ 122,412
Extension of warrants		47,120			47,120
Accretion of preferred stock to liquidation value		(453,427)			(453,427)
Ending balance at Dec. 31, 2014		22,389,936	$ 20,527,866	$ 5,870	$ 16,257,686	$ (14,401,486)
Ending balance, Shares at Dec. 31, 2014			2,738,966	5,870,193
Net loss		(2,619,602)				$ (2,619,602)
Issuance of common stock		$ 582,000		$ 60	$ 581,940
Issuance of common stock, Share				60,000
Series A Preferred Stock conversion to common stock			$ (115,973)	$ 12	$ 115,961
Series A Preferred Stock conversion to common stock, Shares			(15,463)	11,597
Issuance of preferred stock		$ 211,648	$ 211,648
Issuance of preferred stock, Shares			33,046
Issuance of stock options		207,662			$ 207,662
Ending balance at Sep. 30, 2015		$ 20,771,644	$ 20,623,541	$ 5,942	$ 17,163,249	$ (17,021,088)
Ending balance, Shares at Sep. 30, 2015			2,756,549	5,941,790

[1] Subject to the terms of the Certificate of Designation for Series A Convertible Preferred Stock, the listing of our common stock on The Nasdaq Capital Market on September 25, 2014 resulted in the termination of a redemption right in favor of the holders of such preferred stock. Preferred stock that is not redeemable by a stockholder is treated as stockholders' equity as shown in the table above.

XML

Commitments (Details Textual)	3 Months Ended		9 Months Ended
	Sep. 30, 2015 USD ($) ft²	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) ft²	Sep. 30, 2014 USD ($)	Sep. 14, 2015 ft²
Commitments (Textual)
Office space in square feet | ft²	11,695		11,695		12,813
Rent expenses	$ 71,000	$ 56,000	$ 193,000	$ 157,000

XML

Nature of Business and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Nature of business and summary of significant accounting policies (Textual)
Deposits and direct cost advances	$ 31,000		$ 31,000		$ 27,000
Amortization of deferred financing costs	457,000	$ 89,000	757,000	$ 268,000
Future amortization expected	1,096,000		$ 1,096,000
Redemption period for amortization of discount related to financing cost			3 years
Debt issuance costs in financial statement	$ 3,195,000		$ 3,195,000

XML

Concentrations (Details)	Sep. 30, 2015	Dec. 31, 2014
AXA Equitable [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	14.27%	14.55%
John Hancock [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	12.98%	11.48%

XML

Guarantees of Secured Debt by GWG Life

9 Months Ended

Sep. 30, 2015

Guarantees of Secured Debt by GWG Life [Abstract]

Guarantees of secured debt by GWG Life

(16) Guarantees of secured debt by GWG Life

In January 2015, GWG registered a $1.0 billion debt offering of our L Bonds with the SEC. The $1.0 billion L Bond offering is a follow-on to our $250.0 million debt offering of Renewable Secured Debentures (subsequently renamed L Bonds) that was registered with the SEC and completed January 2015 as described in note 7. The L Bonds are secured by the assets of GWG Holdings as described in note 7 and a pledge of all the common stock held by the largest individual shareholders. Obligations under the L Bonds are guaranteed by GWG Life. This guarantee involves the grant of a security interest in all the assets of GWG Life. The payment of principal and interest on the L Bonds is fully and unconditional guaranteed by GWG Life. Substantially all of the Company’s life insurance policies are held by DLP II, DLP III and the Trust. The policies held by DLP II, DLPIII and the Trust are not collateral for the L Bond obligations as such policies serve as collateral for the revolving credit facility.

The consolidating financial statements are presented in lieu of separate financial statements and other related disclosures of the subsidiary guarantors and issuer because management does not believe that separate financial statements and related disclosures would be material to investors. There are currently no significant restrictions on the ability of GWG Holdings or GWG Life, the guarantor subsidiary, to obtain funds from its subsidiaries by dividend or loan, except as follows. DLP II and DLP III are borrowers under a credit agreement with Autobahn, as lender, and DZ Bank, as agent, as described in note 5. The significant majority of insurance policies owned by the Company are subject to a collateral arrangement with DZ Bank, as described in notes 2 and 5. Under this arrangement, collection and escrow accounts are used to fund premiums of the insurance policies and to pay interest and other charges under the revolving credit facility. DZ Bank and Autobahn must authorize all disbursements from these accounts, including any distributions to GWG Life. If the facility advance rate exceeds 50%, the distributions are limited to an amount that would result in the borrowers (DLP II, DLP III, GWG Life, and GWG Holdings) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by the agent. After such amount is reached, the credit agreement requires that excess funds be used for repayments of borrowings before any additional distributions may be made.

The following represents consolidating financial information as of September 30, 2015 and December 31, 2014, with respect to the financial position, and for the three and nine months ended September 30, 2015 and 2014 with respect to results of operations and cash flows of GWG Holdings and its subsidiaries. The parent column presents the financial information of GWG Holdings, the primary obligor of the L Bonds. The guarantor subsidiary column presents the financial information of GWG Life, the guarantor subsidiary of the L Bonds, presenting its investment in DLP II, DLP III and Trust under the equity method. The non-guarantor subsidiaries column presents the financial information of all non-guarantor subsidiaries including DLP II, DLP III and Trust.

Condensed Consolidating Balance Sheets

September 30, 2015	Parent			Guarantor Sub		Non-Guarantor Sub		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	26,354,110		$	1,948,399	$	150,164	$	-		$	28,452,673
Restricted cash		-			2,388,800		4,882,760		-			7,271,560
Policy benefits receivable		-			-		357,014		-			357,014
Investment in life settlements, at fair value		-			-		329,562,250		-			329,562,250
Other assets		2,918,013			1,732,640		1,232,070		-			5,882,723
Investment in subsidiaries		249,001,369			270,221,539		-		(519,222,908	)		-
TOTAL ASSETS	$	278,273,492		$	276,291,378	$	336,184,258	$	(519,222,908	)	$	371,526,220
L I A B I L I T I E S & S T O C K H O L D E R S' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	65,011,048	$	-		$	65,011,048
Series I Secured Notes		-			23,566,913		-		-			23,566,913
L Bonds		243,126,585			-		-		-			243,126,585
Interest payable		7,887,475			3,304,752		185,158		-			11,377,385
Accounts payable and other accrued expenses		1,879,138			568,509		616,348		-			3,063,995
Deferred taxes, net		4,608,650			-		-		-			4,608,650
TOTAL LIABILITIES		257,501,848			27,440,174		65,812,554		-			350,754,576
STOCKHOLDERS’ EQUITY
Member capital		-			248,851,204		270,371,704		(519,222,908	)		-
Convertible preferred stock		2,623,541			-		-		-			20,623,541
Common stock		5,942			-		-		-			5,942
Additional paid-in capital		17,163,249			-		-		-			17,163,249
Accumulated deficit		(17,021,088	)		-		-		-			(17,021,088	)
TOTAL STOCKHOLDERS’ EQUITY		20,771,644			248,851,204		270,371,704		(519,222,908	)		20,771,644
TOTAL LIABILITIES AND EQUITY	$	278,273,492		$	276,291,378	$	336,184,258	$	(519,222,908	)	$	371,526,220

December 31, 2014	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	30,446,473		$	216,231	$	-	$	-		$	30,662,704
Restricted cash		-			82,500		4,213,553		-			4,296,053
Policy benefits receivable		-			-		1,750,000		-			1,750,000
Investment in life settlements, at fair value		-			-		282,883,010		-			282,883,010
Other assets		1,673,728			1,777,534		27,500		-			3,478,762
Investment in subsidiaries		185,636,417			215,124,779		-		(400,761,196	)		-
TOTAL ASSETS	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529
L I A B I L I T I E S & S T O C K H O L D E R S' E Q U I T Y (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes		-			27,616,578		-		-			27,616,578
L Bonds		182,782,884			-		-		-			182,782,884
Interest payable		6,598,250			3,513,615		1,016,654		-			11,128,519
Accounts payable and other accrued expenses		711,993			434,433		571,583		-			1,718,009
Deferred taxes, net		5,273,555			-		-		-			5,273,555
TOTAL LIABILITIES		195,366,682			31,564,626		73,749,285		-			300,680,593
STOCKHOLDERS’ EQUITY
Member capital		-			185,636,418		215,124,778		(400,761,196	)		-
Convertible preferred stock		20,527,866			-		-		-			20,527,866
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,257,686			-		-		-			16,257,686
Accumulated deficit		(14,401,486	)		-		-		-			(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		22,389,936			185,636,418		215,124,778		(400,761,196	)		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529

Condensed Consolidating Statements of Operations

For the nine months ended September 30, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	2,022,774		$	-	$	(2,022,774	)	$	-
Gain on life settlements, net		-			-			33,446,556		-			33,446,556
Interest and other income		38,944			61,694			132,878		-			233,516
TOTAL REVENUE		38,944			2,084,468			33,579,434		(2,022,774	)		33,680,072
EXPENSES
Origination and servicing fees		-			-			2,022,774		(2,022,774	)		-
Employee compensation and benefits		4,671,183			1,509,703			-		-			6,180,886
Legal and professional fees		1,427,388			560,873			-		-			1,988,261
Interest expense		18,011,890			1,984,356			3,152,784		-			23,149,030
Other expenses		3,251,606			2,297,063			97,733		-			5,646,402
TOTAL EXPENSES		27,362,067			6,351,995			5,273,291		(2,022,774	)		36,964,579
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(27,323,123	)		(4,267,527	)		28,306,143		-			(3,284,507	)
EQUITY IN INCOME OF SUBSIDIARY		24,038,616			28,305,979			-		(52,344,595	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(3,284,507	)		24,038,452			28,306,143		(52,344,595	)		(3,284,507	)
INCOME TAX BENEFIT		(664,905	)		-			-		-			(664,905	)
NET INCOME (LOSS)	$	(2,619,602	)	$	24,038,452		$	28,306,143	$	(52,344,595	)	$	(2,619,602	)

For the nine months ended September 30, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	1,462,376		$	-	$	(1,462,376	)	$	-
Gain on life settlements, net		-			-			16,119,517		-			16,119,517
Interest and other income		17,501			229,348			5,218		(228,092	)		23,975
TOTAL REVENUE		17,501			1,691,724			16,124,735		(1,690,468	)		16,143,492
EXPENSES
Origination and servicing fees		-			-			1,462,376		(1,462,376	)		-
Employee compensation and benefits		1,992,554			1,531,720			-		-			3,524,274
Legal and professional fees		1,476,213			141,470			10,086		-			1,627,769
Interest expense		13,371,300			2,334,097			4,025,930		-			19,731,327
Other expenses		1,937,674			1,299,666			268,602		(228,092	)		3,277,850
TOTAL EXPENSES		18,777,741			5,306,953			5,766,994		(1,690,468	)		28,161,220
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(18,760,240	)		(3,615,229	)		10,357,741		-			(12,017,728	)
EQUITY IN INCOME OF SUBSIDIARY		6,742,512			10,357,741			-		(17,100,253	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(12,017,728	)		6,742,512			10,357,741		(17,100,253	)		(12,017,728	)
INCOME TAX BENEFIT		(4,129,670	)		-			-		-			(4,129,670	)
NET INCOME (LOSS)	$	(7,888,058	)	$	6,742,512		$	10,357,741	$	(17,100,253	)	$	(7,888,058	)

For the three months ended September 30, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	1,004,024		$	-	$	(1,004,024	)	$	-
Gain on life settlements, net		-			-			8,189,261		-			8,189,261
Interest and other income		13,922			54,813			25,106		-			93,841
TOTAL REVENUE		13,922			1,058,837			8,214,367		(1,004,024	)		8,283,102
EXPENSES
Origination and servicing fees		-			-			1,004,024		(1,004,024	)		-
Employee compensation and benefits		1,759,589			548,657			-		-			2,308,246
Legal and professional fees		598,530			223,547			-		-			822,077
Interest expense		6,980,132			525,391			1,144,626		-			8,650,149
Other expenses		1,195,417			995,026			40,898		-			2,231,341
TOTAL EXPENSES		10,533,668			2,292,621			2,189,548		(1,004,024	)		14,011,813
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(10,519,746	)		(1,233,784	)		6,024,819		-			(5,728,711	)
EQUITY IN INCOME OF SUBSIDIARY		4,791,035			6,024,762			-		(10,815,797	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(5,728,711	)		4,790,978			6,024,819		(10,815,797	)		(5,728,711	)
INCOME TAX BENEFIT		(2,097,633	)		-			-		-			(2,097,633	)
NET INCOME (LOSS)	$	(3,631,078	)	$	4,790,978		$	6,024,819	$	(10,815,797	)	$	(3,631,078	)

For the three months ended September 30, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Origination and servicing income	$	-		$	153,470		$	-	$	(153,470	)	$	-
Gain on life settlements, net		-			-			5,118,423		-			5,118,423
Interest and other income		4,572			59,372			5,156		(58,871	)		10,229
TOTAL REVENUE		4,572			212,842			5,123,579		(212,341	)		5,128,652
EXPENSES
Origination and servicing fees		-			-			153,470		(153,470	)		-
Employee compensation and benefits		737,475			639,235			-		-			1,376,710
Legal and professional fees		734,024			16,020			10,086		-			760,130
Interest expense		4,679,311			761,828			1,355,597		-			6,796,736
Other expenses		850,122			587,745			74,371		(58,871	)		1,453,367
TOTAL EXPENSES		7,000,932			2,004,828			1,593,524		(212,341	)		10,386,943
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(6,996,360	)		(1,791,986	)		3,530,055		-			(5,258,291	)
EQUITY IN INCOME OF SUBSIDIARY		1,738,069			3,530,055			-		(5,268,124	)		-
NET INCOME BEFORE INCOME TAXES		(5,258,291	)		1,738,069			3,530,055		(5,268,124	)		(5,258,291	)
INCOME TAX BENEFIT		(1,858,100	)		-			-		-			(1,858,100	)
NET INCOME (LOSS)	$	(3,400,191	)	$	1,738,069		$	3,530,055	$	(5,268,124	)	$	(3,400,191	)

Condensed Consolidating Statements of Cash Flows

For the nine months ended September 30, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(2,619,602	)	$	24,038,452		$	28,306,143		$	(52,344,595	)	$	(2,619,602	)
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries		(24,038,617	)		(28,305,978	)		-			52,344,595			-
Gain on life settlements		-			-			(26,651,363	)		-			(26,651,363	)
Amortization of deferred financing and issuance costs		2,832,487			260,455			(1,201,170	)		-			1,891,772
Deferred income taxes		(664,905	)		-			-			-			(664,905	)
Convertible, redeemable preferred dividends payable		509,225			-			-			-			509,225
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			1,392,986						1,392,986
Other assets		(40,145,769	)		(26,745,888	)		-			66,117,118			(774,539	)
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses		4,503,624			123,222			(790,131	)		-			3,836,715
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(30,425,246	)		(30,629,737	)		1,056,465			66,117,118			(23,079,711	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(23,850,860	)		-			(23,850,860	)
Proceeds from settlement of life settlements		-			-			3,822,983			-			3,822,983
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(20,027,877	)		-			(20,027,877	)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility		-			-			(7,150,000	)		-			(7,150,000	)
Payments for redemption of Series I Secured Notes		-			(4,508,130	)		-			-			(4,508,130	)
Proceeds from issuance of L Bonds		87,620,483			-			-			-			87,620,483
Payments for redemption and issuance of L Bonds		(32,376,104	)		-			-			-			(32,376,104	)
Payments from restricted cash		-			(2,306,300	)		(669,207	)		-			(2,975,507	)
Issuance of common stock		582,000			-			-			-			582,000
Payments for redemption preferred stock		(295,185	)		-			-			-			(295,185	)
Issuance of member capital		-			39,176,335			26,940,783			(66,117,118	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		55,531,194			32,361,905			19,121,576			(66,117,118	)		40,897,557
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(4,092,363	)		1,732,168			150,164			-			(2,210,031	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		30,446,473			216,231			-			-			30,662,704
END OF THE PERIOD	$	26,354,110		$	1,948,399		$	150,164		$	-		$	28,452,673

For the nine months ended September 30, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(7,888,058	)	$	6,742,512		$	10,357,741		$	(17,100,253	)	$	(7,888,058	)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
(Equity) of subsidiaries		(6,742,512	)		(10,357,741	)		-			17,100,253			-
Gain on life settlements		-			-			(30,973,250	)		-			(30,973,250	)
Amortization of deferred financing and issuance costs		2,125,269			427,187			18,425						2,570,881
Deferred income taxes		(4,129,670	)		-			-						(4,129,670	)
Convertible, redeemable preferred stock dividends payable		575,513			-			-			-			575,513
(Increase) in operating assets:
Other assets		(35,758,660	)		(29,984,534	)		-			63,647,054			(2,096,140	)
Increase in operating liabilities:
Accounts payable and accrued expenses		2,893,814			591,534			173,311			-			3,658,659
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(48,924,304	)		(32,851,042	)		(20,423,773	)		63,647,054			(38,282,065	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(11,559,435	)		-			(11,559,435	)
Proceeds from settlement of life settlements		-			-			999,125			-			999,125
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(10,560,310	)		-			(10,560,310	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(2,047,928	)		-			-			(2,047,928	)
Proceeds from issuance of L Bonds		48,516,296			-			-			-			48,516,296
Payments for redemption and issuance of L Bonds		(13,816,794	)		-			-			-			(13,816,794	)
Proceeds from restricted cash		-			1,420,000			2,268,236			-			3,688,236
Proceeds from sale of common stock		9,030,000			-			-			-			9,030,000
Payments for redemption preferred stock		(465,239	)		-			-			-			(465,239	)
Issuance of member capital		-			34,931,207			28,715,847			(63,647,054	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		43,264,263			34,303,279			30,984,083			(63,647,054	)		44,904,571
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(5,666,041	)		1,722,237			-			-			(3,937,804	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		32,711,636			738,157			-			-			33,449,793
END OF THE PERIOD	$	27,051,595		$	2,460,394		$	-		$	-		$	29,511,989

For the three months ended September 30, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(3,631,078	)	$	4,790,978		$	6,024,819		$	(10,815,797	)	$	(3,631,078	)
Adjustments to reconcile net loss to net cash flows from operating activities:
(Equity) of subsidiaries		(4,791,035	)		(6,024,762	)		-			10,815,797			-
Gain on life settlements		-			-			(14,516,881	)		-			(14,516,881	)
Amortization of deferred financing and issuance costs		1,103,312			49,339			781,125			-			1,933,776
Deferred income taxes		(1,916,686	)		-			-			-			(1,916,686	)
Convertible, redeemable preferred stock dividends payable		173,993			-			-			-			173,993
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			2,142,986			-			2,142,986
Other assets		(22,146,946	)		(15,631,849	)		-			37,360,805			(417,990	)
Increase (decrease) in operating liabilities:
Accounts payable and other accrued expenses		2,010,129			(105,418	)		629,558			-			2,534,269
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(29,198,311	)		(16,921,712	)		(4,938,393	)		37,360,805			(13,697,611	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(13,626,842	)		-			(13,626,842	)
Proceeds from settlement of life settlements		-			-			80,000			-			80,000
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(13,546,842	)		-			(13,546,842	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(890,586	)		-			-			(890,586	)
Proceeds from issuance of L Bonds		37,122,127			-			-			-			37,122,127
Payments for redemption and issuance of L Bonds		(19,363,047	)		-			-			-			(19,363,047	)
Proceeds (payments) from restricted cash		-			(2,203,800	)		2,855,430			-			651,630
Issuance of member capital		-			21,730,944			15,629,861			(37,360,805	)		-
Payments for redemption preferred stock		(21,187	)		-			-			-			(21,187	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		17,737,893			18,636,558			18,485,291			(37,360,805	)		17,498,937
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(11,460,418	)		1,714,846			56			-			(9,363,047	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		37,814,528			233,553			150,108			-			38,198,189
END OF THE PERIOD	$	26,354,110		$	1,948,399		$	150,164		$	-		$	28,452,673

For the three months ended September 30, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(3,400,191	)	$	1,738,069		$	3,530,055		$	(5,268,124	)	$	(3,400,191	)
Adjustments to reconcile net loss to cash:
(Equity) of subsidiaries		(1,738,069	)		(3,530,055	)		-			5,268,124			-
Gain on life settlements		-			-			(8,761,912	)		-			(8,761,912	)
Amortization of deferred financing and issuance costs		397,659			126,083			339,475			-			863,217
Deferred income taxes		(1,858,100	)		-			-			-			(1,858,100	)
Convertible, redeemable preferred stock dividends payable		186,182			-			-			-			186,182
(Increase) decrease in operating assets:
Policy benefits receivable		-			-			300,000			-			300,000
Other assets		(9,136,310	)		(5,329,716	)		-			13,318,805			(1,147,221	)
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses		922,271			289,132			(720,907	)		-			490,496
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(14,626,558	)		(6,706,487	)		(5,313,289	)		13,318,805			(13,327,529	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(680,000	)		-			(680,000	)
Proceeds from settlement of life settlements		-			-			930,625			-			930,625
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			250,625			-			250,628
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes		-			(509,004	)		-			-			(509,004	)
Proceeds from issuance of L Bonds		15,281,809			-			-			-			15,281,809
Payments for redemption and issuance of L Bonds		(4,494,383	)		-			-			-			(4,494,383	)
Proceeds from restricted cash		-			565,000			100,699			-			665,699
Proceeds from sale of common stock		9,030,000			-			-			-			9,030,000
Issuance of member capital		-			8,356,840			4,961,965			(13,318,805	)		-
Payments for redemption preferred stock		(445,183	)		-			-			-			(445,183	)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		19,372,243			8,412,836			5,062,664			(13,318,805	)		19,528,938
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		4,745,685			1,706,349			-			-			6,452,034
CASH AND CASH EQUIVALENTS
BEGINNING OF THE PERIOD		22,305,910			754,045			-			-			23,059,955
END OF THE PERIOD	$	27,051,595		$	2,460,394		$	-		$	-		$	29,511,989

XML

Restrictions on Cash (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Restrictions on Cash (Textual)
Restricted cash	$ 7,272,000	$ 4,296,000

XML

Subsequent Events

9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

Subsequent events

(18) Subsequent events

Subsequent to September 30, 2015, the Company has issued approximately an additional $18.3 million in principal amount of L Bonds.

XML

Subsequent Events (Details) $ in Millions	9 Months Ended
	Sep. 30, 2015 USD ($)
Subsequent Events (Textual)
Additional principal amount of L bonds	$ 18.3

XML

Nature of Business and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2015

Nature of Business and Summary of Significant Accounting Policies [Abstract]

Nature of business and summary of significant accounting policies

(1) Nature of business and summary of significant accounting policies

Nature of business - GWG Holdings, Inc. (GWG Holdings) and subsidiaries, located in Minneapolis, Minnesota, purchases life insurance policies for its own investment portfolio through its wholly owned subsidiaries, GWG Life, LLC (GWG Life) and GWG Life USA, LLC (GWG Life USA), and GWG Life’s own subsidiaries, GWG Trust (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II), and GWG DLP Funding III, LLC (DLP III). All of these entities are legally organized in Delaware. Unless the context otherwise requires or we specifically so indicate, all references in this report to "we", "us", "our", "our Company", "GWG", or the "Company" refer to these entities collectively. References to particular entities, such as “GWG Holdings” or “GWG Life”, are meant to refer only to the particular entity referenced.

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1) the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Cash and cash equivalents - The Company considers cash in demand deposit accounts and temporary investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains its cash and cash equivalents with highly rated financial institutions. From time to time, the Company’s balances in its bank accounts exceed Federal Deposit Insurance Corporation limits. The Company periodically evaluates the risk of exceeding insured levels and may transfer funds as it deems appropriate. The Company has not experienced any losses with regards to balances in excess of insured limits or as a result of other concentrations of credit risk.

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1)	Receipt of death notice or verified obituary of insured
2)	Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. In an event of a sale of a policy, the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company. Such deposits and direct cost advances were $31,000 and $27,000 at September 30, 2015 and December 31, 2014, respectively.

Deferred financing and issuance costs – Costs incurred to obtain financing under the revolving credit facility, as described in note 5, have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. Amortization of deferred financing costs was $457,000 and $89,000 for the three-month periods ended September 30, 2015 and 2014, and $757,000 and $268,000 for the nine-month periods ended September 30, 2015 and 2014, respectively. Future amortization is expected to be $1,096,000 for the next seven months ending April 30, 2016.  The Series I Secured Notes, as described in note 6, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock, as described in note 8, was also reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which were amortized into additional paid-in-capital over the three-year redemption period. As of December 31, 2014, all of these costs had been fully amortized.

Earnings (loss) per share - Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period. Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock, and outstanding warrants, and stock options.

Subsequent events - Subsequent events are events or transactions that occur after the balance sheet date but before consolidated financial statements are issued. The Company recognizes in the consolidated financial statements the effects of all subsequent events that provide additional evidence about conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing the consolidated financial statements. The Company’s consolidated financial statements do not recognize subsequent events that provide evidence about conditions that did not exist at the date of the balance sheet but arose after the balance sheet date and before the consolidated financial statements are available to be issued. The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are filed for potential recognition or disclosure.

Recently adopted pronouncements - On April 7, 2015 the FASB issued Accounting Standards Update (ASU) No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs,” as part of its simplification initiative. The ASU changes the presentation of debt issuance costs in financial statements. Under the ASU, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. For public business entities, the guidance in the ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. For entities other than public business entities, the guidance is effective for fiscal years beginning after December 15, 2015, and interim periods beginning after December 15, 2016. Early adoption is allowed for all entities for financial statements that have not been previously issued. Entities would apply the new guidance retrospectively to all prior periods (i.e., the balance sheet for each period is adjusted). The impact of the new ASU on the Company’s balance sheet would be a reduction of approximately $3,195,000 to assets and a corresponding reduction to liabilities. There would be no impact on the Company’s statements of operations.

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	40,000,000	40,000,000
Convertible preferred stock, shares outstanding	2,756,549	2,738,966
Convertible preferred stock, liquidation preference	$ 20,674,000	$ 20,542,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	210,000,000	210,000,000
Common stock, shares issued	5,941,790	5,870,193
Common stock, shares outstanding	5,941,790	5,870,193

XML

Common Stock

9 Months Ended

Sep. 30, 2015

Common Stock/Redeemable Preferred Stock[Abstract]

Common Stock

(11) Common Stock

On September 24, 2014, the Company consummated an initial public offering of its common stock that resulted in the sale of 800,000 shares of common stock at $12.50 per share. The sale resulted in net proceeds of approximately $8.6 million after the deduction of underwriting commissions, discounts and expense reimbursements. In connection with this offering, the Company listed its common stock on The NASDAQ Capital Market under the ticker symbol “GWGH” effective September 25, 2014. The Company used the net proceeds from the offering to promote and advertise the opportunities for consumers owning life insurance and investors to profit from participating in the secondary market for life insurance policies, purchase additional life insurance policies in the secondary market, pay premiums on the Company’s life insurance policy assets, fund its portfolio operations, and for working capital purposes.

Stock split — On June 24, 2014, the Company’s Board of Directors and majority stockholders approved a joint resolution to effect an amendment to the Company’s Certificate of Incorporation in the state of Delaware whereby the Company shall enact a reverse split of the common stock such that for every two (2) shares of common stock issued and outstanding immediately prior to the effective date shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) share of common stock. The effective date of the amendment and reverse stock split is June 24, 2014. In lieu of fractional shares, stockholders received cash payments in an amount equal to the fraction to which the stockholder would otherwise be entitled multiplied by the price of the common stock, as determined by the Board of Directors of the Company, but adjusted so as to give effect to the reverse stock split. The par value of the common stock remained at $0.001 per share.

On June 23, 2015, GWG issued 60,000 restricted shares of common stock at $9.70 per share, determined by closing market price, to a vendor as a form of payment for the services the vendor will provide to the Company in the next three years. The cost of the issued shares will be amortized over the next 12 months.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 12, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	GWG Holdings, Inc.
Entity Central Index Key	0001522690
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		5,941,790

XML

Stock Incentive Plan

9 Months Ended

Sep. 30, 2015

Stock Incentive Plan [Abstract]

Stock Incentive Plan

(12) Stock Incentive Plan

The Company adopted the GWG Holdings, Inc. 2013 Stock Incentive Plan on March 27, 2013. On April 23, 2015 the Board of Directors approved amendments to the plan that were subsequently approved by a majority of the Company’s stockholders at the annual meeting of stockholders on June 1, 2015. The plan is administered by the Compensation Committee of the Board of Directors of the Company. The Company’s Chief Executive Officer may, on a discretionary basis and without committee review or approval, grant incentives to new employees of the Company who are not officers of the Company. Incentives under the plan may be granted in one or a combination of the following forms: (a) incentive stock options and non-statutory stock options; (b) stock appreciation rights; (c) stock awards; (d) restricted stock; (e) restricted stock units; and (f) performance shares. Eligible participants include officers and employees of the Company, members of the Board of Directors, and consultants or other independent contractors. 2,000,000 shares are issuable under the plan. No person shall receive grants of stock options and SARs under the plan that exceed, in the aggregate 400,000 shares of common stock in any one year. The term of each stock option shall be determined by the committee but shall not exceed ten years. Vested stock options may be exercised in whole or part by the holder giving notice to the Company. The holder of the option may provide payment for the exercise price or surrender shares equal to the exercise price.

The Company issued stock options for 1,046,551 shares of common stock to employees, officers, and directors of the Company through September 30, 2015. Options for 449,274 shares have vested, and the remaining options will vest over three years. The options were issued with an exercise price between $8.20 and $10.18 for those owning more than 10% of the Company’s stock and between $6.73 and $10.25 for others, which is equal to the estimated market price of the shares on the date of grant valued using Black-Scholes binomial option pricing model. The expected volatility used in the Black-Scholes model valuation of options issued during the year was 17.03% annualized. The annual volatility rate is based on the standard deviation of the average continuously compounded rate of return of five selected comparable companies over the previous 52 weeks. Forfeiture rate of 15% is based on historical Company information and expected future trend. As of September 30, 2015, stock options for 166,499 shares were forfeited and stock options for 28,001 shares were exercised.

In September 2014, we entered into a stock option agreement with a new management employee granting the employee the right to purchase up to 318,000 shares of the Company’s common stock at an exercise price of $12.50. The grant of such rights to purchase the Company’s common stock was treated as an inducement grant and was issued outside the 2013 Stock Incentive Plan. The option agreement specifies that, among other things, options to purchase 159,000 common shares will vest ratably on the first, second and third anniversary of the date of the agreement. The remaining 159,000 options will vest quarterly using a formula based upon the closing price of the Company’s common stock on the last business day of such quarter. The maximum number of these remaining options that will vest is 53,000 in each successive one-year period beginning on the date of the option agreement. As of September 30, 2015, 53,000 of these options have been forfeited and 53,000 have vested.

Outstanding stock options:

	Vested			Un-vested			Total
Balance as of December 31, 2014		314,288			685,813			1,000,101
Granted during the year		61,000			239,950			300,950
Vested during the year		209,903			(209,903	)		-
Exercised during the year		(27,667	)		-			(27,667	)
Forfeited during the year		(55,250	)		(48,083	)		(103,333	)
Balance as of September 30, 2015		502,274			667,777			1,170,051

Compensation expense related to un-vested options not yet recognized is $499,000. We expect to recognize this compensation expense over the next three years ($9,000 in 2015, $239,000 in 2016, $200,000 in 2017, and 51,000 in 2018). The Company issues new common stock for options exercised.

XML

Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
REVENUE
Gain on life settlements, net	$ 8,189,261	$ 5,118,423	$ 33,446,556	$ 16,119,517
Interest and other income	93,841	10,229	233,516	23,975
TOTAL REVENUE	8,283,102	5,128,652	33,680,072	16,143,492
EXPENSES
Employee compensation and benefits	2,308,246	1,376,710	6,180,886	3,524,274
Legal and professional fees	822,077	760,130	1,988,261	1,627,769
Interest expense	8,650,149	6,796,736	23,149,030	19,731,327
Other expenses	2,231,341	1,453,367	5,646,402	3,277,850
TOTAL EXPENSES	14,011,813	10,386,943	36,964,579	28,161,220
LOSS BEFORE INCOME TAXES	(5,728,711)	(5,258,291)	(3,284,507)	(12,017,728)
INCOME TAX BENEFIT	(2,097,633)	(1,858,100)	(664,905)	(4,129,670)
NET LOSS	(3,631,078)	(3,400,191)	(2,619,602)	(7,888,058)
(Income) loss attributable to preferred shareholders	343,644	(117,674)	1,041,648	(344,658)
LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ (3,287,434)	$ (3,517,865)	$ (1,577,954)	$ (8,232,716)
NET LOSS PER SHARE
Basic	$ (0.55)	$ (0.76)	$ (0.27)	$ (1.80)
Diluted	$ (0.55)	$ (0.76)	$ (0.27)	$ (1.80)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic	5,937,320	4,633,097	5,894,956	4,579,920
Diluted	5,937,320	4,633,097	5,894,956	4,579,920

XML

Series I Secured Notes

9 Months Ended

Sep. 30, 2015

Credit Facilities / Series I Secured Notes / L Bonds (formerly Renewable Secured Debentures) [Abstract]

Series I Secured notes payable

(6) Series I Secured Notes

Series I Secured Notes are secured by assets of GWG Life and are subordinate to our revolving credit facility (see note 5). On June 14, 2011, the Company closed the offering to additional investors; however, existing investors may elect to continue advancing amounts outstanding upon maturity subject to the Company’s option to repay such notes. Series I Secured Notes have maturity dates ranging from nine months to seven years with fixed interest rates varying from 5.65% to 9.55% depending on the term of the note. Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note. At September 30, 2015 and December 31, 2014, the weighted-average interest rate of Series I Secured Notes was 8.47% and 8.37%, respectively. The notes are secured by the assets of GWG Life. The principal amount outstanding under these Series I Secured Notes was $23,918,000 and $28,047,000 at September 30, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the Series I Secured Notes and the carrying amount on the consolidated balance sheet is due to netting of unamortized deferred issuance costs. Overall, interest expense includes amortization of deferred financing and issuance costs of $49,000 and $260,000 for the three and nine months ended September 30, 2015, respectively, and $126,000 and $427,000 for the three and nine months ended September 30, 2014, respectively. Future expected amortization of deferred financing costs is $351,000 over the next six years.

Future contractual maturities of Series I Secured Notes and future amortization of their deferred financing costs at September 30, 2015 are as follows:

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Three months ending December 31, 2015	$	1,776,000	$	8,000
2016		12,827,000		103,000
2017		6,154,000		129,000
2018		998,000		28,000
2019		347,000		7,000
Thereafter		1,816,000		76,000
	$	23,918,000	$	351,000

XML

Credit Facilities

9 Months Ended

Sep. 30, 2015

Credit Facilities / Series I Secured Notes / L Bonds (formerly Renewable Secured Debentures) [Abstract]

Credit facilities

(5) Credit facilities

Revolving credit facility – Autobahn Funding Company LLC

On July 15, 2008, DLP II and United Lending entered into a revolving credit facility pursuant to a Credit and Security Agreement (Agreement) with Autobahn Funding Company LLC (Autobahn), providing the Company with a maximum borrowing amount of $100,000,000. Autobahn is a commercial paper conduit that issues commercial paper to investors in order to provide funding to DLP II. DZ Bank AG Deutsche Zentral-Genossenschaftsbank (DZ Bank) acts as the agent for Autobahn. The original Agreement was to expire on July 15, 2013. On January 29, 2013, GWG Holdings, together with GWG Life and DLP II, entered into an Amended and Restated Credit and Security Agreement with Autobahn, extending the facility expiration date to December 31, 2014. On May 29, 2014, GWG Holdings, together with GWG Life and DLP II, entered into an Amendment No. 1 to Amended and Restated Credit and Security Agreement with Autobahn and DZ Bank (as committed lender and Agent). The amendment was entered into for the purpose of extending the maturity date for borrowings under the Agreement to December 31, 2016.Effective May 11, 2015, GWG Holdings, together with certain of its subsidiaries, entered into a Second Amended and Restated Credit and Security Agreement with Autobahn and DZ Bank. The Second Amended and Restated Credit and Security Agreement extends the maturity date of borrowings, under the credit facility to June 30, 2018. Advances under the credit facility made after May 11, 2015 will bear interest at the commercial paper rate of the lender at the time of the advance plus an applicable margin, which is less than under the previous Credit and Security Agreement executed on January 25, 2013. In addition to the extended term and decreased interest rate and borrowing cost, the Second Amended and Restated Credit and Security Agreement removes the requirement that the Company maintain a reserve for certain projected expenditures (including anticipated premium payments required to service its life insurance portfolio), thereby allowing for the Company’s full use of the credit facility up to its limit of $105,000,000.

In connection with the Second Amended and Restated Credit and Security Agreement, GWG Holdings and its subsidiaries entered into certain other agreements and amendments and restatements of earlier agreements entered into in connection with the original and renewal Credit and Security Agreements. Included among these other agreements was an Amended and Restated Performance Guaranty affirming the performance guaranty that GWG Holdings earlier provided in connection with the original and first Amended and Restated Credit and Security Agreements to DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as agent.The amount outstanding under this facility was $65,011,000 and $72,161,000 at September 30, 2015 and December 31, 2014, respectively.

The Agreement requires DLP II to pay, on a monthly basis, interest at the commercial paper rate plus an applicable margin, as defined in the Agreement. The effective rate was 5.43% at September 30, 2015 and 6.24% at December 31, 2014. The Agreement also requires payment of an unused line fee on the unfunded amount under the revolving credit facility. The weighted-average effective interest rate (excluding the unused line fee) was 5.42% and 6.23% for the three months ended September 30, 2015 and 2014, respectively, and 5.81% and 6.22% for the nine months ended September 30, 2015 and 2014, respectively. The note is secured by substantially all of DLP II’s and DLP III’s assets, which consist primarily of life insurance policies.

The Agreement has certain financial and nonfinancial covenants. The Company was in compliance with these covenants at September 30, 2015 and December 31, 2014. The Agreement generally prohibits the Company from:

● changing its corporate name, offices, and jurisdiction of incorporation

● changing any deposit accounts or payment instructions to insurers;

● changing any operating policies and practices such that it would be reasonably likely to adversely affect the collectability of any asset in any material respect;

● merging or consolidating with, or selling all or substantially all of its assets to, any third party;

● selling any collateral or creating or permitting to exist any adverse claim upon any collateral;

● engaging in any other business or activity than that contemplated by the Agreement;

● incurring or guaranteeing any debt for borrowed money;

● amending the Company’s certificate of incorporation or bylaws, making any loans or advances to, investments in, or paying any dividends to, any person unless both before and after any such loan, advance, investment or dividend there exists no actual event of default, potential event of default or termination event;

● removing an independent director on the board of directors except for cause or with the consent of the lender; or

● making payment on or issuing any subsidiary secured notes or debentures, or amending any agreements respecting such notes or debentures, if an event of default, potential event of default or termination event exists or would arise from any such action.

In addition, the Company has agreed to maintain (i) a positive consolidated net income on a non-GAAP basis (as defined and calculated under the Agreement) for each complete fiscal year and (ii) a tangible net worth on a non-GAAP basis (again, as defined and calculated under the Agreement) of not less than $45 million, and (iii) maintain cash and eligible investments at $15 million or above.

Consolidated tangible net worth and net income as of and for the four quarters ended September 30, 2015, as calculated on non-GAAP basis under the Agreement, were $105,605,000 and $41,998,000, respectively.

Advances under the Agreement are subject to a borrowing base formula, which limits the availability of advances on the borrowing base calculation based on attributes of policies pledged to the facility. Over-concentration of policies by insurance carrier, over-concentration of policies by insurance carriers with ratings below a AA- rating, and the premiums and facility fees reserve are the three primary factors with the potential of limiting availability of funds on the facility. Total funds available for additional borrowings under the borrowing base formula criteria at September 30, 2015 and December 31, 2014, were $55,648,000 and $20,585,000 respectively.

On July 15, 2008, GWG Holdings delivered a performance guaranty in favor of Autobahn pursuant to which it guaranteed the obligations of GWG Life, in its capacity as the seller and master servicer, under the Credit and Security Agreement and related documents. On January 29, 2014 and in connection with the Amended and Restated Credit and Security Agreement, GWG Holdings delivered a reaffirmation of its performance guaranty. The obligations of GWG Holdings under the performance guaranty and subsequent reaffirmation do not extend to the principal and interest owed by DLP II and DLP III as the borrower under the credit facility.

XML

Concentrations

9 Months Ended

Sep. 30, 2015

Concentrations [Abstract]

Concentrations

(17) Concentrations

GWG purchases life insurance policies written by life insurance companies having investment grade ratings by independent rating agencies. As a result there may be certain concentrations of contracts with life insurance companies. The following summarizes the face value of insurance contracts with specific life insurance companies exceeding 10% of the total face value held by the Company.

	September 30,		December 31,
	2015		2014
Life insurance company	%		%
AXA Equitable		14.27		14.55
John Hancock		12.98		11.48

The following summarizes the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company:

	September 30,		December 31,
	2015		2014
State of residence	%		%
California		27.11		28.87
Florida		18.66		18.56

XML

Net Loss Per Common Share

9 Months Ended

Sep. 30, 2015

Net loss per common share [Abstract]

Net loss per common share

(13) Net loss per common share

The Company began issuing Series A Preferred Stock on September 1, 2011, as described in note 8. The Series A Preferred Stock and vested stock options are anti-dilutive to the net income (loss) per common share calculation for all three and nine-month periods ended September 30, 2015 and 2014. The Company has also issued warrants to purchase common stock in conjunction with the sale of the Series A Preferred Stock. The warrants are anti-dilutive for all described three and nine-month periods of 2015 and 2014 and have not been included in the fully diluted net income (loss) per common share calculation.

XML

Redeemable Preferred Stock

9 Months Ended

Sep. 30, 2015

Common Stock/Redeemable Preferred Stock[Abstract]

Redeemable Preferred Stock

(9) Redeemable Preferred Stock

The Company is offering 100,000 shares of Redeemable Preferred Stock for sale under a Form S-1 registration statement declared effective by the SEC on November 30, 2015. The per share offering price is $1,000 with a par value per share of $.001.

The Redeemable Preferred Stock ranks senior to our common stock, pari passu to our Series A Preferred Stock and senior or pari passu with all other classes and series of our preferred stock with respect to payment of dividends and rights upon liquidation dissolution or winding up. Redeemable Preferred Stock has a dividend yield of 7% per annum.

Subject to the limitations described below, holders of the Redeemable Preferred Stock will have the option to convert the Redeemable Preferred Stock they purchase from us and hold into common stock at a conversion price equal to the volume-weighted average price of our common stock for the 20 trading days immediately prior to the date of conversion, subject to a minimum conversion price of $15.00 (as the same may be adjusted). The right of holders to convert their Redeemable Preferred Stock is limited to 15% of the stated value of Redeemable Preferred Stock originally purchased by such holder from us and still held by such holder. For this purpose, shares of Redeemable Preferred Stock issued to holders in satisfaction of our dividend-payment obligations will not count as shares “originally purchased” from us.

Beginning one year from the date of original issuance of any shares of Redeemable Preferred Stock to be redeemed, a holder will have the opportunity to request once per calendar quarter that we redeem up to 25% of such holder’s Redeemable Preferred Stock originally purchased from us (plus any preferred shares issued in satisfaction of dividends thereon) at a redemption price equal to the stated value of such redeemed shares, plus any accrued but unpaid dividends thereon, less the applicable redemption fee (if any). As a percentage of the aggregate redemption price of a holder’s shares to be redeemed, the redemption fee shall be:

● 8% if the redemption is requested after the first anniversary and before the second anniversary of the original issuance of such shares.

● 5% if the redemption is requested after the second anniversary and before the third anniversary of the original issuance of such shares.

Beginning three years from the date of original issuance of such shares, no redemption fee shall be subtracted from the redemption price. Subject to certain restrictions and conditions, we will also redeem shares of Redeemable Preferred Stock of a holder who is a natural person (including an individual beneficial holder who holds our preferred shares through a custodian or nominee, such as a broker-dealer) upon his or her death, total disability or bankruptcy, within 60 days of our receipt of a written request from the holder or the holder’s estate at a redemption price equal to the Stated Value, plus accrued and unpaid dividends thereon.

After one year from the date of original issuance of shares of Redeemable Preferred Stock, we will have the right (but not the obligation) to call and redeem such shares of Redeemable Preferred Stock at 100% of their stated value, plus any accrued but unpaid dividends thereon.

We will not redeem or repurchase any preferred shares if we are restricted by applicable law or our Certificate of Incorporation, as amended, from making such redemption or to the extent any such redemption would cause or constitute a default under any borrowing agreements to which we or any of our subsidiaries are a party or otherwise bound. In addition, we will have no obligation to redeem preferred shares upon a redemption request made by a holder if we do not have sufficient funds available to fund that redemption. We will have discretion under the Certificate of Designation for the Redeemable Preferred Stock to determine whether to fund a redemption request.

XML

Contingencies (Details)	9 Months Ended
	Sep. 30, 2015 USD ($)
Contingencies (Textual)
Loaned to Opportunity Finance, LLC	$ 1,000,000
Repayments of loan	$ 177,000

XML

L Bonds (Formerly Renewable Secured Debentures)

9 Months Ended

Sep. 30, 2015

Credit Facilities / Series I Secured Notes / L Bonds (formerly Renewable Secured Debentures) [Abstract]

L Bonds (formerly Renewable Secured Debentures)

(7) L Bonds (formerly Renewable Secured Debentures)

In January 2015, we registered a $1.0 billion debt offering of our L Bonds with the SEC. The $1.0 billion L Bond offering is a follow-on to our $250.0 million debt offering of Renewable Secured Debentures (subsequently renamed L Bonds) which was registered with the SEC in January of 2012 and completed in January 2015. The Company is offering L Bonds on a continuous basis and there is no minimum amount that must be sold before the Company can use proceeds from the sale of L Bonds. The L Bonds are secured by the assets of GWG Holdings and GWG Life and are subordinate to our revolving credit facility (see note 5). L Bonds have maturity dates ranging from six months to seven years with fixed interest rates varying from 4.25% to 9.50% depending on the term of the L Bond. Interest is payable monthly, annually or at maturity depending on the terms of the L Bond. The Company plans to use the net proceeds from the offering of the L Bonds primarily to purchase and finance additional life insurance assets, and to service and retire other outstanding debt obligations. Emerson Equity LLC is serving as the managing broker-dealer for the offering, which is being sold through a network of participating dealers and licensed financial advisors and representatives in minimum increments of $25,000. At September 30, 2015 and December 31, 2014, the weighted-average interest rate of L Bonds was 7.21% and 7.45%, respectively. The amount outstanding under these L Bonds was $247,553,000 and $186,377,000 at September 30, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the L Bonds and the carrying amount on the consolidated balance sheets is due to netting of unamortized deferred issuance costs and cash receipts for new issuances in process. Amortization of deferred issuance costs was $1,892,000 and $4,232,000 for the three and nine months ended September 30, 2015, respectively, and $829,000 and $2,584,000 for the three and nine months ended September 30, 2014, respectively. Future expected amortization of deferred financing costs as of September 30, 2015 is $6,795,000 in total over the next seven years. 

The use of proceeds from the issuances of L Bonds is limited to the following: (1) payment of commissions on sales of L Bonds, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) payment of premiums on life insurance policies, (5) payment of principal and interest on L Bonds, (6) payment of portfolio operations expenses, and (7) general working capital.

Future contractual maturities of L Bonds and future amortization of their deferred financing costs at September 30, 2015 are as follows:

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Three months ending December 31, 2015	$	22,691,000	$	47,000
2016		81,569,000		996,000
2017		52,228,000		1,642,000
2018		46,946,000		2,093,000
2019		13,642,000		483,000
Thereafter		30,477,000		1,534,000
	$	247,553,000	$	6,795,000

The Company entered into an Indenture effective October 19, 2011, as amended, with GWG Holdings as obligor, GWG Life as guarantor, and Bank of Utah as trustee for the benefit of the L Bond holders.  The Indenture has certain financial and nonfinancial covenants.  The Company was in compliance with these covenants at September 30, 2015 and December 31, 2014.

XML

Convertible, Redeemable Preferred Stock (Series A Preferred Stock)

9 Months Ended

Sep. 30, 2015

Convertible Redeemable Preferred Stock (Series A Preferred Stock) [Abstract]

Convertible, redeemable preferred stock (Series A Preferred Stock)

(8) Convertible, redeemable preferred stock (Series A Preferred Stock)

The Company offered 3,333,333 shares of convertible redeemable preferred stock (Series A Preferred Stock) for sale to accredited investors in a private placement on July 31, 2011. The offering of Series A Preferred Stock concluded on September 2, 2012 and resulted in 3,278,000 shares being issued for gross consideration of $24,582,000. As of September 30, 2015, 349,000 shares have been issued as a result of the payment of $2,444,000 in dividends in the form of shares of Series A Preferred Stock and 693,000 shares have been converted to 520,000 shares of the Company’s common stock. The Series A Preferred Stock was sold at an offering price of $7.50 per share. Series A Preferred Stock has a preferred yield of 10% per annum, and each share has the right to convert into 0.75 shares of the Company’s common stock. Series A preferred stockholders also received three-year warrants to purchase, at an exercise price per share of $12.50, one share of common stock for every 40 shares of Series A Preferred Stock purchased. The warrants are exercisable immediately. Upon their original issuance, these warrants had a three-year exercise period. Effective August 1, 2014, the Board of Directors authorized the extension of the warrant exercise period for an additional two years.

In the Certificate of Designations for the Series A Preferred Stock dated July 31, 2011, the Company agreed to permit preferred stockholders to sell their shares back to the Company for the stated value of $7.50 per share, plus accrued dividends.

The Company’s obligation to redeem its Series A Preferred Stock terminated upon the Company completing a registration of its common stock with the SEC which occurred on September 24, 2014 (See note 11). As such, the convertible redeemable preferred stock was reclassified from temporary equity to permanent equity. The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time. As of September 30, 2015, the Company had redeemed an aggregate of 182,000 shares of Series A Preferred Stock. The Series A Preferred Stock shares (i) were convertible, at the election of the Company, into common stock of the Company in the event of either a registered offering of the Company’s common stock with the SEC aggregating gross proceeds of at least $5.0 million and at a price equal to or greater than $11.00 per share; (ii) remain convertible at the option of each holder; and (iii) are required to be converted upon the consent of stockholders holding at least a majority of the then-outstanding Series A Preferred Stock. In connection with the Company’s initial public offering, the Company elected to cause the conversion of 678,000 shares of preferred stock into 508,000 shares of common stock. As of September 30, 2015, the Company had 2,757,000 shares of Series A Preferred Stock outstanding with gross consideration of $20,624,000 (including cash proceeds, conversion of Series I Secured Notes and accrued interest on Series I, and conversion of preferred dividends payable). The Company incurred Series A Preferred Stock issuance costs of $2,838,000, which were amortized into additional paid-in-capital over the three-year redemption period. As of December 31, 2014, all of these costs had been fully amortized.

The Company determined that the grant date fair value of the outstanding warrants attached to the Series A Preferred Stock was $428,000 for warrants outstanding as of September 30, 2015. The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted-average sale price per share of common stock equals or exceeds $14.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption.

Total warrants outstanding as of both September 30, 2015 and December 31, 2014, were 431,954 with a weighted-average remaining life of 1.68 and 2.43 years, respectively. As of September 30, 2015, none of these warrants have been exercised.

Dividends on the Series A Preferred Stock may be paid in either cash or additional shares of Series A Preferred Stock at the election of the holder and approval of the Company. The dividends are reported as an expense and included in the caption interest expense in the consolidated statements of operations. The Company declared and accrued dividends of $516,000 and $632,000 during the three months ended September 30, 2015 and 2014, respectively, and $1,548,000 and $1,912,000 during the nine months ended September 30, 2015 and 2014, respectively, pursuant to a board resolution declaring the dividend. 25,000 and 27,000 shares of Series A Preferred Stock were issued in lieu of cash dividends in the three-month periods ended September 30, 2015 and 2014, and 72,000 and 82,000 shares of Series A Preferred Stock were issued in lieu of cash dividends in the nine-month periods ended September 30, 2015 and 2014, respectively. The shares issued in lieu of cash dividends were issued at $7.00 per share.  As of September 30, 2015, GWG Holdings has $516,000 of accrued preferred dividends that were paid or converted to shares of Series A Preferred Stock on October 15, 2015.

XML

Income Taxes

9 Months Ended

Sep. 30, 2015

Income Taxes [Abstract]

Income taxes

(10) Income taxes

The Company has a no current income tax liability as of September 30, 2015 and December 31, 2014. The components of current and deferred income tax expense (benefit) for the three and nine months ended September 30, 2015 and income tax benefit for the three month ended September 30, 2014, consisted of the following:

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2015			2014			2015			2014
Income tax (benefit):
Current:
Federal	$	(141,000	)	$	-		$	-		$	-
State	$	(40,000	)	$	-		$	-		$	-
Total current tax benefit		(181,000	)		-			-			-
Deferred:
Federal	$	(1,488,000	)	$	(1,221,000	)	$	(504,000	)	$	(3,130,000	)
State	$	(429,000	)	$	(637,000	)	$	(161,000	)	$	(1,000,000	)
Total deferred tax benefit		(1,917,000	)		(1,858,000	)		(665,000	)		(4,130,000	)
Total income tax benefit		(2,098,000	)		(1,858,000	)		(665,000	)		(4,130,000	)

The primary differences between the Company’s September 30, 2015 effective tax rate and the statutory federal rate are the accrual of nondeductible preferred stock dividend expense of $516,000, state taxes, and other non-deductible expenses. The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

XML

Guarantees of Secured Debt by GWG Life (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2015	Jan. 31, 2015
Guarantees of L Bonds (Textual)
Debentures offer for sale	$ 271,471,000
Maximum rate of return on equity fund amount	18.00%
Guarantees of L Bonds [Member]
Guarantees of L Bonds (Textual)
Debentures offer for sale	$ 250,000,000	$ 1,000,000,000
Maximum rate of return on equity fund amount	50.00%

XML

Concentrations (Details 1)	Sep. 30, 2015	Dec. 31, 2014
California [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	27.11%	28.87%
Florida [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	18.66%	18.56%
New York [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states

XML

Guarantees of Secured Debt by GWG Life (Details 2) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,631,078)	$ (3,400,191)	$ (2,619,602)	$ (7,888,058)	$ (5,962,909)
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries
Gain on life settlements	$ 14,516,881	$ 8,761,912	$ 26,651,363	$ 30,973,250
Amortization of deferred financing and issuance costs	1,933,776	863,217	1,891,772	2,570,881
Deferred income taxes	(1,916,686)	(1,858,100)	(664,905)	(4,129,670)
Convertible, redeemable preferred stock issued for dividends	173,993	186,182	509,225	$ 575,513
(Increase) in operating assets:
Policy benefits receivable	2,142,986	300,000	1,392,986
Other assets	417,990	1,147,221	774,539	$ 2,096,140
Increase in operating liabilities:
Accounts payable and other accrued expenses	2,534,269	490,496	3,836,715	3,658,659
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(13,697,611)	(13,327,529)	(23,079,711)	(38,282,065)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	13,626,842	680,000	23,850,860	11,559,435
Proceeds from settlement of life settlements	80,000	930,625	3,822,983	999,125
NET CASH FLOWS USED IN INVESTING ACTIVITIES	(13,546,842)	$ 250,625	(20,027,877)	(10,560,310)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility			(7,150,000)
Payments for redemption of Series I Secured Notes	890,586	$ 509,004	4,508,130	2,047,928
Proceeds from issuance of L Bonds	37,122,127	15,281,809	87,620,483	48,516,296
Payments for redemption and issuance of L Bonds	(19,363,047)	(4,494,383)	(32,376,104)	(13,816,794)
Payments from restricted cash	$ 651,630	665,699	(2,975,507)	3,688,236
Proceeds from sale of common stock		9,030,000		9,030,000
Issuance of common stock		$ (9,030,000)	$ (582,000)	$ (9,030,000)
Issuance of member capital
Payments for redemption preferred stock	$ (21,187)	$ (445,183)	$ (295,185)	$ (465,239)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	17,498,937	19,528,938	40,897,557	44,904,571
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(9,745,516)	6,452,034	(2,210,031)	(3,937,804)
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	38,198,189	23,059,955	30,662,704	33,449,793	33,449,793
END OF PERIOD	28,452,673	29,511,989	28,452,673	29,511,989	30,662,704
Parent [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	(3,631,078)	(3,400,191)	(2,619,602)	(7,888,058)
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries	$ (4,791,035)	$ (1,738,069)	$ (24,038,617)	$ (6,742,512)
Gain on life settlements
Amortization of deferred financing and issuance costs	$ 1,103,312	$ 397,659	$ 2,832,487	$ 2,125,269
Deferred income taxes	(1,916,686)	(1,858,100)	(664,905)	(4,129,670)
Convertible, redeemable preferred stock issued for dividends	$ 173,993	$ 186,182	$ 509,225	575,513
(Increase) in operating assets:
Policy benefits receivable
Other assets	$ (22,146,946)	$ (9,136,310)	$ (40,145,769)	(35,758,660)
Increase in operating liabilities:
Accounts payable and other accrued expenses	2,010,129	922,271	4,503,624	2,893,814
NET CASH FLOWS USED IN OPERATING ACTIVITIES	$ (29,198,311)	$ (14,626,558)	$ (30,425,246)	$ (48,924,304)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility
Payments for redemption of Series I Secured Notes
Proceeds from issuance of L Bonds	$ 37,122,127	$ 15,281,809	$ 87,620,483	$ 48,516,296
Payments for redemption and issuance of L Bonds	$ (19,363,047)	$ (4,494,383)	$ (32,376,104)	$ (13,816,794)
Payments from restricted cash
Proceeds from sale of common stock		$ 9,030,000		$ 9,030,000
Issuance of common stock			$ 582,000
Issuance of member capital
Payments for redemption preferred stock	$ (21,187)	$ (445,183)	$ (295,185)	$ (465,239)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	17,737,893	19,372,243	55,531,194	43,264,263
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(11,460,418)	4,745,685	(4,092,363)	(5,666,041)
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	37,814,528	22,305,910	30,446,473	32,711,636	32,711,636
END OF PERIOD	26,354,110	27,051,595	26,354,110	27,051,595	30,446,473
Guarantor Subsidiary [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	4,790,978	1,738,069	24,038,452	6,742,512
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries	$ (6,024,762)	$ (3,530,055)	$ (28,305,978)	$ (10,357,741)
Gain on life settlements
Amortization of deferred financing and issuance costs	$ 49,339	$ 126,083	$ 260,455	$ 427,187
Deferred income taxes
Convertible, redeemable preferred stock issued for dividends
(Increase) in operating assets:
Policy benefits receivable
Other assets	$ (15,631,849)	$ (5,329,716)	$ (26,745,888)	$ (29,984,534)
Increase in operating liabilities:
Accounts payable and other accrued expenses	(105,418)	289,132	123,222	591,534
NET CASH FLOWS USED IN OPERATING ACTIVITIES	$ (16,921,712)	$ (6,706,487)	$ (30,629,737)	$ (32,851,042)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility
Payments for redemption of Series I Secured Notes	$ (890,586)	$ (509,004)	$ (4,508,130)	$ (2,047,928)
Proceeds from issuance of L Bonds
Payments for redemption and issuance of L Bonds
Payments from restricted cash	$ (2,203,800)	$ 565,000	$ (2,306,300)	$ 1,420,000
Proceeds from sale of common stock
Issuance of common stock
Issuance of member capital	$ 21,730,944	$ 8,356,840	$ 39,176,335	$ 34,931,207
Payments for redemption preferred stock
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	$ 18,636,558	$ 8,412,836	$ 32,361,905	$ 34,303,279
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,714,846	1,706,349	1,732,168	1,722,237
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	233,553	754,045	216,231	738,157	738,157
END OF PERIOD	1,948,399	2,460,394	1,948,399	2,460,394	$ 216,231
Non-Guarantor Subsidiaries [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ 6,024,819	$ 3,530,055	$ 28,306,143	$ 10,357,741
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries
Gain on life settlements	$ (14,516,881)	$ (8,761,912)	$ (26,651,363)	$ (30,973,250)
Amortization of deferred financing and issuance costs	$ 781,125	$ 339,475	$ (1,201,170)	$ 18,425
Deferred income taxes
Convertible, redeemable preferred stock issued for dividends
(Increase) in operating assets:
Policy benefits receivable	$ 2,142,986	$ 300,000	$ 1,392,986
Other assets
Increase in operating liabilities:
Accounts payable and other accrued expenses	$ 629,558	$ (720,907)	$ (790,131)	$ 173,311
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(4,938,393)	(5,313,289)	1,056,465	(20,423,773)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(13,626,842)	(680,000)	(23,850,860)	(11,559,435)
Proceeds from settlement of life settlements	80,000	930,625	3,822,983	999,125
NET CASH FLOWS USED IN INVESTING ACTIVITIES	$ (13,546,842)	$ 250,625	(20,027,877)	$ (10,560,310)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility			$ (7,150,000)
Payments for redemption of Series I Secured Notes
Proceeds from issuance of L Bonds
Payments for redemption and issuance of L Bonds
Payments from restricted cash	$ 2,855,430	$ 100,699	$ (669,207)	$ 2,268,236
Proceeds from sale of common stock
Issuance of common stock
Issuance of member capital	$ 15,629,861	$ 4,961,965	$ 26,940,783	$ 28,715,847
Payments for redemption preferred stock
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	$ 18,485,291	$ 5,062,664	$ 19,121,576	$ 30,984,083
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	56		$ 150,164
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	150,108
END OF PERIOD	150,164		$ 150,164
Eliminations [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	(10,815,797)	$ (5,268,124)	(52,344,595)	$ (17,100,253)
Adjustments to reconcile net income to net cash flows from operating activities:
(Equity) of subsidiaries	$ 10,815,797	$ 5,268,124	$ (52,344,595)	$ 17,100,253
Gain on life settlements
Amortization of deferred financing and issuance costs
Deferred income taxes
Convertible, redeemable preferred stock issued for dividends
(Increase) in operating assets:
Policy benefits receivable
Other assets	$ 37,360,805	$ 13,318,805	$ 66,117,118	$ 63,647,054
Increase in operating liabilities:
Accounts payable and other accrued expenses
NET CASH FLOWS USED IN OPERATING ACTIVITIES	$ 37,360,805	$ 13,318,805	$ 66,117,118	$ 63,647,054
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility
Payments for redemption of Series I Secured Notes
Proceeds from issuance of L Bonds
Payments for redemption and issuance of L Bonds
Payments from restricted cash
Proceeds from sale of common stock
Issuance of common stock
Issuance of member capital	$ (37,360,805)	$ (13,318,805)	$ (66,117,118)	$ (63,647,054)
Payments for redemption preferred stock
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	$ (37,360,805)	$ (13,318,805)	$ (66,117,118)	$ (63,647,054)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD
END OF PERIOD

XML

Concentrations (Tables)

9 Months Ended

Sep. 30, 2015

Concentrations [Abstract]

Summary of the face value of insurance contracts

	September 30,		December 31,
	2015		2014
Life insurance company	%		%
AXA Equitable		14.27		14.55
John Hancock		12.98		11.48

Summary of the number of insurance contracts

	September 30,		December 31,
	2015		2014
State of residence	%		%
California		27.11		28.87
Florida		18.66		18.56

XML

Convertible, Redeemable Preferred Stock (Series A Preferred Stock) (Details) - USD ($)		1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 02, 2012	Jul. 31, 2011	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Convertible Preferred Stock (Textual)
Exercise price of warrants					$ 12.50
Exercise period					3 years
Maturity period of warrant					3 years
Conversion of Series A preferred stock into common stock, description					One share of common stock for every 40 shares of Series A Preferred Stock purchased.
Preferred stock redemption terms					The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time.
Preferred stock, liquidation preference per share			$ 7.50		$ 7.50
Redemption price of preferred shares			$ 7.50		$ 7.50
Series A preferred stock outstanding			2,757,000		2,757,000
Gross consideration from convertible preferred stock					$ 20,624,000
Series A preferred stock issuance costs							$ 2,838,000
Warrant outstanding			$ 431,954		$ 431,954		$ 431,954
Weighted average remaining life of warrants outstanding					1 year 8 months 5 days		2 years 5 months 5 days
Accrued preferred dividend			516,000		$ 516,000
Redeemed shares of Series A preferred stock					182,000
Minimum gross proceeds from common stock offering					$ 5,000,000
Maximum offering price of common stock					$ 11.00
Fair value of outstanding warrants attached to Series A preferred stock					$ 428,000
Term of redemption of warrants prior to expiration					The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted-average sale price per share of common stock equals or exceeds $14.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption.
Declared and accrued dividends			$ 516,000	$ 632,000	$ 1,548,000	$ 1,912,000
Preferred stock issued in lieu of cash dividend			25,000	27,000	72,000	82,000
Cash dividend rate, per share					$ 7
Initial public offering [Member]
Convertible Preferred Stock (Textual)
Convertible preferred stock, shares issued upon conversion			678,000		678,000
Conversion of stock, shares converted into common stock					508,000
Series A 10 % convertible Preferred Stock [Member]
Convertible Preferred Stock (Textual)
Company offering shares of convertible redeemable preferred stock		3,333,333
Series A preferred stock shares sold for cash	3,278,000
Consideration received on sale of Series A preferred stock	$ 24,582,000
Series A preferred stock shares issued in conversion of dividends					349,000
Series A preferred stock value issued in conversion of dividends					$ 2,444,000
Offering price of series A preferred stock			$ 7.50		$ 7.50
Series A preferred stock, Dividend rate					10.00%
Conversion term for series A preferred stock					Each share has the right to convert into 0.75 shares of the Company's common stock.
Convertible preferred stock, shares issued upon conversion			693,000		693,000
Conversion of stock, shares converted into common stock					520,000

XML

Contingencies

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies [Abstract]

Contingencies

(15) Contingencies

Litigation - The Company is not currently subject to any current or ongoing litigation.

Opportunity Finance, LLC, owned by Jon Sabes and Steven Sabes, is subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments that may be deemed preference payments. Jon Sabes and Steve Sabes have pledged their stock ownership in GWG to holders of Series I Secured Notes and L Bonds. In addition, the Company loaned $1,000,000 to Opportunity Finance, LLC, and was repaid in full plus interest of $177,000. This investment amount may also be subject to clawback claims by the bankruptcy court.

XML

Investment in Life Insurance Policies (Tables)

9 Months Ended

Sep. 30, 2015

Investment in Life Insurance Policies [Abstract]

Summary of life insurance policies, under the fair value method and estimated maturity dates, based on remaining life expectancy

	As of September 30, 2015						As of December 31, 2014
Years Ending December 31,	Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2015		-	$	-	$	-		3	$	5,063,000	$	6,000,000
2016		5		7,399,000		8,500,000		7		8,144,000		11,550,000
2017		14		14,484,000		19,557,000		17		21,916,000		35,542,000
2018		26		39,188,000		63,114,000		30		41,994,000		76,206,000
2019		50		55,126,000		109,625,000		45		47,303,000		106,973,000
2020		47		52,173,000		111,187,000		41		43,429,000		102,614,000
2021		51		47,957,000		129,006,000		36		29,789,000		90,921,000
Thereafter		150		113,235,000		437,893,000		112		85,245,000		349,293,000
Totals		343		329,562,000		878,882,000		291	$	282,883,000	$	779,099,000

Reconciliation of gain on life settlements

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Change in fair value	$	14,517,000		$	8,762,000		$	26,651,000		$	30,973,000
Premiums and other annual fees		(6,605,000	)		(5,713,000	)		(19,114,000	)		(17,155,000	)
Policy maturities		277,000			2,069,000			25,909,000			2,301,000
Gain on life settlements, net	$	8,189,000		$	5,118,000		$	33,446,000		$	16,119,000

Estimated expected premium payments to maintain the above life insurance policies assuming no mortalities

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Three months ending December 31, 2015	$	7,315,000	$	412,000	$	7,727,000
2016		30,433,000		412,000		30,845,000
2017		33,390,000		412,000		33,802,000
2018		36,241,000		412,000		36,653,000
2019		40,520,000		412,000		40,932,000
2020		45,023,000		412,000		45,435,000
	$	192,922,000	$	2,472,000	$	195,394,000

XML

L Bonds (Formerly Renewable Secured Debentures)) (Details) - Renewable Secured Debentures [Member]	Sep. 30, 2015 USD ($)
Summary of future contractual maturities of L Bonds
2015	$ 22,691,000
2016	81,569,000
2017	52,228,000
2018	46,946,000
2019	13,642,000
Thereafter	30,477,000
Total	247,553,000
Summary of amortization of deferred financing costs of L Bonds
2015	47,000
2016	996,000
2017	1,642,000
2018	2,093,000
2019	483,000
Thereafter	1,534,000
Total	$ 6,795,000

XML

Fair Value Definition and Hierarchy (Details) - Life insurance policies [Member] - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Summary of reconciliation of investments in life insurance policies
Beginning balance	$ 301,499,000	$ 267,896,000	$ 282,883,000	$ 234,673,000
Purchases	13,626,000	655,000	23,851,000	11,735,000
Maturities (cash in excess of carrying value)	(80,000)	(931,000)	(3,823,000)	(999,000)
Net change in fair value	14,517,000	8,762,000	26,651,000	30,973,000
Ending balance (Sep 30)	$ 329,562,000	$ 276,382,000	$ 329,562,000	$ 276,382,000

XML

Condensed Consolidated Statement of Cash Flows - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,631,078)	$ (3,400,191)	$ (2,619,602)	$ (7,888,058)
Adjustments to reconcile net loss to net cash flows from operating activities:
Gain on life settlements	(14,516,881)	(8,761,912)	(26,651,363)	(30,973,250)
Amortization of deferred financing and issuance costs	1,933,776	863,217	1,891,772	2,570,881
Deferred income taxes	(1,916,686)	(1,858,100)	(664,905)	(4,129,670)
Convertible, redeemable preferred stock dividends payable	173,993	186,182	509,225	$ 575,513
(Increase) decrease in operating assets:
Policy benefits receivable	2,142,986	300,000	1,392,986
Other assets	(417,990)	(1,147,221)	(774,539)	$ (2,096,140)
Increase in operating liabilities:
Accounts payable and accrued expenses	2,534,269	490,496	3,836,715	3,658,659
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(13,697,611)	(13,327,529)	(23,079,711)	(38,282,065)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(13,626,842)	(680,000)	(23,850,860)	(11,559,435)
Proceeds from settlement of life settlements	80,000	930,625	3,822,983	999,125
NET CASH FLOWS USED IN INVESTING ACTIVITIES	(13,546,842)	$ 250,625	(20,027,877)	(10,560,310)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of revolving credit facility			(7,150,000)
Payments for redemption of Series I Secured Notes	(890,586)	$ (509,004)	(4,508,130)	(2,047,928)
Proceeds from issuance of L Bonds	37,122,127	15,281,809	87,620,483	48,516,296
Payments for redemption and issuance of L Bonds	(19,363,047)	(4,494,383)	(32,376,104)	(13,816,794)
Proceeds (payments) from restricted cash	$ 651,630	665,699	(2,975,507)	3,688,236
Issuance of common stock		9,030,000	582,000	9,030,000
Payments for redemption of preferred stock	$ (21,187)	(445,183)	(295,185)	(465,239)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	17,498,937	19,528,938	40,897,557	44,904,571
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(9,745,516)	6,452,034	(2,210,031)	(3,937,804)
CASH AND CASH EQUIVALENTS
BEGINNING OF PERIOD	38,198,189	23,059,955	30,662,704	33,449,793
END OF PERIOD	28,452,673	29,511,989	28,452,673	29,511,989
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	5,385,000	5,095,000	18,529,000	12,877,000
Premiums paid	6,603,000	5,692,000	19,069,000	17,059,000
Stock-based compensation	176,000	44,000	208,000	116,000
Series I Secured Notes:
Conversion of accrued interest and commissions payable to principal	61,000	47,000	188,000	152,000
L Bonds:
Conversion of accrued interest and commission payable to principal	491,000	133,000	929,000	415,000
Convertible, redeemable preferred stock
Conversion to common stock	87,000	4,957,000	116,000	4,957,000
Conversion of dividends payable	$ 172,000	192,000	$ 507,000	573,000
Accretion of convertible, redeemable preferred stock to redemption value		$ 118,000		$ 345,000
Investment in life settlements included in accounts payable	$ 559,000		$ 559,000

XML

Fair Value Definition and Hierarchy

9 Months Ended

Sep. 30, 2015

Fair Value Definition and Hierarchy [Abstract]

Fair value definition and hierarchy

(4) Fair value definition and hierarchy

ASC 820 establishes a hierarchal disclosure framework that prioritizes and ranks the level of market price observability used in measuring assets and liabilities at fair value. Market price observability is affected by a number of factors, including the type of investment, the characteristics specific to the investment and the state of the marketplace including the existence and transparency of transactions between market participants. Assets and liabilities with readily available active quoted prices or for which fair value can be measured from actively quoted prices in an orderly market generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. ASC 820 establishes a three-level valuation hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The hierarchy is broken down into three levels based on the observability of inputs as follows:

● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

● Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary by types of assets and liabilities and is affected by a wide variety of factors, including, for example, whether an instrument is established in the marketplace, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for assets and liabilities categorized in Level 3.

Level 3 Valuation Process

The estimated fair value of the Company’s life settlements are determined on a quarterly basis by the Company’s portfolio management committee, taking into consideration estimated premium payments, life expectancy assumptions, any changes in economic and other relevant conditions, and discount rate assumptions. The discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed in the secondary market, market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies. These inputs are then used to estimate the discounted cash flows using the MAPS probabilistic portfolio pricing model, which estimates the cash flows using various different probabilities and scenarios.  The valuation process includes a review by senior management as of each valuation date.  Management also engages a third party expert to independently test the accuracy of the valuations using the inputs provided by management.

Life insurance policies represent financial instruments recorded at fair value on a recurring basis. The following table reconciles the beginning and ending fair value of the Company’s Level 3 investments in life insurance policies for the three and nine-month periods ending September 30:

	Three month ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Beginning balance	$	301,499,000		$	267,896,000		$	282,883,000		$	234,673,000
Purchases		13,626,000			655,000			23,851,000			11,735,000
Maturities (cash in excess of carrying value)		(80,000	)		(931,000	)		(3,823,000	)		(999,000	)
Net change in fair value		14,517,000			8,762,000			26,651,000			30,973,000
Ending balance (September 30)	$	329,562,000		$	276,382,000		$	329,562,000		$	276,382,000

The fair value of a portfolio of life insurance policies is based on information available to the Company at the reporting date. Fair value is based upon a discounted cash flow model that incorporates life expectancy estimate assumptions. Life expectancy estimates are obtained from independent, third-party, widely accepted life expectancy estimate providers at policy acquisition. These life expectancy values are rolled down monthly through the passage of time by the MAPS actuarial software the Company uses for ongoing valuation of its portfolio of life insurance policies.

On September 15, 2014, 21st Services announced changes to its mortality tables primarily for insureds age 90 and older, as well as updated adjustment factors designed to better underwrite seniors with multiple impairments. These changes represent small portions of 21st Services’ historical underwritings. We expect medical-actuarial underwriting firms to continue improving and refining their underwriting methodology.

The fair value of life insurance policies is estimated using present value calculations of estimated cash flows based on the data specific to each individual life insurance policy. Estimated future policy premium payments are calculated based on the terms of the policy and the premium payment history. The following summarizes the unobservable inputs utilized in estimating the fair value of the portfolio of life insurance policies:

	As of September 30, 2015			As of December 31, 2014
Weighted average age of insured, years		82.6			82.8
Weighted average life expectancy, months		79.2			78.4
Average face amount per policy	$	2,562,000		$	2,677,000
Discount rate		11.07	%		11.43	%

These assumptions are, by their nature, inherently uncertain and the effect of changes in estimates may be significant. The techniques used in estimating the present value of estimated cash flows are derived from valuation techniques generally used in the industry that include inputs for the asset that are not based on observable market data. The extent to which the fair value could reasonably vary in the near term has been quantified by evaluating the effect of changes in significant underlying assumptions used to estimate the fair value. If the life expectancy estimates were increased or decreased by four and eight months on each outstanding policy and the discount rates were increased or decreased by 1% and 2%, while all other variables are held constant, the fair value of the investment in life insurance policies would increase or (decrease) by the amounts summarized below:

	Change in life expectancy estimates
	minus 8 months		minus 4 months		plus 4 months			plus 8 months
September 30, 2015	$	44,959,000	$	22,384,000	$	(21,842,000	)	$	(43,190,000	)
December 31, 2014	$	40,634,000	$	20,130,000	$	(19,664,000	)	$	(38,864,000	)

	Change in discount rate
	minus 2%		minus 1%		plus 1%			plus 2%
September 30, 2015	$	32,445,000	$	15,551,000	$	(14,348,000	)	$	(27,614,000	)
December 31, 2014	$	28,179,000	$	13,522,000	$	(12,502,000	)	$	(24,085,000	)

Other Fair Value Considerations

Carrying value of receivables, prepaid expenses, accounts payable and accrued expenses approximate fair value due to their short-term maturities and low credit risk. The estimated fair value of the Company’s Series I Secured Notes and L Bonds is approximately $273,507,000 based on a weighted-average market interest rate of 7.06% based on an income approach. The combined face value of these debt instruments is $271,471,000 as of September 30, 2015. The carrying value of the revolving credit facility reflects interest charged at the commercial paper rate plus an applicable margin. The margin represents our credit risk, and the strength of the portfolio of life insurance policies collateralizing the debt. The overall rate reflects market, and the carrying value of the revolving credit facility approximates fair value. All of the financial instruments are Level 3 fair value measurements.

The Company has issued warrants to purchase common stock in connection with the issuance of its convertible, redeemable preferred stock. Warrants were determined by the Company to be permanent equity. The fair value measurements associated with the warrants, measured at issuance represent level 3 instruments.

As of September 30, 2015:

Month issued	Warrants issued		Fair value per share		Risk free rate			Volatility			Term
December 2011		68,937	$	0.22		0.42	%		25.25	%	5 years
March 2012		38,130	$	0.52		0.38	%		36.20	%	5 years
June 2012		161,840	$	1.16		0.41	%		47.36	%	5 years
July 2012		144,547	$	1.16		0.41	%		47.36	%	5 years
September 2012		2,500	$	0.72		0.31	%		40.49	%	5 years
September 2014		16,000	$	1.26		1.85	%		17.03	%	5 years
		431,954

Volatility is based upon the weekly percentage change in the stock price of selected comparable insurance companies. The percentage change is calculated on the average price of those selected stocks at the weekly close of business for the year preceding the balance sheet date. We compare annual volatility based on this weekly information.

XML

Commitments (Details)	Sep. 30, 2015 USD ($)
Summary of Minimum lease payments under the lease agreement
Three months ending December 31, 2015	$ 43,000
2016	173,000
2017	178,000
2018	185,000
2019	191,000
2020	198,000
2021	204,000
2022	210,000
2023	217,000
2024	223,000
2025	230,000
2026	38,000
Total	$ 2,090,000

XML

Fair Value Definition and Hierarchy (Tables)

9 Months Ended

Sep. 30, 2015

Fair Value Definition and Hierarchy [Abstract]

Reconciliation of investments in life insurance policies

	Three month ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Beginning balance	$	301,499,000		$	267,896,000		$	282,883,000		$	234,673,000
Purchases		13,626,000			655,000			23,851,000			11,735,000
Maturities (cash in excess of carrying value)		(80,000	)		(931,000	)		(3,823,000	)		(999,000	)
Net change in fair value		14,517,000			8,762,000			26,651,000			30,973,000
Ending balance (September 30)	$	329,562,000		$	276,382,000		$	329,562,000		$	276,382,000

Summary of inputs utilized in estimating the fair value

	As of September 30, 2015			As of December 31, 2014
Weighted average age of insured, years		82.6			82.8
Weighted average life expectancy, months*		79.2			78.4
Average face amount per policy	$	2,562,000		$	2,677,000
Discount rate		11.07	%		11.43	%

Fair value sensitivity analysis on the investment in life insurance policies

	Change in life expectancy estimates
	minus 8 months		minus 4 months		plus 4 months			plus 8 months
September 30, 2015	$	44,959,000	$	22,384,000	$	(21,842,000	)	$	(43,190,000	)
December 31, 2014	$	40,634,000	$	20,130,000	$	(19,664,000	)	$	(38,864,000	)

	Change in discount rate
	minus 2%		minus 1%		plus 1%			plus 2%
September 30, 2015	$	32,445,000	$	15,551,000	$	(14,348,000	)	$	(27,614,000	)
December 31, 2014	$	28,179,000	$	13,522,000	$	(12,502,000	)	$	(24,085,000	)

Warrants Level 3 instruments and measured at fair value upon issuance

Month issued	Warrants issued		Fair value per share		Risk free rate			Volatility			Term
December 2011		68,937	$	0.22		0.42	%		25.25	%	5 years
March 2012		38,130	$	0.52		0.38	%		36.20	%	5 years
June 2012		161,840	$	1.16		0.41	%		47.36	%	5 years
July 2012		144,547	$	1.16		0.41	%		47.36	%	5 years
September 2012		2,500	$	0.72		0.31	%		40.49	%	5 years
September 2014		16,000	$	1.26		1.85	%		17.03	%	5 years
		431,954

XML

Investment in Life Insurance Policies (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Summary of reconciliation of gain on life settlements
Change in fair value	$ 14,517,000	$ 8,762,000	$ 26,651,000	$ 30,973,000
Premiums and other annual fees	(6,605,000)	(5,713,000)	(19,114,000)	(17,155,000)
Policy maturities	277,000	2,069,000	25,909,000	2,301,000
Gain on life settlements, net	$ 8,189,000	$ 5,118,000	$ 33,446,000	$ 16,119,000

XML

Commitments

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies [Abstract]

Commitments

(14) Commitments

GWG Holdings entered into an office lease with U.S. Bank National Association as the landlord. The original lease was for 11,695 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The original lease agreement was effective April 22, 2012, amended on December 14, 2014, and expired on August 31, 2015. Effective September 14, 2015, GWG Holdings entered into a Second Amendment to the lease with U.S. Bank National Association (Second Amendment to Lease). The Second Amendment to Lease increases the office space area to 12,813 square feet and extends the lease expiration date by approximately ten years.

The Company is obligated to pay base rent plus common area maintenance and a share of the building operating costs. Rent expenses under this agreement were $193,000 and $157,000 during the nine-month periods ended September 30, 2015 and 2014, respectively, and $71,000 and $56,000 during the three-month periods ended September 30, 2015 and 2014, respectively.

Minimum lease payments under the Second Amendment to Lease are as follows:

Three months ending December 31, 2015	$	43,000
2016		173,000
2017		178,000
2018		185,000
2019		191,000
2020		198,000
2021		204,000
2022		210,000
2023		217,000
2024		223,000
2025		230,000
2026		38,000
	$	2,090,000